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Thesis Abstract 
 
Herein we present a synthetic route to the homoallylic alcohols 4, using the well-established 
asymmetric organocatalysed allylation of aldehydes. Alcohols 4 were transformed in one step into the 
substituted tetrahydrofurans 7 in the presence of achiral Lewis acids, forming three chiral centres from two 
(Scheme 1).1 
 
Scheme 1: Synthesis of the substituted tetrahydrofurans. 
 
 
A synthetic route towards analogous homoallylic alcohols 5 and 6 and substituted tetrahydropyrans 8 
or diols 9 respectively, has also been developed (Scheme 2).  
                     
Scheme 2: Synthesis of substituted tetrahydropyrans and 1,5-diols. 
 
During the synthesis of the organocatalyst 13 an unexpected side reaction was observed. Since the 
transformation of 10 into 11 is a well established route in the synthesis of many compounds of pharmaceutical 
importance, yet the literature has been reporting notoriously low yields without further attempts at 
optimalization, we studied this reaction in detail to shed light on the formation of the unexpected byproduct 12 
(Scheme 3). 
 
 
 
 
 
 
 
 
Scheme 3: Synthesis of the novel organocatalyst 13.  
 
 In the last part of the project, we synthesized amino acid-based sulfonamide catalysts, and applied them 
in the total synthesis of the natural product Speranskatine A. We also investigated the mechanism of the cross-
aldol reaction of ketones catalyzed by leucinol; the experimental results were backed-up by the quantum 
calculations. 
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Orbitals are for mathematicians, organic chemistry is for those who like to cook. 
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Abbreviations and Acronyms   
  
Ac  Acetyl   
AcOH  Acetic acid   
aq.  Aqueous 
BSA  Benzenesulfonic acid 
Bn  Benzyl   
Bu  Butyl  
oC  Degrees centigrade 
cat, cat* Catalyst, chiral catalyst 
CSA  Camphorsulfonic acid 
Cp  Cyclopentyl  
Cy  Cyclohexyl  
DCM  Dichloromethane 
DHP  3,4-Dihydro-2H-pyran 
DIBAL Diisobutylaluminium hydride 
DIPEA Hünig’s base, N,N-diisopropylethylamine 
DMAP  4-Dimethylaminopyridine 
DMDO Dimethyldioxirane 
DME  1,2-Dimethoxyethane 
DMF  Dimethylformamide   
DMP  Dess–Martin periodinane 
DMPU  3-Dimethyl-3,4,5,6-tetrahydro-2(1H)-pyrimidinone 
DMS  Dimethylsulfide 
DMSO  Dimethylsulfoxide   
DNBSA 2,4-Dinitrobenzenesulfonic acid 
dr  Diastereoisomeric ratio 
EDCI  1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide 
ee    Enantiomeric excess   
Et  Ethyl  
eq.   Equivalents 
EWG  Electron withdrawing group 
HMPA  Hexamethylphosphoramide   
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HOBt  Hydroxybenzotriazole 
HWE  Horner–Wadsworth–Emmons 
i-, iso-  Isomeric (branched alkyl chain)  
IBX  2-Iodoxybenzoic acid 
L, L*  Ligand, chiral ligand  
LA, LA* Lewis acid, chiral Lewis acid  
LAH  Lithium aluminium hydride 
LB, LB* Lewis base, chiral Lewis base  
LDA  Lithium diisopropylamide 
M  Metal   
mCPBA m-chloroperoxybenzoic acid 
Me  Methyl  
MeCN  Acetonitrile  
mmol  Millimole 
n-  Normal (linear alkyl chain)   
NBS  N-bromosuccinimide 
NCS  N-chlorosuccinimide 
Nu  Nucleophile   
[ox]  Oxidising agent, oxidation, oxidative conditions   
PicAm  2-benzyl-3-phenyl-1-(pyridin-2-yl)propan-1-amine 
Ph  Phenyl 
PPTS  Pyridinium p-toluenesulfonate 
Pr  Propyl  
PTSA   p-toluenesulfonic acid 
Py             Pyridine 
[red]  Reducing agent, reduction, reductive conditions 
RT  Room temperature 
s-, sec-  Secondary (branched alkyl chain)   
sat.             Saturated 
tart  Tartarate 
TBAF  Tetrabutylammmonium fluoride  
TBCO  2,4,4,6-Tetrabromocyclohexa-2,5-dienone  
t-, tert-  Tertiary (branched alkyl chain)  
TBDMS tert-butyldimethylsilyl   
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TFA  Trifluoroacetic acid   
TfOH  Trifluoromethanesulfonic acid   
TMS  Trimethylsilyl    
p-Tol  p-tolyl,  p-methylphenyl 
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1 Organocatalysis 
 
Organocatalysis by definition is a metal-free form of catalysis which uses small 
organic molecules rather then metals and metal complexes. Organocatalysis is in many ways 
similar to the enzyme catalysis, i.e., the kinetics of the organocatalysed reaction often follow 
the Michaelis-Menten equation, describing the reversible formation of a catalyst (enzyme)-
substrate complex. If the catalyst-substrate complex is reactive enough, no achiral 
background reaction is taking place and if the catalyst dissociates from the substrate with a 
sufficient rate, only a catalytic amount of the activator is required. 
Transition metal complexes transfer the chirality from their chiral ligands through an 
organised transition state resulting from the strong interaction between the central metal atom 
of the catalyst and the reactants. Organocatalysts, like enzymes typically rely on weaker 
interactions, usually hydrogen bonding and π-π stacking. 
Although organocatalysis is often not as enantioselective as the enzyme reactions, 
organocatalysts are usually not strictly substrate specific and thus more versatile. Some 
organocatalysts are quite ‘picky’; others, such as cinchona alkaloids, amino acids, amino acid 
derivatives or oligopeptides, have a very broad spectrum of applications.  
Furthermore, organocatalysts are usually more robust and insensitive to oxygen and 
air moisture and do not involve the toxicity and pollution issues or high price of the metal. 
They lack problems involving leaching of the toxic metals into the products, which is 
especially important in pharmaceutical industry.  
Although organocatalysed reactions have been known for more than a century, the 
term ‘organocatalysis’ was introduced by MacMillan in 2001 describing enantioselective 
synthesis using ‘organic catalysts’.2  However, the first records of organocatalysts go back as 
far as to the 1908 when Bredig and Rosenthaler described the hydrocyanation of 
benzaldehyde using quinine or quinidine respectively.3 In 1974 Hajos published a remarkably 
simple intramolecular aldol reaction catalysed by proline (3 mol %), yielding the Hajos–
Parrish ketone with 93% ee.4 The proline catalyst had then been forgotten for almost 30 
years, as the attempts to establish the highly enantioselective intermolecular version of this 
reaction failed.  
Enantioselective organocatalysis was revived by the Barbas, MacMillan, List, 
Denmark, and Kobayashi groups as well as our own group and others, and now represents a 
robust and powerful tool in organic synthesis.  
11 
 
2 Asymmetric Allylations 
 
2.1 Chiral auxiliaries vs. organocatalysts 
 
For a long time the classic approach to asymmetric allylations was based on the use of 
optically active Lewis acid complexes, such as tin(II) triflate complexes with various chiral 
diamines.5 Another type of Lewis acid, boranes, were first introduced in the 1970s by 
Mikhailov who used triallyl boranes 14 to make the homoallylic alcohols 16. 
 
Scheme 4: Allylation with triallyl boranes. 
 
In the eighties, Herold & Hoffmann and Brown & Jadhav used asymmetric boranes 
such as 17 with the camphor or α-pinene moiety respectively, to make homoallylic alcohols 
18 (Scheme 5).6 
 
 
Scheme 5: Camphor chiral borane auxiliary. 
 
 
Roush and Corey employed the diisopropyl tartarate and 1,2-diamino-1,2-diphenylethane 
respectively to obtain homoallylic alcohols 18 with moderate to excellent enantioselectivities 
(Scheme 6).7  
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Scheme 6: Roush's and Corey's chiral auxiliaries. 
  
 
In contrast to these chiral auxiliaries, Reetz introduced a sulfonamide derivative of 
camphor 21, which he used in a catalytic amount to furnish the homoallylic alcohols with up 
to 96% ee.8 In 1991, Yamamoto reported on allylation of various aldehydes with substituted 
allylsilanes catalysed by chiral borane 22 with enantioselectivities up to 66 % ee.9  
 
 
Scheme 7: Reetz's and Yamamoto's catalysts. 
 
Metals, such as Ti or Sc (which bind to the carbonyl oxygen, thus increasing the 
electrophilicity of the carbonyl carbon), complexed with a chiral ligand have also been 
commonly used by Costa or Evans group and by others.10 
Rather than increasing the reactivity of the carbonyl group with a Lewis acid, 
coordination of a Lewis base to the nucleophile does further increase its nucleophilicity, 
promoting the addition reaction. Assuming that only the activated nucleophile-Lewis base 
complex will react, the activator (Lewis base) can be used just in a catalytic amount, provided 
it is released readily after the reaction and returned into the catalytic circle.11  
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A Lewis acid - Lewis base complex, as the product of the neutralisation reaction is in 
general expected to have increased thermodynamic stability and thus decreased reactivity. 
The complexation of a Lewis base to the electrophile will decrease the overall electron 
density at the electrophile (Lewis acid) centre, but reactivity-wise, it is more important to 
consider how the electrons are distributed over the molecule. Obviously, in general, it is 
desirable to enhance the electrophilicity of the Lewis acidic centre, rather than make the 
reactants to quench each other’s reactivity.  
Although the main electron transfer in this ‘neutralisation’ reaction is from the donor 
(Lewis base) to the acceptor (Lewis acid), in complex species the electrons are redistributed 
over the peripheral ligands of the acceptor, which results in the overall decrease of the 
electron density of the central atom of the electrophile (Scheme 8). 
XnD AYn DXn AYn
δ+δ−
DXn AYn-1
+
Y−DXn AYn
δ+ δ−
Lewis
base
Lewis
acid
decreased
electrophilicity
of the Lewis acid
increased
electrophilicity
of the Lewis acid
 
Scheme 8: Lewis base - Lewis acid reaction. 
 
The important consequence of this fact is the activation of the electrophile, as its 
central atom becomes more Lewis acidic and electrophilic (and its ligands of course more 
nucleophilic). The peripheral bonds compensate for the changes of the electron density and 
also, the higher the coordination number, the longer the peripheral bonds are and the more 
electrophilic the central atom becomes.  
The bond lengths for SiF4, SiF5- and SiF62- for example are 1.56, 1.66(ax)/1.62(eq) 
and 1.69 Å, respectively, i.e., the bonds become longer and the silicon atom becomes more 
electrophilic/Lewis acidic with the increasing number of ligands.12 This facilitates the 
activation of the electrophile by coordinating the non-bonding lone pair of a functional group 
of the electrophile (aldehyde, ketone, imine, etc.). 
Silicon usually forms bonds with only four other atoms, completing the electronic 
requirement for an outer-shell octet. Thus the central silicon atom displays sp3 hybridization 
and the molecule assumes a tetrahedral geometry. The ability of silicon to expand its 
coordination shell (similarly to phosphorus and antimony) has been intensively studied only 
during the last decades.13 Silicon’s ability to coordinate beyond the octet rule was originally 
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explained by involving the 3d orbitals in the hybridization, as in the case of transition metals. 
It was later concluded however, that the d orbitals are too diffuse to participate in the 
hybridization and currently, the theory of the three centred four electrons bond (3c-4e) is 
widely accepted. The tetravalent silicon is sp3 hybridized, the pentavalent silicon is formally 
sp2 hybridized (trigonal bipyramid with the axial bonds slightly longer due to the Jahn-Teller 
effect), and the hexavalent silicon is formally sp hybridized (tetragonal bipyramid).  
 
Figure 1. Tetra-, penta- and hexavalent silicon species.  
 
The hypervalent bonds (the penta and hexavalent species) are electron rich at the 
ligands and electron deficient at the central silicon atom – hence the overall increased 
electrophilicity and affinity towards the carbonyl oxygen. The synthetic consequences are as 
follows: The tetracoordinated silicon (for example the allyl trichlorosilane 23) is a weak 
Lewis acid and not reactive enough for the nucleophilic transfer of the allyl moiety (Scheme 
9). The pentavalent species 24 is formed with either negatively charged (Cl-, F-) or neutral 
(HMPA, DMF, DMPU, DMSO) Lewis base coordinated to the central atom. The carbon-
silicon bond becomes longer and weaker and the allyl moiety is more prone to be transferred 
to the corresponding carbonyl or similar group. Coordination of another ligand generates the 
hexacoordinated species 25 and further increases the carbon bond length and thereby the 
reactivity towards the acceptor. Depending on how nucleophilic the Lewis base is, the 
ligand(s) around the central silicon atom (i.e., chloride in the case of trichlorosilanes) may or 
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may not dissociate from the hypervalent species 24 or 25 to form ‘hyperreactive’ ionic pairs 
26 or 27 (Scheme 9).  
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Scheme 9: Activation of allyltrichlorosilane with the Lewis base. 
 
To further confirm that the hypervalent silicates are the key intermediates and active 
species in the allylation reaction, Kobayashi conducted a series of 29Si NMR experiments, 
and dramatic changes in the chemical shifts of the crotyl trichlorosilane were observed in 
various solvents (for example +8 ppm in CDCl3 and -170 ppm in d7-DMF for the 
allyltrichlorosilane, i.e., almost 180 ppm difference), confirming the extensive coordination 
of the polar aprotic solvents to the silicon atom.14  
The mechanism of the silicon activation with fluoride anions is based on the rapid 
bonding of fluoride onto the silicon atom (the average Si-F bond energy is about 570 kJ/mol). 
The silicon species forms a pentacoordinated silicate, which itself is already an active allyl 
donor, however in the presence of Lewis basic solvent coordinates another molecule of the 
Lewis base to form a hexacoordinated silicate (Scheme 10). This one undergoes an allyl 
transfer to the carbonyl compound and the resulting alkoxide is trapped by the silicate 
regenerating the fluoride anion and the neutral Lewis base.  
16 
 
Si
L L L
L
L
Si
L
L
L
L Si
L
L
L
L L
4-coordinated 5-coordinated 6-coordinated
L = Cl-, F-, RO-, DMF, HMPA, DMSO, DMPU  
 
Scheme 10: Further activation of the tetracoordinated Si species. 
 
The realisation of the fact that not only anions, such as Cl-, F-, but also the neutral 
Lewis bases (i.e., common polar aprotic solvents, e.g., DMF or DMSO), can activate the 
tetracoordinated silanes, set ground for developing new mild methods of organocatalysis and 
chiral modifications of the organocatalysts. The electrophilicity of the hypervalent silicon 
species increases almost 300 times after the first coordination and almost 10 000 time for the 
hexacoordinated complexes compared to the original sp3 hybridized species.15 The overall 
reactivity can be tuned by a careful choice of the catalyst (halides or various neutral Lewis 
bases) and the silane (polyalkyl-, polyalkoxyl-, polyhalo-silanes).  
The reduction potential of silanes has been extensively studied for many years now 
and the silicon complexes with fluorides (penta- and hexavalent fluorosilicates) were the first 
species to be used in the allylation reactions, especially since introduction of TBAF and its 
congeners (which are soluble in organic solvents and replaced the previously used inorganic 
fluorides).16  
A large variety of catalysts have been developed for the enantioselective allylation of 
aldehydes, e.g., optically active phosphoramides, formamides, imines, and N-oxides amongst 
the most common ones. The scope, limitations and selectivities of various catalysts differ 
remarkably.11 
 The mechanism by which chiral Lewis bases activate the allyl trichlorosilanes 28 
starts with the coordination of the chiral Lewis base to the silicon atom (Scheme 11). The 
complex 29 thus formed coordinates to the aldehyde and the resulting ternary complex of the 
allylation reagent, aldehyde, and chiral Lewis base reacts through a six-membered chair 
transition state 30 where both diastereo- and enantioselectivity are controlled and the chirality 
of the chiral Lewis base is translated to the intermediate 31. Dissociation of the Lewis base 
from the trichlorosilyl ether 31, followed by hydrolysis, gives the chiral homoallylic alcohol 
33. 
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 In the crotylation reaction for example, assuming the reaction proceeds through the 
cyclic transition state organised around the hypervalent silicon, (E)-alkene produces a 
homoallylic alcohol with the anti configuration whereas (Z)-alkene then naturally gives the 
syn product (Scheme 11).  
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Scheme 11: Crotylation of aldehydes. 
 
 
2.1.1 Chiral Phosphoramides as Organocatalysts in the 
Asymmetric Allylation  
  
 The first example of enantioselective allylation catalysed by chiral phosphoramide, 
which was also the first enantioselective Lewis base-catalysed allylation published, was 
reported nearly 20 years ago by Denmark.17 It was shown that HMPA efficiently catalyses 
the allylation of benzaldehyde and Denmark first investigated the use of a stochiometric 
amount of chiral phosphoramide, achieving moderate enantioselectivities, while the reaction 
was highly diastereoselective (for the addition of crotylsilanes). Subsequent investigation of 
optically active phosphoramides showed that the Lewis base 34 is an efficient organocatalyst 
applicable for a wide range of substrates and the reaction of allyltrichlorosilane and various 
aldehydes led to the desired homoallylic alcohols (Scheme 12). Similar results were obtained 
for the crotylations of benzaldehyde with (E)- and (Z)-crotyltrichlorosilanes, with excellent 
diastereoisomeric ratios. Anti diastereoisomers were obtained preferentially from (E)-
substrates, whereas syn diastereoisomer was formed when (Z)-crotyltrichlorosilane was 
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employed. However both yields and enantioselectivities were moderate (up to 66 % ee) and 
high catalyst loading was required (25 mol% or more).  
The rate and selectivity of allylation were dependant on the nature of the aromatic 
aldehyde used, both electron-donating and electron-withdrawing substituents dramatically 
reduced the selectivity, as well as substitution in the ortho position.  
 
 
 
Scheme 12: Denmark's chiral phosphoramides. 
 
 Later, the structure of this type of catalysts was improved by using the bidentate 
bisphosphoramides (41, 42 and 43) (it was shown that when the monodentate catalyst 
concentration is very low, the reaction proceeds with only one molecule of the 
phosphoramide coordinated to the silicon atom, jeopardizing the enantioselectivity of the 
reaction) capable of chelation of silicon in the transition state of the allylation reaction 
(Scheme 13).18 Typical catalyst loadings were 5-10 mol% and the reaction reached full 
conversion in a span of few hours.  
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Scheme 13: Denmark's bisphosphoramide catalysts. 
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 This type of catalysts can even be used for the construction of quarternary stereogenic 
centres (Scheme 14), thus the intermediate in the synthesis of serotonin antagonist 45 was 
prepared with high diastereoselectivity and enantioselectivity.  
 
 
Scheme 14: Allylation on the sterically hindered reaction center. 
 
 Several other phosphoramides, such as 46 or 47, have been developed by Iseki and 
other groups giving up to 90% ee (Scheme 15).19 Employing the catalyst 46 or 47 resulted in 
good yields and moderate to good enantioselectivities, however extended reaction times (up 
to 7 days) were required.  
 
Scheme 15: Other phosphoramide catalysts.  
 
Optimized procedure for the allylation reaction employed the N,N-
diisopropylethylamine (Hünig’s base) as an additive and proton scavenger; surprisingly this 
one was superior to the other ones used, such as triethyl amine. Nakajima postulated that the 
Hünig’s base increases the rate of the catalyst turnover by facilitating the cleavage of the 
catalyst-silicon bond. 
The mechanism of the phosphoramide-catalysed allylation has been investigated, 
particularly by the Denmark group (Scheme 16). For some of the studies, instead of silicon, 
Denmark used the complexes with tin, which exhibit almost the same coordination properties 
as silicon but much stronger bonding, which allowed detailed NMR and crystallographic 
studies that were then extrapolated to Si. The key step is the complexation of the allylsilane 
20 
 
28 with the Lewis base catalyst to form the hypercoordinated reactive silicon species 48. This 
intermediate reacts with the electrophilic aldehyde 36a forming the homoallylic alcohol. The 
aldehyde is also coordinated to the silicon intermediate in the transition state 49. Two 
molecules of the catalyst are involved in the complex with both substrates (the reaction was 
found to be following first order kinetics towards both silane and aldehyde and a second 
order towards the monodentate phosphoramide promoter), this dual activation leads to the 
high diastereo- and enantioselectivity (Scheme 16).20  
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Scheme 16: Activation of allyltrichlorosilane with phosphoramides. 
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2.1.2 Chiral Formamides as Organocatalysts in the Asymmetric 
Allylation 
 
Following on the original observations made by Nishio and Kobayashi, that DMF as 
a solvent promoted the allylation of aldehydes with trichlorosilanes,21 it was not surprising 
that chiral formamides were found to be versatile organocatalysts for the asymmetric 
allylation of aldehydes. Iseki and Kobayashi developed the catalyst 56, which catalysed 
allylation and crotylation of various aldehydes with enantioselectivities up to 98%.22 (E)-
crotyltrichlorosilane gave predominantly the corresponding anti homoallylic alcohol 55 with 
99% selectivity, whereas the reaction with the (Z)-isomer was extremely sluggish (Scheme 
17). Formamides of this type however need at least 20 mol% loading to work efficiently and 
require the HMPA presence as a co-catalyst. The reaction is also rather sluggish, requiring up 
to two weeks to achieve full conversion. However, interestingly 56 is one of the few catalysts 
reported to the date, that give excellent enantioselectivies for aliphatic aldehydes (and 
interestingly giving almost racemic products for the aromatic ones).23   
 
 
Scheme 17: Iseki's formamide catalyst. 
 
 
2.1.3 Chiral N­Oxides as Organocatalysts in the Asymmetric 
Allylation   
 
 Chiral N-oxides,24 which possess significant nucleophilicity toward the silicon atom, 
were first used as catalysts in enantioselective allylation ten years ago by Nakajima. He 
developed the Lewis basic bis-oxide 57 with axial chirality. 57 catalysed the reaction of a 
range of aromatic, aliphatic and α,β-unsaturated aldehydes with allyltrichlorosilane (Scheme 
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18).25 10 mol % loading of the catalyst was typically used and enantioselectivities up to 92% 
were obtained for the aromatic substrates, whereas enantioselectivities in the reactions of 
aliphatic aldehydes were in general quite poor. The use of diisopropylethylamine as an 
achiral additive was found to be crucial because of the acceleration of the reaction, especially 
at low temperatures (conducting reactions at low temperatures improved the asymmetric 
induction considerably). Again, allylation using (E)-crotyltrichlorosilanes gave anti-
diastereoisomers (such as 39) whereas use (Z)-crotyltrichlorosilanes led to syn-homoallylic 
alcohols (such as 40).  
 
Scheme 18: Nakajima's N-oxide catalyst. 
   
 Hayashi reported that catalyst 60 can be used with loading as low as 0.01 mol % 
without loss of enantioselectivity (although the reaction time were longer and the yields 
somewhat lower).26  
 
Scheme 19: Hayashi's bipyridine catalyst. 
 
This 2,2’-bipyridine-N,N’-dioxide 60, whose chirality originates from the biaryl axial 
chirality, was prepared in 9 steps from 2,9-diphenylphenanthroline.27 This catalyst was found 
to have high catalytic activity as well as high enantioselectivity for the asymmetric allylation 
of aromatic aldehydes with allyltrichlorosilane. With catalyst loading of 0.1 mol%, the 
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reaction was complete within 2.5 hours, which stands in a remarkable contrast to the much 
lower catalytic activity of most of the other chiral Lewis bases, where at least 1-10 mol % 
loading is usually required. The activity of the catalyst decreased rapidly when the phenyl 
groups were substituted by methyl, hydrogen or tert-butyl groups respectively. The high 
catalytic activity was attributed mainly to the π-π stacking between the phenyl groups and the 
aromatic ring of the aldehyde which probably enhances the activity as well as 
enantioselectivity. Some of Hayashi’s results are summarized in Table 1.  
 
Scheme 20: Allylation of anisaldehyde catalysed by 60. 
 
Table 1: Hayashi's catalyst 60. 
entry catalyst loading (%) solvent T (°C) time (h) Yield (%) ee  (%) 
1 1 CH3CN -45 0.25 96 94 
2 0.1 CH3CN -45 2.5 96 94 
3 0.01 CH3CN -45 12 68 94 
4 0.5 CH2Cl2 -78 2.5 90 78 
5 0.1 CH2Cl2 -45 2.5 91 76 
 
 Crotylation of benzaldehyde catalysed by Hayashi’s catalyst 60 gave the usual syn or 
anti γ-allylated homoallylic alcohols respectively (depending on the configuration of the 
double bond) with high diastereoselectivities but moderate enantioselectivities (around 70%). 
Enantioselectivities were strongly dependent on the nature of the aromatic ring of the 
aldehyde, giving the best results for the electron rich systems. Aliphatic aldehydes gave 
inferior results, showing both poor reactivity and enantioselectivity.  
 Hayashi developed a synthetic route to the ligands of type 60 and a broad range of 
catalysts with various substituents in the 2,2’-positions have been prepared by his group.28 
However, the original structure 60 has shown the best results.  
 In 2002, prior to Hayashi’s paper, the chiral bipyridine N-monoxide PINDOX (58a) 
and its dimethyl analogue 58b were introduced by Kočovský and Malkov, which catalysed 
allylation of various aromatic aldehydes with allyltrichlorosilane at up to 98% ee.29 Again, 
the saturated aldehydes showed only poor asymmetric induction, highlighting the importance 
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of π-conjugation. Interestingly, the corresponding N,N’-dioxide gave both lower yield and 
enantioselectivity than the N-oxide. It was suggested that while one N-O group of 58 
coordinates to the silicon atom of the allyl silane (increasing its nucleophilicity), the other 
nitrogen stabilizes the intermediate by chelation and thus reducing the number of other 
diastereoisomeric transition states, which results in high enantioselectivity.     
 
Scheme 21: PINDOX and its dimethyl analogue. 
 
 Other weakly coordinating groups with affinity to silicon could mimic the behaviour 
of the second pyridine nitrogen and thus a range of new catalysts was prepared, where the 
pyridine moiety was replaced by a substituted benzene ring (compounds 60a-d, Scheme 
22).30 However, all of them showed lower activity than their bipyridine counterpart. 
Relatively high asymmetric induction in the case of both methoxy-substituted and 
unsubstituted derivative in comparison with their fluoro- and bromo-substituted counterparts 
suggested that electronic properties of the phenyl ring may play a more important role than 
coordination.   
 
Scheme 22: Other N-oxide catalysts. 
 
 In 2003, synthesis of quinoline-type N-oxide catalyst QUINOX (61) was published by 
Kočovský and Malkov.31 QUINOX catalysed allylation of benzaldehyde with 
allyltrichlorosilane with 87% ee, enantioselectivity was not altered even if the catalyst 
loading was decreased to 1 mol%. However, whereas electron rich aldehydes (such as p-
methoxybenzaldehyde) gave almost racemic products, electron poor aldehydes (such as p-
trifluoromethylbenzaldehyde) reacted with 96% enantioselectivity. This was compatible with 
the hypothesis of the arene-arene interactions of the catalyst with the aldehyde substrate. 
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Allylation with the crotyltrichlorosilane were also examined, both PINDOX (58a) and 
QUINOX (61) produced mainly anti homoallylic alcohol when (E)-isomer of the starting 
material was used. Interestingly, QUINOX catalysed the reaction of (Z)-crotyltrichlorosilane 
with higher rate, which represents a reversal of the trend commonly observed with other N-
oxide catalysts, which usually show preference for the (E)-isomer.  
 In 2005 Kočovský and Malkov introduced another pyridine-type N-oxide METHOX 
(62), where the benzene ring is substituted by three methoxy groups. METHOX catalysed 
allylation of aromatic benzaldehydes with high enantioselectivities (up to 96% ee) and 
confirmed the hypothesis that methoxy groups effects are of electronic rather than steric 
origin (decreasing the electron density in the ring by introducing electron withdrawing 
substituents, such as fluorine, had a detrimental effect on both conversion and 
enantioselectivity). The nature of the aldehyde seemed to have little effect on the outcome, 
i.e., both electron-rich and electron-poor aldehydes reacted with both high conversion and 
enantioselectivities. Increasing the steric hindrance around the carbonyl group (i.e., 
introducing the ortho substituents onto the aldehydic aromatic ring) had a detrimental effect 
on the reaction. Reducing the catalyst loading had no effect on enantioselectivity, though the 
reaction slowed down. Rising the temperature from the original -40°C to room temperature 
(during the reaction of benzaldehyde with allyltrichlorosilane) led to a decrease to the 87% ee 
from the original 96% ee, thus as usual, the low temperature is a prerequisite for achieving 
good enantioselectivities.  
METHOX was also proven to be the catalyst of a choice in the allylation and 
crotylation of conjugated aliphatic and aromatic aldehydes.32  
 
Scheme 23: Allylation of aldehydes with METHOX. 
  
As METHOX exhibits high kinetic preference for the (E)-crotyltrichlorosilane, 
technical grade crotyl chloride (E/Z = 5 : 1) is sufficient as a starting material.  
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Scheme 24: Crotylation of aldehydes with METHOX. 
 
A few years ago Kotora introduced the bis(tetrahydroisoquinoline) N,N’-dioxides 
(R,R)-63 and (S,R)-63 and demonstrated their application in the allylation of a range of 
aromatic and aliphatic aldehydes.33 
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Scheme 25: Kotora's dioxide catalysts. 
 
Both dioxides were prepared by the cyclotrimerization of the tetrayne 64 with (R)-
tetrahydrofurannitrile 65 and benzonitrile 66. Interestingly, the one-pot cyclotrimerization of 
all three components in the presence of CpCo(CO)6 under the microwave irradiation in THF 
afforded 67 in an acceptable 28% yield (as a mixture of two diastereoisomers), contaminated 
with 20% of the undesired 68.  
 
 
 
 
Scheme 26: Synthesis of Kotora's catalyst. 
 
Oxidation of 67 by mCPBA gave a mixture of N,N’-dioxides (R,R)-63 and (S,R)-63, 
which were separated by column chromatography of silica gel. Several aldehydes were 
screened; for selected examples see Table 2. Enantioselectivities showed to be strongly 
solvent dependent, with best results being obtained in THF and PhCl.  
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Scheme 27: Crotylation of aromatic aldehydes catalysed by Kotora's catalyst. 
 
Table 2: Some of Kotora's results for various aldehydes. 
Entry R Solvent 
(R,R) 
Yield (%)      ee (%) 
(S,R) 
Yield (%)       ee (%) 
1 H MeCN 99 53 (S) 99 44 (R) 
2 H PhCl 99 93 (R) 99 94 (S) 
3 H THF 99 93 (R) 98 96 (S) 
4 4-MeO THF 99 86 (R) 90 91 (S) 
5 4-CF3 THF 76 95 (R) 91 87 (S) 
6 2-Cl THF 45 46 (R) 42 14 (S) 
 
Aliphatic α,β-unsaturated aldehydes react with a lower rate, however the allylation of 
crotonaldehyde proceeded with 85% ee for both diastereoisomers of the catalyst, aldehydes 
with longer aliphatic chains gave the homoallylic alcohols with excellent >95% 
enantioselectivities. Reactions typically reached full conversion in several hours, catalyst 
loading varied from 1 mol % to 5 mol %.  
 
2.1.4 The Allyl Transfer 
 
In the presence of an acid, the allylic functionality can be stereoselectively transferred 
from γ-homoallylic alcohol (70) to an aldehyde to obtain the respective α-homoallylic alcohol 
(71) (Scheme 28). Nokami assumed that the allyl transfer reaction proceeds in the direction 
giving a sterically less hindered homoallylic alcohol and thermodynamically more stable 
olefin.34 Addition of powdered molecular sieves 4Å to the reaction medium led to improved 
yields as did a lower reaction temperature (-25 °C). Several catalysts were investigated 
(Zn(OTf)2, AgOTf, PhSO2NHOH); the best results were obtained with tin(II) triflate.  
 
Scheme 28: Allyl transfer. 
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The first general enantioselective allyl transfer reaction was developed by Nokami in 
2001.35 As a source of chirality, Nokami used (-)-menthone which was subjected to the 
crotylation reaction with the corresponding Grignard reagent to give the homoallylic alcohol 
72. This reacted readily with a number of aldehydes with no loss of enantiopurity in all cases 
(Scheme 29). From several catalysts investigated (PTSA, CSA, BSA, Sn(OTf)2), PTSA gave 
the best results.  
 
Scheme 29: Allyl transfer with menthone-derived chiral  auxiliary. 
 
 Nokami and Sumida proposed the following mechanism for the allyl transfer 
(Scheme 30).36 The reaction proceeds via hemiacetal 74, derived from an aldehyde and the 
homoallylic alcohol 39, oxycarbenium ion 75, followed by a [3.3] sigmatropic rearrangement 
in the presence of a suitable acid.  
 
 
Scheme 30: Allyl transfer mechanism. 
 
 Nokami also investigated the allyl transfer using compound 39 as an allyl donor. The 
reaction of 39 and dihydrocinnamaldehyde gave 84 as a major product but a substantial 
amount of byproduct 79 was isolated. Formation of the byproduct 79 suggested that 
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benzaldehyde, formed during the reaction of 39 with dihydrocinnamaldehyde, reacts with 39 
competitively.  
 
Scheme 31: Side reactions during the allyl transfer. 
 
Chirality in both syn and anti γ-adduct was stereospecifically transferred to the 
corresponding α-adduct. Anti isomers gave exclusively (E) α-homoallylic alcohols with 
inversion of configuration at the chiral centre. Reaction of the syn isomers was less 
stereospecific, nevertheless giving (Z) configuration of the double bond predominantly (Z/E 
ratio being between 18/1 – 7/1 according to the Nokami's report). The difference in the 
selectivity between syn and anti can be rationalized by the six-membered transition state 
model (Scheme 32).  
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Scheme 32: Mechanism of the byproducts formation during the allyl transfer. 
  
Nokami also explored alternative catalysts and found that many acids as well as 
simple hydrogen chloride catalysed the isomerization of γ-homoallylic alcohol 92 to its α-
isomer 93 (Scheme 33 and Table 3).  
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Scheme 33: Screening of Lewis acids in Nokami's allyl transfer. 
 
Table 3: Conversion of γ-adducts to α-adducts. 
entry catalysta  anti/syn ratio of 92 t (h) E/Z ratio of 93 yield of 93 (%) 
1 Sn(OTf)2 23/1 2 25/1 88 
2 Cu(OTf)2 19/1 4 20/1 80 
3 Zn(OTf)2 17/1 48 25/1 72 
4 AgOTf 23/1 95 25/1 83 
5 AlCl3 25/1 6 50/1 51 
6 SnCl4 33/1 8 23/1 77 
7 BF3.Et2O 1/1 24 1/1 73 
8 TfOH 18/1 2 17/1 89 
9 HClb 100/1 4 100/1 84 
a10 mol% of catalyst used unless stated otherwise b1 eq. of  HCl used in a form of anhydrous 
1M solution in diethyl ether (commercial from Aldrich) 
  
Nokami concluded that the actual nature of the catalyst for the allyl transfer reaction 
is not completely clear. The BrØnsted acid HCl served as a good catalyst, and could be 
created from a Lewis acid in situ with alcohol or trace of moisture.  
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2.2 Methods of Preparation of Substituted        
Tetrahydrofurans 
 
Substituted tetrahydrofurans are featured in a large number of antibiotics,37 polyene 
mycotoxins and other biologically important natural products, such as Galbacin,38 
Aplydilactone,39 Mupirocin,40 Annoreticuin,41 Bullatalicin,42 Gigantecin,43 amongst others.44 
The polyether antibiotics are a class of compounds isolated from fermentation cultures of 
Streptomyces and characteristically contain 3-5 oxygen atoms serving as ligands for the 
complexation of metal cations. The framework of these molecules is dominated by the 
presence of substituted tetrahydrofurans, tetrahydropyrans, and spiroketal systems. Their 
structural complexity and diversity (as well as commercial value of many of them) continue 
to challenge synthetic organic chemists for more than three decades after the landmark 
syntheses of Lasalocid A or Monensin were reported.45 Construction of polyether antibiotics 
is, to a large extent, an exercise in the enantioselective preparation of substituted 
tetrahydrofurans and tetrahydropyrans. Hence, considerable attention has been focussed on 
the development of efficient and stereocontrolled routes to these key structural fragments. 
Several methods have been developed to address the problem of stereoselective synthesis of 
the core tetrahydrofuran ring of these molecules. There have been three major approaches: 
resolution of racemates, use of chiral auxiliaries and taking advantage of stereochemistry 
already set up in previous steps. 
In the synthesis of Lasalocid A, Kishi and co-workers used reduction of ketone 94 by 
LiAlH4 in the presence of (±)-2-(o-toluidinomethyl)pyrrolidine followed by resolution of the 
racemate, epoxidation of the double bond followed by the epoxide opening giving 96 in 75% 
yield and 8:1 ratio of diastereoisomers (Scheme 34).  
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Scheme 34: Synthesis of tetrahydrofuran fragment of Lasalocid A. 
 
In the synthesis of Salinomycin, Kocieński used (2S)-bornane-10,2-sultam 100 
(Oppolzer’s chiral auxiliary) to prepare chiral diene 98.46 Oxidative cyclization afforded the 
desired tetrahydrofuran 99 in 54 % yield as a 6:1 mixture of diastereoisomers (Scheme 35).  
 
 
 
 
 
Scheme 35: Synthesis of tetrahydrofuran fragment of Salinomycin. 
 
In the synthesis of Monensin, Kishi took advantage of the fact that bromination of the 
olefin 101 occurs selectively from one face, being assisted by the neighbouring group 
participation. Opening of the bromonium ion provided tetrahydrofuran 103 in 57% yield 
(Scheme 36).47   
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Scheme 36: Synthesis of tetrahydrofuran fragment of Monensin. 
 
 
2.2.1 Oxidative Cyclization of 1,5­Dienes 
 
In 1965 Klein reported that 1,5-dienes can be converted into tetrahydrofurans when 
treated with potassium permanganate under mildly alkaline conditions.48 Years later, when 
interest in polyether antibiotics had developed, the synthetic possibilities of this pioneering 
work were extended. The reaction is general, and cis-2,5-bis(hydroxymethyl)-
tetrahydrofurans (such as 105) can be generated from the appropriate dienes with complete 
stereocontrol (Scheme 37).  
 
 
Scheme 37: Oxidative cyclization. 
 
The mechanism suggested by Baldwin49 (Scheme 38) involves an initial [3+2] 
cycloaddition of MnO4- to one of the diene double bonds and the resulting ester 107 is 
oxidized by another molecule of permanganate to the Mn(VI) diester 108. This species then 
undergoes an intramolecular cycloaddition to the remaining double bond producing cis 
tetrahydrofuran 109 on hydrolysis.  
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Scheme 38: Mechanism of the oxidative cyclization. 
 
Oxidative cyclization of 1,5-dienes has been employed in a synthesis of the (racemic) 
ring system of Monensin (Scheme 39).  
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Scheme 39: Synthesis of the tetrahydrofuran fragment of Monensin. 
 
2.2.2 Halocyclization 
 
A different approach to 2,5-disubstituted tetrahydrofurans has been developed by 
Bartlett.50 This method involves the use of unsaturated alcohols or the corresponding ethers 
which undergo electrophilic cyclization with iodine in acetonitrile (Scheme 40). It was found 
that formation of trans-2,5-disubstituted tetrahydrofurans (trans-113) predominates when 
free alcohols are used, and that cis isomers (cis-113) are the major products from the 
corresponding ethers. 
37 
 
 
Scheme 40: Halocyclization. 
 
Halocyclization has also been applied, in the present context, to unsaturated acids. 
Iodolactonization of unsaturated acids with iodine in acetonitrile provides mainly the 
thermodynamically favoured lactone with high selectivity51 that are convertible into 
tetrahydrofurans.52 Iodolactone 114 was prepared in an enantiomerically pure form from  the 
corresponding carboxylic acid and treated with stabilized carbanions to give the epoxide 115, 
which undergoes, under the reaction conditions, a ring closure to afford tetrahydrofurans 116 
and 117 with the exocyclic double bond. A mixture of (E) and (Z) isomers is usually 
obtained, their ratio depends on the nature of the carbanion used. The (Z) isomer can be also 
converted into the (E) isomer on treatment with sodium alkoxide in ethanol. 
Tetrahydrofurans, such as 116 or 117, can be hydrogenated from the less hindered face, 
giving products 118 or 119 respectively (Scheme 41).  
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Scheme 41: Iodolactonization in the synthesis of substituted tetrahydrofurans. 
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2.2.3 Epoxidation­Cyclization 
 
The epoxidation approach has been used to generate the tetrahydrofuran fragment of 
Ionomycin.53 Asymmetric epoxidation of 120 and the reaction with phenyl isocyanate gave 
phenylurethane 121 which was treated with the perchloric acid to afford the cyclic carbonate 
122. Hydroxyl group protection, base-catalysed hydrolysis of the acetate, and deprotection set 
the stage for a second asymmetric epoxidation. The intermediate epoxide was not isolated 
and the Lewis acid-catalysed cyclization involving the free hydroxyl occurred spontaneously, 
forming tetrahydrofuran 123.  
 
 
Scheme 42: Synthesis of the tetrahydrofuran fragment of Ionomycin 
 
 
2.2.4 Ring Contraction of Tetrahydropyrans 
 
Bartlett investigated the formation of 2,5-disubstituted tetrahydrofurans by the ring 
contraction of appropriately substituted tetrahydropyrans.54 The approach is based on the fact 
that the 1,3-asymmetric induction is more easily attained in a 6- rather than in a 5-membered 
ring. The unsaturated alcohol 124 was treated with TBCO to generate the desired 
tetrahydropyran 125 as the major cyclic ether. Tetrahydropyran 125 was then treated with 
silver(I) tetrafluoroborate in aqueous acetone, and the 2,5-disubstituted tetrahydrofuran 127 
was isolated in a good yield. According to the authors, the ring contraction takes place via 
intermediate formation of a bridged oxonium ion 126. Nucleophilic capture of this 
carbocation by solvent yields the observed product 127. 
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Scheme 43: Tetrahydropyran ring contraction 
 
It is possible to improve the ring contraction methodology by using thallium(III) ions 
as electrophiles instead of bromine.55 Treatment with thallium(III) converted unsaturated 
alcohols into the substituted tetrahydrofurans in a single step (lifetime of the thalliated 
intermediate appears to be extremely short).  
 
 
2.2.5 Ester Enolate Claisen­Ireland Rearrangement 
 
The Claisen-Ireland ester enolate rearrangement constitutes another route to 
tetrahydrofurans.56 Ireland reported that stereochemical control was possible through the 
stereoselective enolate formation. They showed that [3,3] sigmatropic rearrangement of a 
number of allylic esters 128  in the form the enolate ions produces γ,δ-unsaturated acids 129 
(Scheme 44).  
 
Scheme 44: Claisen-Ireland rearrangement. 
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It was demonstrated that kinetic enolization with LDA gives selectively the enolates 
in which the geometry is solvent dependent, when using THF, formation of a (Z)-enolate was 
favoured, while a mixture of THF and HMPA gives mainly the (E)-enolate isomer.  
These results have been applied to the tetrahydrofuran chemistry as follows (Scheme 
45): Transformation of glycal 130  into ester 131 (required for Claisen-Ireland 
rearrangement) prior to enolate formation is achieved simply by reaction of the lithium 
alcoholate with the requisite acid chloride.57 Next, ester enolate of appropriate geometry must 
be generated. Ireland reported that kinetic enolization using lithium diisopropylamide in THF 
at -78°C affords predominantly (90% of the total) the Z-enolate 135, while the use of LDA in 
THF containing HMPA gives the E-enolate 132 (as 80-90% of the total). The [3,3] 
sigmatropic rearrangement is triggered by warming either the lithium enolates 135, 132 or the 
corresponding silyl enolates 136, 133 to room temperature. After hydrolysis, the 
functionalized dihydrofurans 137 or 134 are isolated. Hydrogenation then gives the 
corresponding substituted tetrahydrofurans. This ester enolate rearrangement has been used 
frequently in the synthesis of polyether antibiotic. 
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Scheme 45: Claisen-Ireland rearrangement in the synthesis of tetrahydrofurans (after 
hydrogenation). 
 
 
2.2.6 Mercuricyclization 
 
Mercuricyclization of unsaturated alcohols has been used to generate 2,5-disubstituted 
tetrahydrofuranyl systems (mainly trans substituted rings formed). In the last step of the 
process the mercury group is removed by the borohydride reduction. The mercuricyclization 
route has been used mainly to make bis-tetrahydrofurans (Scheme 46).58  
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Scheme 46: Mercuricyclization 
 
 
2.2.7 Cyclization of 1,4­Diols 
 
The cyclization of a 1,4-diol system was used by Still in the synthesis of Monensin to 
construct the central tetrahydrofuran ring in 67% yield.59 In this protocol the diol is usually 
converted into the monomesylate, followed by the stereospecific ring closure.  
 
 
Scheme 47: Structure of Monensin. 
 
 
2.2.8 Radical Cyclization 
 
Radical-mediated cyclizations have also been extensively used for the construction of 
oxygen-containing ring systems.60 Thus, for instance, radical cyclization in the presence of 
tributylstannane and triethylborane was employed in the total synthesis of (-)-Amphidinolide 
K.61 The reaction gave mainly (16:1) the cis-2,5-disubstituted oxolane intermediate 143 after 
acidic destannylation (Scheme 48).   
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Scheme 48: Synthesis of the tetrahydrofuran fragment of Amphidinolide K. 
 
 
2.2.9 Lewis Acid­Promoted Prins Cyclization 
 
In 1996, Mikami and Shimizu unexpectedly obtained the substituted tetrahydrofuran 
146 in an attempted glyoxylate-ene reaction of silyl ether 144, presumably via the Prins 
reaction to form a carbon-carbon bond, followed by intramolecular reaction and an attack of 
the siloxy group onto the cationic intermediate to form the tetrahydrofuran 146.62  
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Scheme 49: The Prins reaction. 
 
 
Mikami and Shimizu screened several silyl groups and the less bulky but relatively 
stable dimethyl-iso-propylsilyl protecting group was found to be the best choice.62 This 
method is suitable for mono- and disubstituted furan rings, its drawback have been relatively 
low yields. 
 
2.2.10 Oxy­Palladation 
 
Oxy-palladation reactions of 1,4-hydroxy-alkenes lead to the formation of 
tetrahydrofuranyl Pd(II) intermediates 149 through the attack of the -OH group on an alkene-
Pd complex 148 (Scheme 50).63 By trapping with CO/MeOH, the organo-Pd intermediate is 
readily converted into the cyclic ester 151. The intermediate 149 has not been detected but it 
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was proposed to undergo a β-hydride elimination in the absence of CO to give the alkene 
150.  
 
 
Scheme 50: Oxy-palladation. 
 
Substrates which are unable to eliminate β-hydride can undergo vinylation (via Heck 
reaction) i.e. one-pot ring closure and extension of the side chain (Scheme 51). 
 
 
Scheme 51: reaction in the synthesis of tetrahydrofurans. 
 
 
2.2.11 Miscellaneous methods 
 
Freifeld and co-workers prepared 2-alkylidene tetrahydrofurans 155 which can serve 
as building blocks in the synthesis of many natural products and can be converted into 
substituted tetrahydrofurans by simple hydrogenation.64 Intermediate 155 was prepared by 
the LiClO4 mediated cyclization of dilithiated diketone 154 with epibromohydrin. The 
hydrogenation of 155 afforded tetrahydrofuran 156. The stereoselectivity of the latter reaction 
is dependent on the nature of the substituent R and reaction conditions and is usually strongly 
in favour of the formation of cis disatereoisomer (Scheme 52).  
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Scheme 52: The epoxide ring opening. 
 
Allenes have become popular in the metal-catalysed addition reactions, they closely 
parallel the behaviour of alkynes in their reactivity toward Ag(I)-mediated nucleophilic 
additions. However, unlike alkyne substrates, allenes offer the potential of axial chirality to 
allow enantio- and diastereoselective reactions.65 Nearly 30 years ago Olsson and Claesson 
reported that tetrahydrofurans, such as 159, can be prepared by the 5-endo-trig-cyclization of 
allenic alcohols 157 (Scheme 21).66  
 
Scheme 53: Allenes in the synthesis of tetrahydrofurans. 
 
 
In 2004, this approach was used by Fürstner in the synthesis of Amphidinolide, where 
enantiopure allenes were obtained first and then treated with AgNO3/CaCO3 in acetone to 
afford the corresponding tetrahydrofurans with excellent chirality transfer.67 
 
Seleno-cyclizations are another route to the oxygen heterocycles, especially 
tetrahydrofurans (Scheme 54); this method gives almost quantitative yields under extremely 
mild reaction conditions.68   
 
 
Scheme 54: Seleno-cyclization. 
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Marsden and Cossy simultaneously developed a novel method for the preparation of 
functionalized tetrahydrofurans via cyclic allylsiloxanes. Marsden used homoallylic silanes 
162 with Grubbs’ catalyst to produce the cyclic allylsilanes 163 in good yields, which reacted 
with various aldehydes in the presence of boron trifluoride etherate to afford substituted 
tetrahydrofurans 164 (Scheme 55).69  
 
 
Scheme 55: Approach to the trisubstituted tetrahydrofurans by Marsden and co-
workers. 
 
Cossy converted homoallylic silanes 165 with Grubbs’ catalyst into cyclic allylsilanes 
166, which reacted with aldehydes, ketones or ketals to give substituted tetrahydrofurans 167 
with high diastereoselectivity (Scheme 56).70   
 
 
Scheme 56: Approach to the trisubstituted tetrahydrofurans by Cossy and co-workers. 
 
Cossy interprets the formation of tetrahydrofurans by the following mechanism 
(Scheme 57).70 Reaction of the silylether moiety of the cyclic allylsiloxanes 172 with the 
electrophiles 168 (carbonyl compounds or their acetals activated by the Lewis acid TMSOTf) 
generates oxonium ions 169 which can be trapped intramolecularly by the allylsilane, thus 
generating the oxygenated heterocycle 171. A chairlike transition state, in which the 
substituents preferentially occupy pseudo-equatorial positions, can account for the 
stereochemical outcome of this reaction. 
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Scheme 57: Proposed mechanism of the ring contraction. 
 
There have been plenty of approaches to the synthesis of heterocycles using indium 
chemistry.71 A few years ago, Loh reported on the formation of tetrahydrofurans from 
homoallylic alcohols catalysed by In(OTf)3.72 The reaction of homoallylic alcohols (173) 
with aldehydes gave an unexpected mixtures of compounds 174 and 175 (Scheme 58). The 
82 : 83 ratio depends strongly on reaction conditions,73 on the ratio of starting materials, and 
the nature of the aldehyde and homoallylic alcohol used. Some of Loh’s results are 
summarized in Table 4. 
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Scheme 58: Indium chemistry in the synthesis of tetrahydrofurans. 
 
Table 4: Outcome of Loh’s “allyl transfer” reaction (Scheme 58) depending on reaction 
conditions. 
entry R In(OTf)3 
eq. 
RCHO 
 eq. 
T /°C time/h yield/% 
(ratio of 174:175) 
1 PhCH2CH2 0.1 0.1 25 240 54 (81:19) 
2 PhCH2CH2 0.2 0.1 25 192 70 (59:41) 
3 PhCH2CH2 0.1 0.1 40 14 56 (70:30) 
4 PhCH2CH2 0.1 1.0 40 14 60 (3:97) 
5 Ph 0.1 0.1 40 14 28(72:28) 
6 Ph 0.1 1.0 40 14 66 (3:97) 
7 CH3(CH2)7 0.1 0.1 40 14 59 (75:25) 
8 CH3(CH2)7 0.1 1.0 40 14 58 (7:93) 
 
Interestingly, when the reaction was performed in the presence of a catalytic amount 
of indium triflate (0.1 equiv) and aldehyde (0.1 equiv), product 174 was formed preferentially 
with the selectivity up to 81%. On the other hand, upon increasing the amount of aldehyde, 
compound 175 became the major product with selectivity up to 97%. The double bond in 
product 175 always had (E) geometry.  
Loh suggested a reaction mechanism which involves first an In(OTf)3 promoted 
conversion of the homoallylic alcohol 176 into the corresponding intermediate 177b via a 
[3,3]-sigmatropic rearrangement. This step is followed by an additive incorporation of an 
oxygen and indium across the double bond to give the tetrahydrofuranyl-indium species 180. 
Trapping of 180 with a proton source would form 181 while an alternative nucleophilic attack 
at the parent aldehyde would form 182 after elimination (Scheme 59).  
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Scheme 59: The mechanism postulated by Loh. 
 
 
No cyclization was observed with 1-alkyl-2-methyl-3-butenols and 1-alkyl-3-
butenols, and only the allyl transfer was observed.  
O
O
Shidasterone
183  
Scheme 60: Structure of Shidasterone. 
 
Loh demonstrated practical use of this method in the synthesis of Shidasterone,74 a 
steroid with recently discovered antitumor activity. 
Loh and Cheng have further reported that when the cyclization was conducted at 0 °C, 
the reaction took a completely different turn to afford the tetrahydrofuran product 186 instead 
of 187, which can be viewed as a result of an exocyclic Oppolzer’s type III cyclization.75,76 
Temperature appears to function as the key switch in alteration of the reaction pathway.  
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Scheme 61: Temperature influence in Loh's cyclizations. 
 
Table 5. Some of Loh and Cheng’s results which show the influence of the temperature 
and different substituents (Scheme 61). 
entry R2 T/°C yield of the main product (%)  
1 PhCH2CH2 40 65 
2 PhCH2CH2 0 95 
3 CH3(CH2)7 40 81 
4 CH3(CH2)7 0 69 
5 Ph 40 97 
6 Ph 0 72 
7 cyclohexyl 40 75 
8 cyclohexyl 0 77 
 
All reactions proceeded smoothly to afford various five-membered cyclic ethers but 
not with a very good stereoselectivity. This can be accounted for by the relatively non-rigid 
five-membered transition state 189 (Scheme 62). 
 
 
 
Scheme 62: Proposed mechanism of the cyclization. 
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Another mechanism was proposed for the formation of 187. It involves an oxonium-
ene type cyclization to afford the carbocation intermediate 192, prior to the 1,3-shift, 
rearranging to the thermodynamic product 187 under thermal conditions (Scheme 63).  
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Scheme 63: Proposed mechanism of the formation of thermodynamic product 187. 
 
This mechanism is supported by the fact that 190 is converted into 187 upon refluxing 
in dichloromethane in the presence of indium triflate. However, when the experiment was 
carried out in the presence of a 2,6-di-tert-butyl-4-methylpyridine, no reaction took place and 
only starting material was isolated. Furthermore, trifluoromethanesulfonic acid also catalyses 
the same transformation of 190 to 187. The latter observations indicate that a complex protic 
acid is formed in the reaction system, which catalysed the in situ generation of a carbocation, 
triggering the postulated thermodynamic 1,3-shift.  
Loh and Tan reported that no desired tetrahydrofuran product 195 was obtained when 
monosubstituted homoallylic alcohol 194 was subjected to the same reaction conditions 
(Scheme 64), apparently disubstitution at the distal end of the double bond is essential to this 
oxonium-ene type cyclization. Here, instead of the furan 195, α-adduct 196 was isolated as a 
main product together with a small amount of γ-adduct 197 and traces of Prins cyclization 
product 198 (Scheme 64 and Table 6). 
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Scheme 64: Homoallylic alcohols with the monosubstituted double bond at the distal 
end under "Loh's conditions". 
  
Table 6: Some of Loh and Tan’s results which show the influence of different 
substituents. 
entry R R2 yield/% ratio of 
products 
196/197formed 
1 Cy PhCH2CH2 25 >95 : 5 
2 (CH3)2CH PhCH2CH2 23 >95 : 5 
3 n-C8H17 PhCH2CH2 25 76 : 24 
4 Ph PhCH2CH2 45 >95 : 5 
5 Cy PhCH2CH2 49 >95 : 5 
6 t-Bu PhCH2CH2 69 >95 : 5 
 
Loh and Tan also explored various catalysts in the reaction of alcohol 199 with 
dihydrocinnamaldehyde (Scheme 65). Whereas CSA, PTSA, InBr3, Ag(OTf)3, La(OTf)3, and 
Lu(OTf)3 did not work at all, Yb(OTf)3, Cu(OTf)2, Sc(OTf)3, Sn(OTf)2, and In(OTf)3 gave 
different ratios of products 200, 201 and 202 (Table 7). 
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Scheme 65: Influence of the Lewis acid. 
 
Table 7: Screening of various Lewis acids. 
entry catalyst yield of 200 (%) yield of 201 (%) 
1 Yb(OTf)3 15 5 
2 Cu(OTf)2 22 3 
3 Sc(OTf)3 40 28 
4 Sn(OTf)2 55 23 
5 In(OTf)3 69 10 
 
The following mechanism of the formation α-adducts, γ-adducts and Prins cyclizaton 
products were suggested (Scheme 66). The α-adduct 209 was generated from the In(OTf)3 
promoted allyl transfer reaction of the γ-adduct 207. Thus, alcohol 207 underwent a 
thermodynamic conversion to the preferred linear regioisomer 209. The stereochemistry was 
retained after the allyl transfer from the original homoallylic alcohol 204. The steric effect is 
very important, and the whole rearrangement process was driven by the difference in steric 
bulk of the two substrates. The cyclic Prins product 202 was derived from the oxonium ion 
205 which can cyclize to give a stable cation 203 which reacts further to give the six 
membered ring 202.   
 
 
54 
 
 
Scheme 66: Proposed mechanism. 
 
In 2006 Peng and Hall reported on the synthesis of homoallylic alcohols 210 
containing a trimethylsilyl moiety, which upon treatment with aldehydes gave all-syn 
trisubstituted tetrahydrofurans 7 with high diastereo- and enantioselectivity (Scheme 67 and 
Table 8).1 The diastereoselectivity is explained by the pseudo-diequatorial arrangement of R1 
and R2 in the transition state 211. 
 
 
Scheme 67: Peng & Hall's cyclization. 
 
Table 8: Examples of Peng & Hall's cyclizations. 
Entry R1 R2 yield (%) ee (%) 
1 PhCH2CH2 Ph 75 93 
2 PhCH2CH2 n-C7H15 82 95 
3 Ph PHCH2OCH2 72 91 
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 Remarkably, the use of ketones instead of aldehydes in this reaction provides 1,1,2,4-
tetrasubstituted furans 212 in high yields (Scheme 68).   
 
 
Scheme 68: Ketones in the Peng & Hall's cyclization. 
 
Also, both syn and anti crotyl reagents 213 and 214 were prepared and their reactions 
with aldehyde gave the corresponding tetrasubstituted tetrahydrofurans 215 and 216. 
 
 
Scheme 69: A way to prepare the tetrasubstituted tetrahydrofurans. 
  
Enantiopure starting materials (homoallylic alcohols) for those reactions were 
prepared using the pinanediol chiral auxiliary. From pinanedioxy ethyleneboronic ester 217, 
intermediate 218 was prepared in two steps. Intermediate 218 adds onto aldehydes with very 
good E/Z selectivity and enantioselectivities forming the homoallylic alcohol 210 (Scheme 
70).  
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Scheme 70: Enantioselective version with the chiral auxiliary. 
 
As depicted in transition structure 219, the enantioselectivity is controlled by the 
configuration of the reagent’s α-carbon centre and the preference for a pseudo-equatorial 
orientation of the substituent. 
An obvious drawback of this method is the need of one equivalent of an expensive 
chiral auxiliary, which cannot be recovered from the reaction (5g of (+)-vinylboronic acid 
pinanediol ester currently costs £158.00 at Aldrich).   
 
Homoallylic alcohols can be prepared enantioselectively by an allylation reaction 
from the corresponding trichlorosilanes by using a catalytic amount of chiral catalyst (which 
can be later recovered from the reaction mixture).77   
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2.3 Results and discussion 
2.3.1 Project Aim 
 
Lewis base-catalysed enantioselective allylation of aldehydes has become a powerful 
tool for the C-C bond formation, providing a robust alternative to the boron chemistry, using 
allyl boranes and a stoichiometric amount of chiral auxiliaries. It has been demonstrated 
recently that the homoallylic alcohols, products of the allylation of aldehydes with 
allyltrichlorosilanes, are themselves powerful allylating agents, which broadened the scope of 
the method even more. Further advancement can be achieved by decorating the 
allyltrichlorosilane with another functionality which would enable further synthetic 
development.78 
We envisioned that the bifunctional allyldisilane 1 would allow a stereoselective triple 
allylation of aldehydes, resulting in a stereocontrolled construction of trisubstituted 
tetrahydrofurans. Interestingly, the two silicon groups in the disilane have in fact orthogonal 
reactivities. Allytrimethylsilane requires Lewis acid catalysis to undergo the transformation, 
whereas allyltrichlorosilyl reagents are activated by the Lewis bases. With the bifunctional 
disilane 1, the key stereogenic centres are constructed in the first allylation step and the 
subsequent diastereoselective cyclization cascade then requires just a non-chiral Lewis acid. 
The first steps of the cascade mirrors the analogous cross-crotylation. The key difference is 
that the alcohol 4 has a latent allylsilane functionality, which is unmasked by the [3.3] 
sigmatropic rearrangement (221  Æ 222), and the five-membered ring 7 is closed by the 
intramolecular allylation (Scheme 71). 
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Scheme 71:  The reaction cascade towards the substituted tetrahydrofurans. 
 
 
2.3.2 Synthesis of the Disilane 
 
There are at least two feasible ways to prepare the intermediate 228 (Scheme 72 and 
73) from the corresponding propargyl-based starting material.  
 
 
 
Scheme 72: Synthesis of the intermediate 228 from the propargylic alcohol. 
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Route 2 (Scheme 73) is somewhat shorter, and looks more feasible at the first glance. 
However, Route 1 (Scheme 72) was explored first, taking into account the cost of the 
starting materials, low published yields of the Grignard step and last but not least the use of 
the toxic mercury(II) chloride suggested in this transformation involved in Route 2.  
 
Scheme 73: Synthesis of the intermediate 228 from the propargylic bromide. 
 
 
Propargylic alcohol 223 was protected as a tetrahydropyranyl ether 224,79 which was 
deprotonated with n-butyllithium, and treated with (chloromethyl)trimethylsilane using the 
published conditions.80 However, only poor conversion (~6%) was observed, due to the poor 
electrophilicity of the (chloromethyl)trimethylsilane. The more reactive 
(iodomethyl)trimethylsilane and (trifluoromethansulfonylmethyl)trimethylsilane are 
commercially available but considerably more expensive. (Iodomethyl)trimethylsilane 227 
was therefore prepared by the Finkelstein reaction of 225 with an excess of sodium iodide in 
acetone and reacted readily with the deprotonated propargylic alcohol to give intermediate 
227 in good yield.81  
Surprisingly, the deprotection step turned out to be quite tricky. The published method 
using PTSA in methanol gave disappointingly low yields and a lot of undesired byproducts. 
We investigated alternative deprotection protocols involving AcOH in THF,82 MgBr283, 
PPTS84 and few others and identified PPTS in aqueous ethanol at an elevated temperature as 
an optimal method, see Table 9 for details.  
 
Table 9: Deprotection of 227. 
Entry Reagent Reaction conditions Yield % 
1 PTSA, aq. MeOH solution 0°C, then 20h at 20 °C 60 
2 AcOH, THF, water (vol. ratio 14:2:1) 24 h at 20 °C 0 
3 MgBr2, Et2O 24 h at 20 °C 0 
4 PPTS, aq. EtOH solution 24 h at 20 °C 88 
5 PPTS, aq. EtOH solution 24 h at 55 °C 98 
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Reduction of the triple bond by lithium aluminium hydride (228 to 229) proceeded 
uneventfully, and the (E)-isomer was formed exclusively as expected (Scheme 74).       
 
 
Scheme 74: Synthesis of the chloride 230. 
 
The conversion of alcohol 229 into chloride 230 proved to be quite problematic and 
required a great deal of optimization. The published procedure using an excess of thionyl 
chloride at low temperatures failed completely, giving just a complex mixture of products.85 
Surprisingly, by using thionyl chloride and an excess of amine base in dichloromethane we 
obtained a mixture of (E) and (Z) isomers of allylic chloride. We assumed that the allylic 
rearrangement of 229 took place and the resulting carbocation 235 (stabilized by the silicon 
in β-position) allowed the isomerisation of the double bond and formation of 237 to occur 
(Scheme 75). Unfortunately, the (Z)-isomer (which was always formed preferentially despite 
varying reaction conditions) is unsuitable for further enantioselective allylation using 
METHOX as a catalyst.   
 
Scheme 75: Isomerization of the allylic chloride 230. 
 
After this failure we switched to procedures that utilize milder chlorinating reagents. 
Lithium chloride in the presence of methanesulfonyl chloride and lutidine or collidine in 
DMF was reported to be selectively converting allylic alcohols into chlorides.86 However, 
using the reported conditions (typically at 0 °C), we isolated just starting materials, whereas 
at elevated temperatures we obtained a complex mixture of products, probably due to the 
nucleophilic attack onto the double bond. Another mild method that has been claimed not to 
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give any allylic rearrangement products involved a treatment with N-chlorosuccinimide and 
DMS at low temperatures.87 However, we obtained only a complex mixture, again with none 
of the desired product present.  
We switched to the methods employing triphenylphosphine and various chlorinating 
agents. The reaction with triphenylphosphine in tetrachloromethane appeared promising and 
the desired allylic chloride was formed (although the conversion was poor even after 
prolonged time under reflux).88 Finally, the reaction with triphenylphosphine and 
hexachloroacetone or N-chlorosuccinimide gave the desired allylic chloride with full 
conversion.89  
However, this reaction is typically carried out at 0 °C in order to prevent the side 
reactions and requires excess (usually at least 2 equivalents) of triphenylphosphine in order to 
reach reasonable conversion under those conditions. Unfortunately, due to the sensitive 
nature of the product, the crude reaction mixture cannot be purified by column 
chromatography, which leads to decomposition (even when basic silica gel or alumina treated 
with triethylamine are employed). Upon heating, the nucleophilic substitution on the allylic 
chloride with the remaining triphenylphosphine took place, giving rise to the phosphonium 
salt, distillation was therefore not an option as a purification method. With just one equivalent 
of the triphenylphosphine present, the reaction became too slow at 0 °C, on the other hand 
upon warming up to room temperature, too many byproducts were formed. We tried to 
oxidise the remaining triphenylphosphine carefully with a slight excess of hydrogen peroxide 
at low temperature to get triphenylphospine oxide (which is insoluble in diethyl ether and 
non-polar solvents, hence easy to separate), however the product decomposed under those 
conditions. We observed a similar degradation of the product when methylation of the excess 
triphenylphosphine was attempted with iodomethane in order to produce an insoluble 
phosphonium salt, which could be filtered off from the reaction mixture.  
In conclusion, the best method found was leave the reaction mixture at 5-10 °C with 
one equivalent of triphenylphosphine and N-chlorosuccinimide, while monitoring the 
progress by TLC carefully. When quenched in time, this method gave full conversion, 
typically after several hours, and almost no byproducts detected in the crude mixture. The 
chlorination methods used are summarized in Table 10.  
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Table 10: Chlorination of 229. 
Entry Reagent T (°C) Result 
1 SOCl2 0 complex mixture 
2 SOCl2/Et3N/CH2Cl2 0 predominantly cis allyl 
chloride 
3 SOCl2/Hünig’s 
base/CH2Cl2 
0 predominantly cis allyl 
chloride 
4 LiCl/MsCl/DMF 0 0 % conversion 
5 LiCl/MsCl/DMF RT decomposition 
6 NCS/DMS -30 decomposition 
7 Ph3P/CCl4 RT 6 % conversion 
8 Ph3P/hexachloroacetone 5 >99% conversion 
9 Ph3P/NCS 5 >99% conversion 
 
Trichlorosilylation reaction, using the optimised conditions for the allyl/crotyl 
chloride substrate analogues (i.e., room temperature, cat. amount of Cu(I) chloride, amine 
base as a proton scavenger, 2-3 hours to reach the full conversion) proceeded slowly, giving 
very low conversion <10% even after prolonged reaction time and no changes were observed 
even upon raising the temperature (which, not surprisingly, also led to the decomposition of 
the sensitive trichlorosilane after a few hours). Employing the more active Cu(I) bromide or 
iodide instead of chloride as a catalyst had no effect, increasing the catalyst loading up to 
10% had no effect either. Attempts were therefore made to synthesize more reactive starting 
material, i.e. bromide (with NBS a CBr4), iodide and triflate. However, procedures using 
various brominating and iodinating agents to convert 229 into 231 or 232 failed, as well as 
the Finkelstein procedure, giving usually just a complex mixture of products.   
 
Me3Si
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Cl
Me3Si
SiCl3
Me3Si
Br Me3Si
I
230 1229
231 232
HSiCl3
CuCl
Scheme 76: Synthesis of the disilane. 
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It was however found that upon increasing the amount of the copper “catalyst” to at 
least one equivalent, full conversion was achieved within a few hours (similarly to the 
allyl/crotyl chloride substrate analogue). This observation may actually solve the problems 
connected with the synthesis of the analoguous trichlorosilane 239, where similar conversion 
issues were encountered in our group several years ago; this hypothesis has not been tested 
yet however (Scheme 77).90  
 
Br Cl
notoriously low yields,
used as a crude mixture
Br SiCl3 R
O
184238 239  
Scheme 77: Problems connected with the synthesis of analogous trichlorosilane 
previously in our group. 
 
2.3.3   Allylation of Aldehydes 
 
As a model reaction, racemic homoallylic alcohol 4a bearing the trimethylsilane 
moiety was prepared by from p-tolualdehyde by allylation with trichlorosilane 1 and DMF as 
a Lewis base catalyst (Scheme 78).21 As in the case of simple crotylation, the reaction gave 
exclusively the anti-configured product (as expected from the 6-membered chair transition 
state), which was confirmed by the NMR spectroscopy and X-ray crystallography. 
p-Tol
O
p-Tol
OH
Me3Si
Me3Si
SiCl3
DMF
(±)-4a1  
Scheme 78:  Model allylation of p-tolualdehyde. 
 
A series of racemic homoallylic alcohols 4 was then prepared by allylation of 
aldehydes 36 with the bifunctional allyldisilane 1, again using DMF as an achiral Lewis base 
(Scheme 79). Results are summarized in Table 11.  
 
 
Scheme 79: Allylation of aldehydes with the disilane 1. 
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Table 11: Allylation of various aldehydes. 
aThe reactions were carried out with 0.5 mmol of aldehyde, 0.4 mmol of disilane and 0.5 
mmol of DMF. bIsolated yield; all products were diastereoisomerically pure (>99:1 dr), as 
evidenced by 1H NMR spectroscopy. cSee Scheme 80 for the structures of the selected 
aldehydes.  
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Scheme 80: Some of the model aldehydes used in the allylation reaction. 
 
 Aldehydes were selected mostly according to their electronic properties to explore the 
scope and limitations of the reaction. The piperonal-, vanillin- and gallic-like moieties of 
aldehydes 36j, 36k and 36i are also a common motif in several natural products.  
 
 
 
 
 
Entry R1 Aldehydea  Product 4 Yield [%]b 
 1 Ph 36a 4a 88 
 2 4-MeC6H4 36b 4b 92 
 3 4-FC6H4 36c 4c 85 
 4 4-CF3C6H4 36d 4d 90 
 5 4-NO2C6H4 36e 4e 91 
 6 3-MeOC6H4 36f 4f 80 
7 nC5H11 36gc 4g 79 
8 nPrCH=CH 36hc 4h 90 
9 3,4,5-(MeO)3C6H2 36ic 4i 71 
10 2-MeO-3-OTBDMS-C6H3 36jc 4j 75 
11 piperonyl 36kc 4k 67 
12 PhC2H4 36lc 4l 77 
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2.3.4    Asymmetric Allylation of Aldehydes 
 
Next, we endeavoured to prepare these homoallylic alcohols enantioselectively. A 
whole range of organocatalysts have been developed by our group in recent years including 
chiral N-oxides, amides and others (Scheme 82) and several of them were tested in the 
allylation reaction with the above mentioned disilane. (Scheme 81 and Table 12).   
 
Scheme 81: The enantioselective allylation of 36. 
 
Table 12: Screening of various catalysts. 
Entry Aldehyde 36, R1 a Catalystg Loading 
[mol%] 
Solvent b t c 
 
Yield of 4  
[%]d 
ee of 4 
[%]e 
 1 36a, Ph 62 20 CH3CN 7d 52 93 
 2 36a, Ph 62 10 CH3CN 11d 23 10f 
 3 36c, 4-FC6H4 62 15 CH3CN 7d 45 97 
 4 36d, 4-CF3C6H4 62 15 CH3CN 7d 55 90 
 5 36e, 4-NO2C6H4 62 20 CH3CN 7d 46 94 
 6 36f, 3-MeOC6H4 62 15 CH3CN 7d 41 96 
 7 36c, 4-FC6H4 61 50 DCM 10d 47 89 
 8 36d, 4-CF3C6H4 61 20 DCM 9d 50 99 
 9 36a, Ph 244 10 THF 12h 80 90 
10 36d, 4-CF3C6H4 244  5 THF 12h 73 97 
11 36f,  3-MeOC6H4 244  5 THF 12h 73 77 
12 36i,  n-C5H11 244  5 THF 12h 80 73 
13 36k, n-PrCH=CH 244  5 THF 12h 83 98 
14 36a, Ph 245 10 THF 12h 82 96 
15 36a, Ph 245  1 THF 24h 70 91 
16 36d, 4-CF3C6H4 245  5 THF 12h 79 94 
17 36f,  3-MeOC6H4 245  5 THF 12h 71 87 
18 36l, PhC2H4 245  5 THF 12h 85 30 
aThe reactions were carried out with 0.5 mmol of aldehyde and 0.4 mmol of disilane at        
-35 oC. bThe solvent was optimized for each catalyst previously.91 cReaction time: d - days, 
h - hours. dIsolated yield; all products were diastereoisomerically pure (>99:1 dr), as 
evidenced by 1H NMR spectroscopy. eDetermined by chiral HPLC or GC. The relative 
configuration was established by 1H NMR spectroscopy. fReaction at room temperature. 
gSee Scheme 82 and Scheme 83. 
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Scheme 82: Some of the organocatalysts developed in our group. 
 
However, the early experiments involving METHOX (62), our most successful 
allylation catalyst to date, were not very promising. Whilst allylation and crotylation 
reactions of aldehydes catalysed by METHOX are usually complete within hours, when using 
the disilane 1 we did not observe any notable conversion even after 48 hours at -40°C.77 
Upon increasing the temperature the sensitive starting material eventually decomposed.  
It had been demonstrated that bulky trichlorosilanes react considerably more slowly 
and require higher catalyst loading and longer reaction time.92 We screened several 
organocatalysts under various reaction conditions and whereas at room temperature the 
starting material usually decomposed before the allylation could have taken place, at lowered 
temperatures the reaction became very sluggish. Pyridine-based catalyst 243 (PINDY) did not 
work at all, N,N-dioxide 246 showed moderate enantioselectivity but with low yield, with 239 
(Kenamide) and 240 (Kenphos) the yields increased but at the expense of enantioselectivity. 
Finally, 61 (QUINOX) gave good 89% ee in the allylation of p-fluorobenzaldehyde and 
excellent 99% ee in the allylation of p-trifluoromethylbenzaldehyde (Table 12, entries 7 and 
8). The reaction was very slow though and usually took several days to complete and thus the 
yields were low to moderate, most likely due to the decomposition of the starting material 
during this long reaction time.   
 Encouraged by these results, we turned back to METHOX, this time allowing the 
reaction to run for several days at -35 °C in the freezer. Conversion was checked in the 
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intervals of 2-3 days to minimize the damage to the sensitive starting material. Allylation of 
various aldehydes with trichlorosilane 1 catalysed by METHOX gave homoallylic alcohols 
with ees over 90%  (Table 12, entries 1 - 6). 
Organocatalyst 241 gave full conversion, in a period of few hours, unfortunately this 
catalyst was not available in an enantiopure form (as attempts for its resolution, e.g., by 
crystallization with BINOL,31 failed, and this catalyst was therefore abandoned for the time 
being).93 The results were however suggesting the N,N’-dioxides, such as 241 or PINDIOX, 
242 could be the catalysts of choice. Efforts were made to prepare an analogue of the N-
dioxide catalyst 241 (see Chapter 3.2.1. for details).     
We eventually turned to the N,N’-dioxide catalysts 244 and 245, which gave us both 
excellent conversion and enantioselectivities in just several hours (Scheme 83 and Table 12, 
entries 9-18).33  These catalysts worked even with aliphatic aldehydes and we got moderate 
73% ee for the functionalization of hexanal and excellent 98% for allylation of hex-2-enal. 
This is to the best of our knowledge the first example of an effective addition of an allyl 
trichlorosilane to an aliphatic aldehyde, which are notoriously difficult substrates, and with 
the exception of Kobayashi’s chiral formamide, most of other organocatalysts do not work 
for this type of reaction at all.11 
We were also able to lower the catalyst loading to 5 mol% without any loss of 
enantioselectivity or notable loss of the reaction rate. Upon decreasing the catalyst loading  to 
1 mol%, full conversion was reached after 24 hours, with ee still over 90%.     
 
 
Scheme 83: The most active dioxide catalysts. 
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2.3.5 The Intramolecular Cascade Allylation 
 
Alcohol 4b was reacted with another aldehyde in the presence of a Lewis acid to give 
rise to a mixture of diastereoisomers (Scheme 84). Both products were in ~ 1:1 ratio, 
depending on the reaction conditions and the nature of the starting aldehyde, syn-7b (bearing 
all the substituents on the same side of the ring) and anti-7b (with the vinyl group on the 
opposite side). Upon decreasing the temperature, the disatereoisomeric ratio changed in 
favour of product syn-7b  (Scheme 84 and Table 13), therefore compound syn-7b  will be 
referred to as a syn tetrahydrofuran (or kinetic) product from now on in the text, compound 
anti-7b will be referred to as an anti product. Configuration was established by extensive 
NOE analysis (see the experimental part for details). 
 
Scheme 84: Intramolecular allyl transfer to form tetrahydrofurans 7b. 
 
Table 13: Intramolecular allyl transfer (Scheme 84). 
entry R2 T/°C solvent ratio of syn-7b : anti-7b 
1 PhCH2CH2 20 CHCl3 1 : 1.5 
5 p-Tol 60 CHCl3 1 : 1a 
2 p-Tol 20 CHCl3 1.2 : 1 
3 p-Tol -50 CHCl3 1.7 : 1 
4 p-Tol -90 CH2Cl2b 5:1 
aOnly traces of the cyclic products 7b, compound 247 was observed as a major product. 
bDichloromethane used as a solvent, as chloroform freezes at -63 °C 
 
When the reaction temperature was decreased to -90 °C, we were able to obtain a 
mixture of syn-7b and anti-7b  in 5 : 1 ratio (Table 13, entry 4). However, attempts to obtain 
the anti diastereoisomer anti-7b  selectively by increasing the reaction temperature failed as 
yields dropped drastically and the alcohol 247 was identified as the main product of the 
reaction, presumably via the mechanism shown in the Scheme 85.  
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Scheme 85: The unexpected product 247 and a possible mechanism of its formation. 
 
Several Lewis acids were screened in the reaction of the homoallylic alcohol 4b with 
p-tolualdehyde; the results are summarized in (Scheme 86 and Table 14). All reactions were 
carried out at room temperature in CHCl3 as a solvent. 
Tol
SiMe3
OH
TolCHO
RT, CHCl3
cat
O TolTolO TolTol
+
4b anti-7bbsyn-7bb
(~ 10-50 mg scale)
 
Scheme 86: LA screening. 
 
Table 14: Results of the LA screening. 
entry catalyst conversion ratio of syn-7bb  and anti-7bb 
1 Sn(OTf)2 full 1.2 : 1 
2 Cu(OTf)2 full 2.6 : 1 
3 Ag(OTf)2 full N/Aa 
4 ZnI2 full N/Ab 
5 SnCl2 full N/Ab 
6 AlCl3 full N/Ac 
7 Ph3SiCl 0 % N/Ad 
8 TMSOTf full 1 : 1e 
9 TfOH full N/Af 
aNo trace of desired cyclic products 7, unknown byproduct. bCompound 247 as the only 
product. cStarting material decomposed. dNo reaction, only starting material isolated. eOnly 
traces of the cyclic products 7, compound 247 was observed as a major product. Reaction 
was repeated at -40°C, giving 30% of compounds syn-7bb  and anti-7bb in 1:1 ratio and 
70% of compound 247. fCompound 247 as the only product. Reaction was repeated at -40°C 
with the same result.   
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 As can be seen from Table 14, if one wishes to obtain the tetrahydrofuran products, 
tin(II) triflate and copper(II) triflate are the catalysts of choice. Catalyst loading was varied 
from 5-50 mol % and did not have any notable effect on the outcome of the reaction or ratio 
of the tetrahydrofuran diastereoisomers. 
Early experiments were run in chloroform as a solvent, as this proved to be the best 
choice for the ‘standard’ allyl transfer reaction. However, several solvents were screened in 
the model reaction of the homoallylic alcohol 36b with p-tolualdehyde; the results are 
summarized in Table 15. All reactions were carried out at room temperature with 50 mol% 
loading of tin(II) triflate as a catalyst.   
 
Scheme 87: Solvents screening. 
 
Table 15: Results of the solvents screening. 
entry solvent conversion ratio of syn-7bb  and anti-7bb 
1 dichloromethane full 1.9 : 1 
2 chloroform full 1.2 : 1 
3 tetrachloromethane full 1 : 1.4 
4 diethyl ether full 5.7 : 1 
5 tetrahydrofuran full 9.9 : 1 
6 hexane full N/Aa 
7 benzene full N/Aa 
8 methanol full 9.4 : 1 
9 ethyl acetate full 9.1 : 1 
10 dimethylformamide 0 % N/Ab 
11 dimethylsulfoxide 0 % N/Ab 
12 acetonitrile full N/Aa 
aCompound 247 as the only product. bNo conversion, only starting material isolated. 
It seems that polar (entry 8) and etheric solvents (entries 4, 5) enhance the 
diastereoisomeric ratio in favour of the kinetic product. Non-polar solvents (entries 6, 7) as 
well as elevated temperature promote the formation of 247. In polar aprotic solvents (entries 
10, 11) no reaction took place. THF emerged as the solvent of choice then, with methanol and 
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ethyl acetate following closely behind. On the other hand, in chlorinated solvents (entries 1-
3), the reaction was not diastereoselective, giving an almost equimolar ratio of syn and anti 
products. 
 Taking into account these results, we carried out reaction of 4b with p-tolualdehyde at 
-90 °C in tetrahydrofuran, obtaining a mixture of products syn-7bb and anti-7bb in 21:1 
ratio. Rationale behind the temperature influence is as follows (Scheme 88): 
 
 
Scheme 88: Mechanism of formation of the syn and anti tetrahydrofuran product. 
 
 The major products formed under the kinetic conditions (low temperature) are the all-
syn substituted tetrahydrofurans. The first steps of the cyclization (Scheme 88, 4 → B) were 
expected to mirror the analogous cross-crotylation,94 however, the key difference between 
alcohols 4 and the non-functionalized analogues of 4 (i.e., homoallylic alcohols without the 
trimethylsilyl moiety), is that 4 has a latent allylsilane functionality, which is unmasked by 
the oxonia-Cope rearrangement (4 → A): the intermediate C, arising from A via TS B 
contains both the activated carbonyl fragment and the allylsilane moiety. This intermediate is 
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then set for yet another intramolecular allylation (C → all-syn 7 or C → trans 7). In this final 
allylation, low temperature favors TS D, affording the all-syn product, as the trimethylsilyl 
chain is already prearranged in the equatorial position from the previous sigmatropic 
rearrangement. Higher temperature on the other hand would tend to allow for the competing 
pathway to operate to some extent (C → E → anti 7), to give the anti product (Scheme 88).   
 
2.3.6   Scope and Limitations 
 
Homoallylic alcohol 4b was reacted with several aldehyde representatives containing 
electron rich and poor aromatic rings and aliphatic moiety to explore the scope of the 
reaction. With p-fluorobenzaldehyde (Scheme 89), a mixture of 7bc and the unexpected 
byproduct 7cc  in ~ 1 : 1 ratio was obtained, two diastereoisomers of each in 1:1 ratio.  
Scheme 89: Unwanted byproducts during the cyclization. 
 
p-Fluorobenzaldehyde was used in a slight excess (1.2 eq), and both p-
fluorobenzaldehyde and p-tolualdehyde were observed in the crude reaction mixture despite 
the fact that the latter aldehyde was not present before. This observation, as well as the 
formation of 7cc, can be rationalized by the following mechanism (Scheme 90).  
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Scheme 90: Formation of the byproduct 7cc. 
 
Homoallylic alcohol 2 reacts with p-fluorobenzaldehyde, forming the intermediate 
251 via the oxonia-Cope rearrangement. Then, either cyclization (intramolecular allyl 
transfer) can take place as outlined before, forming 7bc as the previously expected product. 
Alternatively, p-tolualdehyde is released forming the γ-homoallylic alcohol 252 as a product 
of “standard” allyl transfer. Alcohol 252 then reacts further with p-fluorobenzaldehyde (as it 
is more electrophilic than p-tolualdehyde) forming 7cc. 
One could expect that the intramolecular transformation of 251 into 7bc is much 
faster than the formation of 252. However, the relatively electron-rich tolyl moiety is 
decreasing reactivity of the adjacent carbonyl group, so that one could expect that when a 
more electron deficient aryl moiety is used instead of tolyl, formation of 7cc will be 
suppressed.  
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A different result was attained when we used p-methoxybenzaldehyde as a substrate 
(Scheme 91). A mixture of the expected 7bn as well as the undesired 7bb was obtained in 
ratio 1 : 3.5. The side product had the aryl moieties of the original homoallylic alcohol on 
both “sides” of the tetrahydrofuran ring. Both p-methoxybenzaldehyde and p-tolualdehyde 
were detected in the crude mixture.   
 
 
Scheme 91: Unwanted byproducts during the cyclization. 
 
This result can also be rationalized by the mechanism similar to that above (Scheme 
92), taking into account the fact that this time, p-tolualdehyde is the most reactive aldehyde 
present in the system. Intermediate 254 undergoes either the ‘standard’ allyl transfer giving 
the γ-homoallylic alcohol 255 and eventually the tetrahydrofuran 7bn or undergoes the 
cyclization giving the ‘unexpected’ product 7bb. 
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Scheme 92: Formation of the byproduct 7bb. 
 
 
Reaction of 4b with benzaldehyde gave the expected product 7ba with just a trace of 
the byproduct 7aa (Scheme 92).  
  
 
Scheme 93: Reaction of 4b and 36a. 
 
For summary of the results see Scheme 94 and Table 16. 
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Scheme 94: The cyclization and the unwanted byproducts. 
 
Table 16: Products distribution depending on the electron properties of the aldehyde. 
entry R2 solvent T/°C product(s), (ratio) 
ratio  
of   the   syn : anti 
diastereoisomers  
1 PhCH2CH2 CHCl3 20 I only 1 : 1.5 
2 Ph CHCl3 20 I : II (1: 1) 1.4 : 1 
3 p-F-C6H4 CHCl3 20 I : II (1 : 1) 1 : 1 
4 p-F-C6H4 THF -90 I : II (1 : 2)  6.2 : 1 
5 p-MeO-C6H4 CHCl3 20 I: III (1 : 2.5) 1.2 : 1 
6 p-MeO-C6H4 THF -90 I : III (1 : 3.5) 4.3 : 1 
7 CH3CH=CH THF -90 no reaction N/A 
 
Racemic homoallylic alcohols 4 were subjected to the allyl-transfer reaction with 
aldehydes 36, catalysed by the Lewis acid (Scheme 95). For this allylation sequence, the 
reaction conditions were optimized to give preferentially kinetic product all-syn-7. The 
results are summarized in Table 17. Most of the cyclizations were carried out with racemic 
alcohols 4, however preservation of the enantiointegrity during the cyclization cascade was 
illustrated by employing the enantioenriched 4 (entries 1, 9, 11 and 20). As mentioned 
before, low temperature was found to be a prerequisite for achieving high 
diastereoselectivity; at room temperature, it dropped considerably (compare entries 6 and 7).  
The reaction offers a diverse substrate scope: apart from the representative aromatic 
aldehydes 36 (entries 1-15), it also proved to work well with aliphatic (entries 16, 17, 20, 
21), α,β-unsaturated (entry 18, 19, 23 and 24), and heteroaromatic aldehyde (entry 25).  
 
 
Scheme 95: Cyclizations at optimized conditions. 
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Table 17: Examples of the intramolecular allyl transfer. 
Entry Alcohol 4, R1 a Aldehyde 36, R3 Tetrahydrofuran  7 Yield  [%]b Dr c (all-syn-7/anti-7) 
(ee [%]) 
1 4a, Ph  36a, Ph 7aa 95 > 25:1 (90)d 
2 4a, Ph 36b, 4-MeC6H4 7ab 90 > 25:1 
3 4a, Ph 36d, 4-CF3C6H4 7ad 80    20:1 
4 4a, Ph 36g, 4-ClC6H4 7ag 94    21:1 
5 4a, Ph 36h, 3-BrC6H4 7ah 87 > 25:1 
6 4b, 4-MeC6H4 36b, 4-MeC6H4 7bb 85 > 25:1 
7e 4b, 4-MeC6H4 36b, 4-MeC6H4 7bb 86    10:1 
8f 4b, 4-MeC6H4 36b, 4-MeC6H4 7bb 88   1.2:1 
9 4c, 4-FC6H4 36a, Ph 7ca 92 > 25:1 (87, 95)g 
10 4c, 4-FC6H4 36g, 4-ClC6H4 7cg 90    23:1 
11 4d, 4-CF3C6H4 36a, Ph 7da 79 > 25:1 (90)i 
12 4e, 4-NO2C6H4 36a, Ph 7ea 90 > 25:1  
13 4e, 4-NO2C6H4 36b, 4-MeC6H4 7eb 89 > 25:1 
14 4e, 4-NO2C6H4 36g, 4-ClC6H4 7eg 92 > 25:1 
15 4a, Ph 36o, 3-BrC6H4 7ao 89  > 25:1   
16 4a, Ph 36i,  nC5H11 7ai 88    10:1 
17 4a, Ph 36j,  cC6H11 7aj 85    10:1 
18 4e, 4-NO2C6H4 36k, nPrCH=CH 7ek 91 > 25:1 
19 4e, 4-NO2C6H4 36l,  Me(CH=CH)2 7el 80      7:1 
20 4k, nPrCH=CH 36i,  nC5H11 7ki 92      9:1 (95)j 
21 4a, Ph 36j, Et 7aj 25     10:1 
22 4a, Ph 36k, iPr 7ak 0     n/a 
23 4a, Ph 36l,cyclohexenyl  7al 55     15:1 
24 4a, Ph 36m, cinnamyl 7am 49     12:1 
25 4a, Ph 36n, furyl 7an 45     9:1 
26 4c, 4-FC6H4 36b, p-Me-C6H4 7ch 91    15:1 
27 4k, nPrCH=CH 36a, Ph 7ka 82    20:1 
 aThe reactions were carried out with 0.5 mmol of aldehyde and 0.4 mmol of disilane using 
10-50 mol% of Sn(OTf)2 at -90 oC. bIsolated yield. cDr was determined by NMR 
spectroscopy, ee was determined by chiral HPLC or GC  dThe starting alcohol 4a was of 93% 
ee. eThe reaction was carried out at RT. fCHCl3 was used as a solvent (at RT). gThe starting 
alcohol 4c was of 89% ee and 97% ee, respectively. iThe starting alcohol 4d was of 90% ee. 
jThe starting alcohol 4k was of 98% ee.  
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Scheme 96: Examples of enantiopure tetrahydrofurans made. 
 
 
When the homoallylic aliphatic alcohol 4k was employed as a substrate for the 
cyclization, either with benzaldehyde or pentanal, only the expected tetrahydrofurans (as a 
mixture of diastereoisomers, see Scheme 96) were observed in the crude reaction mixture 
(Table 17, entries 20, 27). This implies that the aliphatic homoallylic alcohol 4k is 
sufficiently reactive and no isomerisation takes place.   
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Scheme 97:The intramolecular allylation sequence for the (E)-trichlorosilane. 
 
  
As mentioned before, silanes with the E configuration of the double bond give anti 
configured homoallylic alcohols with (Scheme 97). Trichlorosilanes with the cis 
configuration of the double bond (which give the syn homoallylic alcohols) are not suitable 
for the allylation reaction catalysed by METHOX, which we expected to be the catalyst of 
choice during the early experiments. However, with respect to the configuration of the final 
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tetrahydrofuran product, the configuration of the homoallylic alcohol (syn or anti) and thus 
the configuration of the double bond of the starting trichlorosilane 1, is actually immaterial.  
 
 
Scheme 98: The intramolecular allylation sequence for the (Z)-trichlorosilane. 
 
Hence, in general, it is not important how stereoselective the reduction of the triple 
bond or chlorination are because both isomers yield the same all-syn tetrahydrofuran product 
in the end, even if we use the mixture of two isomers as a starting material, as long as the 
catalyst we use in the allylation reaction is not as stereospecific as METHOX. 
 To prove this concept, alcohol 228 was hydrogenated in the presence of the Lindlar 
catalyst, giving alkene 226 with Z configuration on the double bond exclusively (Scheme 
98). A one-pot reaction to convert 227 into 256 was attempted, however no conversion of 227 
was observed even after several days. Chlorination of 256 using the same procedure as for E 
isomer gave surprisingly a 1:1 mixture of Z and E chlorides 257 and 230, trichlorosilylation 
of this mixture then gave a 1:1 mixture of the corresponding E and Z trichlorosilanes 258 and 
1, which afforded a mixture of syn and anti diastereoisomers of alcohol 4, again in 
approximate 1:1 ratio.   
 This mixture of syn and anti homoallylic alcohols 4 (inseparable on the column) gave 
only one diastereoisomer (all-syn) of 7aa when treated with benzaldehyde in the presence of 
Lewis acid (Scheme 99).    
80 
 
Me3Si
OTHP
Me3Si
OH
Me3Si Lindlar cat.
OH
Me3Si
Cl
(Z)
Ph
SiMe3
OH
(Z)
H2
Me3Si
SiCl3
(Z)
PPTS, EtOH
NCS, Ph3P
HSiCl3PhCHO
DMF
O PhPh
all-syn-7aa
1) H2, Lindlar cat. 2) PPTS, MeOH
227 228 226
257
258
anti-4a
Ph
SiMe3
OH
syn-4a
Me3Si
Cl
230
Me3Si
SiCl3
1
PhCHO
Sn(OTf)2
MeOH
(E)
+
98%
94%
54%
(both isomers)
86%
(both
isomers)
76%
(both isomers)
91%
(both isomers)
 
Scheme 99: Allylation with the E and Z disilane. 
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2.3.7 Tetrasubstituted Tetrahydrofurans   
 
As the next logical step in the tetrahydrofuran project, we used the methodology 
developed in the synthesis of tetrasubstituted tetrahydrofurans to make the tetrasubstituted 
tetrahydrofurans. This would open an easy synthetic pathway towards a whole range of 
relatively simple natural products with the tetrahydrofuran core 259, such as Galbacin 260, 
Verrucosin 261 or Beilschmin 262 and others (Scheme 100). Note the piperonyl-, vanillin- 
and gallic-like aryl moiety, which are a common motif of relatively simple natural products.  
 
Scheme 100: Some of the simple natural products with the tetrahydrofuran core. 
 
As the first approach towards this type of compounds we decided to redecorate the 
starting disilane 1 in order to obtain the corresponding homoallylic alcohols 264 with a 
substituent on the other side of the double bond (Scheme 101). These alcohols, when exposed 
to the optimized allyl-transfer conditions in the presence of a Lewis acid were expected to 
undergo the cyclization, forming the tetrasubstituted tetrahydrofurans 263.  
 
Scheme 101: Route to the tetrasubstituted tetrahydrofurans. 
 
Therefore, we attempted to synthesize the analogue of the bifunctional allyldisilane 1 
using a modification of the original reaction sequence (Scheme 102). We started off with the 
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but-3-yn-2-ol (rather than propargylic alcohol), protected as THP ether (266), and introduced 
the trimethylsilyl moiety. The deprotection step turned out to be rather troublesome however, 
giving poor yields. Attempts at protecting the but-3-yn-2-ol with various silyl groups also 
proved to be an exercise in futility as the subsequent deprotection was not particularly 
selective with respect to the trimethylsilyl moiety. Reduction of the triple bond of 268 and the 
subsequent chlorination of alcohol 269 using the previously optimized conditions worked 
well, however attempts to introduce the trichlorosilyl group onto the secondary carbon of 270 
using the standard trichlorosilane-based procedure failed despite several attempts. 
 
 
Scheme 102: Attempted synthesis of the modified disilane. 
 
 
Choosing a different approach towards the modified disilane, we started with the 
propargylic bromide 229, introduced the trimethylsilyl moiety first, and then obtained the 
intermediate 268 by the nucleophilic addition of the deprotonated 272 onto the acetaldehyde 
(Scheme 102). After reduction of the triple bond and chlorination, we attempted the Grignard 
chemistry this time, in order to introduce the trimethylsilyl moiety and failed again however, 
getting only a complex mixture of products.  
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We then chose a different strategy, and rather then making the allyldisilane 265, we 
attempted to modify the homoallylic alcohols of type 4, which we previously made (Scheme 
103).  
 
Scheme 103: Attempted modification of the original homoallylic alcohol 4. 
 
 Grubbs chemistry (Grubbs catalyst 1st and 2nd generation and Grubbs-Hoveyda 
catalyst, see the Experimental part for details) was attempted first, however the alcohols 
failed to react and even after tedious optimizations attempts, protection of the alcohol 
functionality and increasing the temperature/reaction time, we were able to obtain only traces 
of the desired product 273a  (Scheme 104). This failure apparently stems from the steric 
hindrance in the substrate-catalyst complex caused by bulky trimethylsilyl moiety, as the 
model metathesis reactions on the simple homoallylic alcohols without the trimethylsilyl 
moiety worked fine.95 
 
Scheme 104: Attempted metathesis. 
  
Another transformation, carbopalladation of alcohol 4a, under the atmosphere of 
carbon monooxide in the presence of Pd2+ catalyst, was successfully applied for similar 
substrates in our group before. For the alcohol 4a we however isolated lactone 275 as the 
only product, as a result of double carbonylation of the double bond followed by 
lactonization (Scheme 105).96     
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Scheme 105: Carbopalladation of the homoallylic alcohol. 
 
We decided to switch from metathesis to traditional Wittig chemistry, and in order to 
do so, homoallylic alcohol 4f was subjected to ozonolysis first, to obtain the corresponding 
aldehyde. Early experiments resulted only in decomposition of the starting material, probably 
due to the oxidation of the silicon moiety. However, after decreasing the temperature to -90 
°C and careful monitoring the progress of the reaction and immediate quenching, we reached 
full conversion just after 2-5 minutes.  
The aldehyde 276f decomposes readily on the column of silicagel or alumina, but can 
be readily used as a crude material, as the ozonolysis at the low temperatures typically gave a 
practically pure product (Scheme 106).  
 
 
Scheme 106:Ozonolysis of the homoallylic alcohol. 
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Several Wittig and HWE conditions were then explored in order to get the ester 
(Schemes 107 and 108). 
 
Scheme 107: The HWE reaction. 
  
Disappointingly, following the published conditions, HWE reagent in the presence of 
the strong base (NaH) gave just the cinnamic-like ester 310 and conjugated ester 311, as 
products of the retro aldol mechanism, followed by the HWE reaction of the undesired 
substrates.  
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Scheme 108: Formation of the unwanted products.. 
 
In order to avoid the strongly basic conditions and thus the retro-aldol pathway, the 
HWE reagent was treated with lithium chloride and deprotonated with weaker triethyl amine 
and/or Hünig’s base respectively (Scheme 109).  
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Scheme 109: HWE reaction in the presence of LiCl. 
 
Upon mixing the lithium enolate 281 with the aldehyde, we obtained the same pair of 
undesired products 277a and 277b. The same outcome was observed using the HWE reagent 
282 (Scheme 109). 
With the Wittig reagent 283 no reaction took place, despite varying the reaction 
conditions and increasing the temperature and reaction time (Scheme 110).  
 
 
Scheme 110: Attempted Wittig reaction. 
 
Finally, using the Wittig reagent 284, the desired ester was obtained in 85% yield 
(Scheme 111).97 
 
 
Scheme 111: Successful Wittig reaction. 
 
Ester 284 however did not undergo the cyclization under the Lewis acidic conditions, 
as the conjugated double bond is apparently too electronically poor to undergo the oxonia-
Cope rearrangement. Ester 284 was therefore reduced to alcohol with DIBAL and cyclization 
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of the resulting alcohol 285f was attempted in the presence of LA. This reaction however 
gave a complex mixture of products under the cyclization conditions (not surprisingly, taking 
into account the two alcohol moieties present in the substrate).   
 
 
Scheme 112: Reaction sequence towards the substituted homoallylic alcohol 321. 
 
Alcohol 285f was then transformed into sulfonate 286f and reduced with DIBAL in 
the final attempt to produce a suitable homoallylic alcohol substrate for the cyclization 
reaction. The reduced product 287f reacted readily when exposed to the Lewis acidic 
conditions (although more slowly than the unsubstituted analogue), giving however a 
complex mixture of various diastereoisomers, unseparable by chromatography. Attempts to 
get at least one of them preferentially, by varying the reaction conditions failed (see Scheme 
113 for the summary of results). 
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Scheme 113: Results of the attempted cyclizations. 
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2.3.8 Other Bifunctional Disilanes 
 
We used the methodology developed during the synthesis of the original disilane 1 in 
the synthesis of another novel disilane 2 (Scheme 114).  
R
OH
Me3Si
Me3Si
SiCl3
Lewis base
RCHO
1 4  
Scheme 114: Allylation with the original disilane 1. 
 
We envisioned that 2, when used in the allylation of aldehydes, would give the 
homoallylic alcohols 5 with the (methylene)trimethylsilyl moiety at the β-position to the 
alcohol (Scheme 115)..  
 
Scheme 115: Allylation with the analogous disilane 2. 
 
We further expected that these alcohols, in the presence of the aldehyde and Lewis 
acid, would cyclize to afford the substituted tetrahydropyrans 8 with the exocyclic double 
bond (Scheme 116). The mechanism was anticipated to be similar to that outlined before in 
the synthesis of tetrahydrofurans, however this time no [3.3] sigmatropic rearrangement can 
take place and after the nucleophilic attack onto the activated carbonyl (Scheme 116, 
intermediate 288), a stable 6-membered ring would be formed.   
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Scheme 116:  Intramolecular allylation to form the substituted tetrahydropyrans. 
 
Disilane 2 was synthesized from the malonate 291 in four steps as follows (Scheme 
117): Dimethylmalonate 291 was deprotonated by sodium hydride and alkylated by 
(iodomethyl)trimethylsilane. Alkylation with the cheaper (chloromethyl)trimethylsilane was 
also attempted, however with poor conversion even after prolonged reaction time. The more 
reactive iodide 225 was then prepared, using the Finkelstein procedure (vide supra). 
Reduction with LiAlH4 gave the alcohol 293, which was transformed into the chloride 294 
and then to trichlorosilane 2 using the protocols previously developed for the analogous 
disilane 1. Disilane 2, when treated with benzaldehyde in the presence of a Lewis base 
(DMF), afforded the expected racemic homoallylic alcohol 5a, in a good yield.  
 
 
Scheme 117: Synthesis of the homoallylic alcohols 5. 
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As the next step, we explored the enantioselective version of this transformation. We 
first used the N-oxide 62  (METHOX) as a chiral catalyst, and obtained the alcohol 5a with 
33% ee. Other organocatalyst were also screened, all of them however worked with low 
enantioselectivities (Scheme 118 and Table 18). Monooxide QUINOX (Table 18, entry 2) 
gave almost racemic product and dioxides 244 and 245 gave poor enantioselectivities around 
30% even after optimalization.   
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Scheme 118: The enantioselective version. 
 
Table 18 Enantioselective allylations of benzaldehyde with the trichlorosilane 2. 
Entry Catalyst Solvent Yield (%) ee (%) 
1 METHOX (62) MeCN 80 33 
2 QUINOX (61) DCM 67 7 
3 (S,R)-ANET (244) THF 55 30 
4 (R,R)-ANET (245) THF 62 31 
 
Low enantioselectivies are probably caused by the steric clash between the molecule 
of the catalyst and the bulky trimethylsilyl group in the six-membered transition state of the 
allylation step (Scheme 119). This would force the reaction to proceed through the less 
hindered linear transition state, where the chirality of the catalyst is not transferred 
effectively.   
 
 
 
Scheme 119: Cyclic and linear transition state. 
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As expected, after treatment with another portion of benzaldehyde in the presence of 
Lewis acid, alcohol 5a gave the substituted tetrahydropyran 8aa with the syn configuration of 
the phenyl substituents (Scheme 120).  
 
 
Scheme 120: Intramolecular allylation. 
 
Another disilane 3 was prepared from propargyl alcohol in several steps (vide infra), 
using a slightly modified procedure previously developed during the synthesis of the original 
disilane 1. The vinylsilane 3 is a close analogue of the disilane 1, however one carbon shorter 
and was expected to give the homoallylic alcohols of type 6 on reaction with aldehydes. 
These homoallylic alcohols were expected to undergo cyclization in the presence of a Lewis 
acid and another portion of aldehyde, to form the dihydropyrans 329 (Scheme 121).  
 
 
Scheme 120: Allylation with the disilane 3. 
 
The vinylsilane 3 was synthesized as follows: Propargyl alcohol was protected as a 
THP ether 224, deprotonated, and alkylated with chlorotrimethylsilane (Scheme 121). After 
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deprotection, the triple bond was reduced with lithium aluminium hydride, giving the alkene 
301. After screening of several methods, oxalyl chloride in the presence of DMF was found 
to be the chlorinating agent of choice to produce the allyl chloride 302. Trichlorosilylation of 
the latter derivative with an excess of trichlorosilane and in the presence of one equivalent of 
copper(I) chloride furnished the desired disilane 3. 
 
OHMe3Si
Cl
SiCl3
Me3Si
Me3Si
1) n-BuLi OTHP
Me3Si
PPTS, EtOH
2) Me3SiCl
OH
Me3Si
OTHP
224 299
301
3
300
302
LiAlH4
(COCl)2
DMF
HSiCl3
CuCl
97%
95%
94%
90%67%  
Scheme 121: Synthesis of the  disilane 3. 
The disilane 3 was then used in the allylation of benzaldehyde. When treated with 
benzaldehyde in the presence of an achiral Lewis base (DMF), the expected homoallylic 
alcohol 6a was obtained in moderate yield as pure anti stereoisomer (Scheme 122).  
Ph
SiMe3
OH
45%
SiCl3Me3Si
PhCHO, DMF
3 6a  
Scheme 122: Allylation of benzaldehyde with the disilane 3. 
 
Two other examples of the homoallylic alcohol were prepared, with the electron poor 
and electron rich aromatic moiety, by the allylation of p-tolualdehyde and p-trifluoromethyl 
benzaldehyde respectively to form 6b and 6d (Scheme 123). 
 
SiMe3
OH
17%
SiCl3Me3Si
CF3C6H4CHO
SiMe3
OH
F3C
29%
CH3C6H4CHO
36b 6d
 
Scheme 123: Allylation of the electron rich and electron poor aldehyde with disilane 3.  
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In the enantioselective version of the allylation of aldehydes with 3, we tried three 
organocatalysts that proved to be most successful with the analogous trichlorosilane 1. We 
obtained moderate enantioselectivities but very low yields, which we were not able to 
optimalize (Scheme 124 and Table 19).   
 
Ar
OHcat*
+ ArCHO
SiMe3
SiCl3Me3Si
3 6  
Scheme 124:Enantioselective version of the allylation. 
 
Table 19: Enantioselective allylations of aldehydes with the trichlorosilane (3). 
Entry Catalyst Ar Yield (%) ee (%) 
1 METHOX (62) Ph 10 45 
2 QUINOX (61) Ph 9 32 
3 METHOX (62) p-CH3C6H4 15 63 
4 QUINOX (61) p-CH3C6H4 8 23 
5 QUINOX (61) p-CF3C6H4 10 35 
6 (S,R)-ANET (245) p-CF3C6H4 11 56 
 
Alcohol 6a, disappointingly, upon treating with tin(II) triflate as a Lewis acid did not 
give the expected dihydropyran 297 but just a product of a Peterson olefinaton 303 (Scheme 
125).  
 
Ph
SiMe3
OH
Ph
O
R
RCHO
Lewis acid
RCHO
Lewis acid
Ph
6 297303
 
Scheme 125: Intramolecular allylation of aldehyde 6a. 
  
 We then protected the alcohol moiety of 6a as a TMS ether to prevent the SN1 
elimination during the "cyclization" conditions. In the presence of tin(II) triflate, nucleophilic 
attack at the aldehyde carbonyl took place to furnish the diol 9aa. (Scheme 126).  
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Scheme 126: Allylation with the TMS protected homoallylic alcohol 6a. 
 
 This is the same class of diols as those made by Roush,98 using a boron chiral 
auxiliary or Thomas,99 (Scheme 127) using allylation of aldehydes with organostannanes (he 
further used the diols in the synthesis of natural products - patulolides). We however avoided 
both the use of expensive chiral auxiliaries or toxic organotin compounds. 
 
R
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Bu3Sn R
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305 306  
 
   
Scheme 127: E. J. Thomas's chemistry. 
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3 Development of a Novel N,N'­Dioxide Catalyst 
 
3.1 N­Oxide Catalysts With the Axial Chirality 
 
The application of chiral N-oxides in catalysis can be roughly divided into two 
groups. They can serve as chiral ligands for the transition metals, or especially in 
organosilicon chemistry, as organocatalysts themselves. The high nucleophilicity  of  the N-
oxide oxygen, together with its affinity to silicon, represents an ideal combination of 
properties to serve as activators/chiral ligands for the  organo-silicon reagents. 100  
A large number  of N-oxide organocatalysts have been developed in our group in the 
past few years.31 Some of them rely purely on axial chirality or central chirality, others on a 
combination of both. Differences in the reactivities and enantioselectivities of chiral pyridines 
and their N-monooxides a N,N'-dioxides can be demonstrated in the series of three catalysts, 
PINDY, PINDOX, PINDIOX (Scheme 128). The monooxide can be selectively made by 
oxidation of the  bipyridine 243 with one equivalent of mCPBA (as there is unrestricted 
rotation about the py-py axis, it can be assumed that the electron density on the other ring will 
be reduced after introducing the first oxygen, due to conjugation between the aromatic rings, 
although weak).101  
 
Scheme 128: The PINDY-derived catalyst series. 
 
Although the allylation of aldehydes with the crotyl trichlorosilane (E)-28 (Scheme 
129) was much faster with the dioxide, it was found to be much less enantioselective. It was 
proposed that the coordination of the second nitrogen to the silicon atom plays an important 
role in the transition state. 
 However, in the case of bulky trichlorosilanes, such as 1, it was found necessary to 
use the dioxide catalyst, as both PINDY and PINDOX failed to catalyse the reaction with 
appreciable rate.   
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Scheme 129: Crotyltrichlorosilane and the novel disilane. 
 
Catalysts, relying solely on axial chirality, such as QUINOX (Scheme 130), are 
usually synthesized as racemates and co-crystallized with an enantiopure partner (usually 
BINOL), and separated by crystallization or on a column.31  
 
 
 
Scheme 130: QUINOX and BINOL. 
  
 QUINOX, is prepared in two steps from the commercially available 1-chloro-
isoquinoline 308 and 2-methoxy-1-naphthylboronic acid 309, which in turn is prepared from 
1-bromo-2-methoxy naphthalene by lithiation with n-BuLi in THF, followed by a reaction 
with (MeO)3B and subsequent hydrolysis of the intermediate boronate ester with HCl.31 The 
biaryl intermediate 310 is prepared by the Suzuki-Miyaura coupling of 1-chloro-isoquinoline 
308 with the corresponding boronic acid 309 in DME in the presence of cesium carbonate 
and a catalytic amount of palladium triphenylphosphine. Treatment of 246 with mCPBA then 
provides the N-oxide 61 in almost quantitative yield (Scheme 131).  
 The N-oxide is resolved by co-crystallization with (R)-(+)-BINOL from CH2Cl2. The 
crystals contain the molecular compound (R)-BINOL·(R)-QUINOX. Flash chromatography 
of the latter material gives (R)-(-)-QUINOX (> 99% ee) and the recovered (R)-(+)-BINOL. 
The mother liquor provides the enantiomerically enriched (S)-(+)-QUINOX, which can be 
purified by co-crystallization with (S)-(-)-BINOL to produce (S)-(+)-QUINOX (>99.8% ee 
after a single crystallization). 
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Scheme 131: Synthesis of QUINOX. 
 
In the process of screening the chiral catalysts for the allylation of aldehydes with the 
bulky disilane 1, we came across the N,N’-dioxide 241, which afforded the full conversion of 
the starting disilane 1 in a few hours, in contrast to METHOX or QUINOX, which typically 
took days in order to take the reaction to the completion (vide supra). 
 
Scheme 132: Allylation with the bulky disilane 1. 
 
The bisisoquinoline catalyst 241, was synthesized in our group several years ago and 
was shown to be highly active and gave moderate to good enantioselectivities for most of the 
substrates (Scheme 133 and Table 20).   
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Scheme 133: Allylation of aldehydes catalysed by the dioxide 241. 
 
Table 20: Results of the allylation of aldehydes catalysed by the dioxide 241. 
Entry R Time (h) ee(%) 
1 Ph 18 81 
2 4-MeC6H4 18 69 
3 3,5-Me2C6H3 18 71 
4 4-ClC6H4 30 76 
5 4-MeOC6H4 18 2 
6 3,4-(MeO)C6H3 18 10 
 
Racemic dioxide 13a was prepared (similarly to QUINOX) in four steps from the 
commercially available o-methylbenzamide (Scheme 134).   
Scheme 134: Synthetic path towards 241. 
 
Racemic dioxide 13a however resisted a number of attempts at classical resolution 
and was eventually resolved by chiral HPLC on a very small scale. Attempted synthesis of 
13a via 246 (which in turn can be prepared enantiomerically pure) via coupling with PhBr, 
was unsuccessful (Scheme 135).102 
 
N+
N+
O-
O-
N+
N+
O-
O-
Ph
Ph
PhBr, (AcO)2Pd
Bu3P, HBF4
246 13a  
Scheme 135: Alternative attempted synthesis of 13a. 
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We envisaged that a catalyst like 13b-d, bearing additional moiety on the phenyl rings 
might crystallize more easily with BINOL, while retaining the activity of  the original 
compound.   
 
Scheme 136: Analogues of the dioxide 241. 
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3.2 Results and Discussion  
 
This part of the project was completed in the cooperation with the undergraduate Erasmus 
exchange student Michal Májek. 
 
3.2.1   Synthesis of the Catalyst 
 
o-Methylbenzamide 10 was prepared from the corresponding chloride 1 by reaction 
with excess of methylamine. The cyclic amide 11b was then prepared by the annulation with 
p-methoxybenzonitrile mediated by an excess of butyllithium in THF (Scheme 137).  
Cl
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H2O NH
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1: nBuLi
2: p-MeOPhCN
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312 10 11b
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65%
 
Scheme 137: Synthesis of the intermediate 11b. 
 
11b was treated with POCl3 at high temperatures, giving the chloroisoquinoline 311b 
(Scheme 138).  
 
Scheme 138: Chlorination of 11b. 
 
The latter derivative then underwent the dimerization, mediated by the in situ 
generated (Ph3P)2NiCl2 in the presence of zinc in DMF affording the biaryl 312b (Scheme 
139).   
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Scheme 139: The coupling reaction. 
 
The  oxidation step turned out to be rather troublesome. We screened several 
oxidising reagents: hydrogen peroxide,103 peroxyacetic acid,104 DMDO105 and mCPBA.106 
Peroxyacetic acid in acetic acid was found not to be reactive enough at room temperature, no 
N-oxide was formed from 312b even after several days, and upon heating, inseparable 
mixtures were formed.   
DMDO was formed in situ from oxone and acetone (Scheme 140), however in this 
case we encountered solubility problems. Since oxone is insoluble in acetone, mixtures of 
acetone and water are needed, otherwise no DMDO is generated. 314 is very poorly soluble 
in acetone, and addition of water induced immediate precipitation of 314 and no reaction took 
place.  
 
 
Scheme 140: Synthesis of oxone. 
 
mCPBA was selected in the end as the oxidant of choice, although it is far from being 
an ideal reagent. Oxidation of 312b with mCPBA in DCM at room temperature first led to the 
monoxide 315b, but various oxidation byproducts are also formed, that could not be 
separated from the monoxide by chromatography. Further oxidation did not proceed 
smoothly, since the steric congestion already increased significantly after the first oxidation. 
A large excess of mCPBA, and long reaction times were needed (10 eq, 7 days at RT) in 
order to form the desired bis-isoquinoline dioxide. When we tried to speed up the reaction of 
reaction by elevating the temperature, the quantity of byproducts increased sharply (Scheme 
141).  
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We were not able to separate enantiomers of 13b by co-crystallization with BINOL. 
As in the case of its predecessor, solubility was the main problem. Solvents usually used in 
this operation are DCM, toluene and benzene as well as binary solvents mixtures: DCM with 
n-hexane, n-heptane, and cyclohexane failed completely. In all cases, either viscous oils, or 
crystals of racemic N,N'-dioxide 13b were obtained from the mother liquors. We were able to 
efficiently resolve 13b only by chiral HPLC on a milligram scale. Co-crystallisation of the 
monooxide 315b with BINOL might be more feasible, as the solubility of the catalyst 
decreases sharply with increasing number of N-oxides units in the molecule. Therefore the 
monooxide 315b might have comparable solubility to BINOL, however the limiting problem 
is the poor availability of the monoxide, as our attempts to purify it either by crystallization 
or by chromatography failed.  
 
 
Scheme 141: The oxidation step. 
 
This part of the project was then unsuccessful. However, during the course of 
synthesis, we observed some interesting behaviour of the intermediate 316 (Scheme 142).  
  
 
3.2.2 Mechanism of the Cyclization Step 
 
Transformation of tolylamides 10 into the isoquinolines of type 11 is a reaction that 
has been known for more than 30 years (Scheme 142). This reaction is often used in the 
synthesis of pharmacologically interesting targets and, according to the literature, is known to 
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give notoriously low yields.107 However, we did not come across any study addressing this 
problem in detail. Similar to the published procedures, we typically got yields between 30-
40%. The mechanism of this transformation and the loss of the N-methyl group is discussed 
on the page 109. 
 
Scheme 142: The annulation step. 
 
 The lithium cation is coordinated to the imine nitrogen, which facilitates the 
deprotonation of the adjacent methyl group by the second equivalent of BuLi, by a similar 
principle as in directed ortho methalation (DoM). 
 
After the initial experiments we decided to scale up from the initial 500 mg scale to 
about 20 g scale. We followed the reaction sequence, and we isolated the product in 65% 
yield, which however to our surprise turned out to be amine 12b rather than the expected 
isoquinolone 11b, as was also proven by X-ray analysis.  
 
 
Scheme 143: Unexpected outcome of the reaction after scale-up. 
 
However, we managed to convert the amine 12b into the chloride 311b (Scheme 
144). If 12b is heated up to 80 °C in AcOH, elimination of ammonia takes place, and 318 is 
formed. 318 was chlorinated to form the salt 319b. It was reported before that similar systems 
undergo dealkylation under acidic conditions.108 It turns out that 319b is a strong alkylating 
agent, and that it loses the methyl in the presence of POCl3 under reflux. Therefore, it is 
possible to get the desired product 311b in one step from 318b.   
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Scheme 144: Transformation of the unwanted aminal 12b into the chloride intermediate 
311b. 
 
However, we were wondering why the unexpected aminal 12b was formed during the 
same reaction conditions we used before and we decided to investigate this reaction further. 
The protonated form of the intermediate formed by the reaction of 316 with the nitrile 
(Scheme 145, compound 322b), has a structure similar to the known compound 320. 
According to the literature,109 the equilibrium between 320 and 321 is strongly influenced by 
the dielectric constant of the solvent (Scheme 145 and Table 21) and thus we expected a 
similar behaviour for our system and the equilibrium between 322b and 323b.  
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Scheme 145: The imine-enamine equilibrium. 
 
Table 21: Published ratio of imine 320 : enamine 321 depending on the solvent. 
 
 
 
 
 
 
 
 
 
We tried to verify the hypothesis about the influence of the solvent by a set of 
experiments. (Scheme 146 and Table 22). We created the intermediate 316 in THF, reacted it 
with benzonitrile, and the resulting solution was diluted by a large volume of other solvent 
(toluene, MeCN or DMF; at this point the lithium anion was fully consumed and hence there 
was no competing reaction between benzonitrile and acetonitrile e.g.), and then quenched by 
adding water dropwise into the mixture (method G, as it was called for the needs of this 
experiment). Nearly no difference in the product distribution was found - a majority of the 
lactam (product of type I, see Scheme 146) was formed in all cases, i.e. the solvent did not 
have any influence on the outcome of the reaction. See Scheme 146 and Table 22, entries 1, 
2, and 3 for the results. This means, that either no equilibrium is formed (all 322b stays as 
imine), or that the cyclization to form the lactam is very fast under the given conditions.  
 
Solvent Dielectric constant Ratio of 320 : 321 
chloroform 4.8 2.9 
nitrobenzene 34.8 0.5 
DMSO 46.7 0.3 
107 
 
 
 
 
Scheme 146: Different method of quenching the reactive intermediate. 
 
Table 22: Various methods of quenching the reactive intermediate. 
Entry Solvent 
Quenching 
medium 
Method 
Type I 
product 
Type II 
product 
Type III 
product 
1 toluene H2O G 70% 2% 7% 
2 DMF H2O G 78% 5% 3% 
3 MeCN H2O G 76% 4% 1% 
4 THF H2O F 12% 56% 8% 
5 THF 
10 vol. % H2O 
in THF 
F 21% 44% 4% 
6 THF 
1 vol. % H2O 
in THF 
F 33% 37% 7% 
 
In another set of experiments we used the quenching method F (the lithium salt is 
added dropwise to the quenching medium), but besides of using pure water, we also used 
solutions of water in THF (10 vol. % and 1 vol. % water in THF, Table 22, entries 4, 5, and 
6). A difference in the product distribution was now observed: with decreasing concentration 
of water in the quenching medium, the ratio of the aminal (type II product) to the 
isoquinoline (type I product) changed from 5 : 1 (when pure water is used for quenching), to 
almost 1 : 1 (when 1% water in THF is used). 
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Scheme 147: Different outcome of the reaction depending on the quenching method. 
 
The more intuitive way of quenching the reactive intermediate is adding the reaction 
mixture slowly to water (so that in every  moment there is an excess of water). We observed 
that using this method, the formation of the undesired aminal 12 is promoted. However, if we 
reverse the operation and add water to the reaction mixture we obtained 11 as the main 
product (Scheme 147).  
We also found out that the nature of the nitrile plays a role only when the reaction 
mixture is added to water (method F), in the other case, when the reaction is quenched by 
adding water to the reaction mixture (method G), the influence of the electronic nature of the 
nitrile is negligible. (Scheme 148 and Table 22). The original literature107 also suggested 
using the saturated solution of NH4Cl as a quenching medium, however we did not find any 
notable difference when water was used.  
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Scheme 148: Cyclization with various nitriles.   
 
Table 22. Products distribution depending on the quenching method and nature of the 
nitrile. 
Entry R 
Quenching 
medium 
Method 
Product I 
(%) 
Product II 
(%) 
Product 
III (%) 
1 H NH4Cl F 8% 65% 12% 
2 H NH4Cl G 73% 4% 13% 
3 H H2O F 12% 56% 8% 
4 H H2O G 85% 5% 7% 
5 OMe NH4Cl F 5% 40% 6% 
6 OMe NH4Cl G 41% 1% 12% 
7 CF3 NH4Cl F 14% 33% - 
8 CF3 NH4Cl G 35% 2% - 
  
When  we decrease the concentration of water immediately available to solvate the 
OH- ions (which are created by reaction of water and lithium salt) then naked OH- can act as 
a strong base, deprotonating the nitrogen atom of imine 317, which results in an immediate 
cyclization (Scheme 149).  
 
 
Scheme 149: Mechanism of formation of lactam 11. 
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The key step in this mechanism is the deprotonation of the imine. According to the 
literature,110 pKa values of this type of imines are around 26. The nature of the nitrile does not 
affect the formation of product 11, because the aromatic moiety cannot stabilize the negative 
charge on the nitrogen. The process depends only on the concentration of water in the system. 
Low concentration of water allows the deprotonation of imine by the non-solvated OH- ions, 
which would not be possible in the aqueous medium. This also explains, why the same ratio 
of products was observed in all experiments in different solvents, when method G (water 
added to the reaction mixture) was employed. Toluene, THF, MeCN, and DMF are all very 
poor in anion solvation, therefore the naked OH- immediately deprotonated the imine, which 
quickly cyclized. On the other hand, if water is used as a bulk solvent (method F), then the 
OH- ions are solvated, and unable to effectively abstract the hydrogen from imine. Using 
NH4Cl solution for the workup, as suggested by the original literature,107 is then in fact 
contra-productive. It only further decreases the pH of the  solution, and we saw that high pH 
is crucial for high yields of the desired amide product. The likely reason, why saturated 
NH4Cl solution was used in original literature, was an attempt to suppress the hydrolysis of 
imine intermediate 317 to the ketone. But as we found, this hydrolysis reaction is slower than 
the cyclization of imine 317 anion to lactam 11 – the corresponding ketone was never 
isolated from the reaction mixture. Therefore, there is no reason why NH4Cl solution should 
be used for the workup.  
  
When excess of n-butyllithium was used, as the original literature suggests, the 
substituted valerophenones 328 were always isolated. (Scheme 150) Apparently, the excess 
of nitrile is then only an expensive trap for the organolithium and exactly two equivalents of 
n-BuLi should be used. 
 
Scheme 150: A side reaction of the nitrile with the BuLi. 
The aminal 12 could be formed by the sigmatropic rearrangement as follows (Scheme 
151): 
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Scheme 151: Possible mechanism of the formation of aminal 12. 
 
However, the key step in this mechanism is the imino/enamine tautomerism, which 
would generate the enamine. The enamine itself can undergo the electrocyclic reaction 
(Scheme 151). This tautomeric equilibrium should be strongly influenced by the dielectric 
constant of the solvent, which was not observed. Furthermore, precedents for this type of 
eletrocyclic reactions usually exist at temperatures above 150 °C, whereas our reaction was 
complete at room temperature in a few seconds.  
We decided to model the transition state of this reaction (DFT, PBE1PBE 6-311G(d)),  
getting ∆E≠ = 170 kJ mol-1, which is too high for the reaction to proceed at the room 
temperature. To rule this mechanism out beyond doubt, we worked up the reaction with 
deuterated water (added the reaction mixture dropwise to the deuterated water). Should this 
mechanism be taken into an account, we would have detected the deuterium in the final 
product, however none of this was observed (Scheme 152).  
 
Scheme 152: Quenching of intermediate 332 by adding the mixture into the deuterated 
water. 
 
In the other mechanism we proposed, the key step in the formation of the product 12 
is the protonation of the imine: 
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Scheme 153: Proposed mechanism of the formation of aminal 12. 
 
According to the literature,111 the pKaH of this kind of imines are around 7, hence the 
protonation can occur in the aqueous medium. Dielectric constant of the solvent does not 
affect the formation of 12. The important factor is the concentration of water in the system, 
enabling the protonation of the imine, which we did observe. The substituents on the aromatic 
ring of the nitrile can stabilize/destabilize the cation intermediate 334 and thus influence the 
formation of 12, which was observed too (Table 22). The ratio of products 12/11 is 
decreasing in the order of MeOC6H4>Ph>CF3C6H4 (the electron withdrawing groups are 
destabilizing the cation 334 and thus disfavouring the formation of the product 12). 
 In most cases, independent of the method of quenching used (F,G),  the byproducts of 
type 339 were formed (Scheme 154). The mechanism for their formation is quite 
straightforward: after the nucleophilic attack of the imine anion onto the amide, instead of 
elimination of the methylamine (which would result in type I products), hydroxide is 
eliminated, and 339 (type III product) is formed (Scheme 154). 
 
 
Scheme 154: Proposed mechanism for the formation of the byproduct 339. 
 
To conclude, we have shown that if the formation of the lactam 11 is to be promoted, 
the reactive intermediate has to be quenched by carefully adding water (not ammonium 
chloride) into the mixture, and not the other way round. Electron donating groups further 
promote the formation of 11. The aminal byproducts 12, which have not been previously 
described in the literature and which, most likely were the reason for low yields of the 
cyclization reactions, were isolated and characterized.  
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4 Asymmetric Aldol Reactions 
4.1 Recent Development in the Asymmetric Aldol 
Reactions 
 
 The asymmetric intermolecular cross-aldol reactions between aldehydes and 
aldehydes or aldehydes and ketones have proved to be an important tool for C-C bond 
formation, which has been extensively explored for the construction of chiral β-hydroxy 
aldehydes or β-hydroxy ketones in synthetic organic chemistry. By contrast, enantioselective 
intermolecular cross-aldol reaction between ketones, which produces 3-substituted-3-hydroxy 
ketones with quaternary stereogenic centres, is much more challenging, especially in the 
organocatalytic realm.112 The key position amongst the organocatalysts catalysing aldol 
reaction has been held for a long time by proline and its derivatives, which is partly related to 
the key function of proline carboxyl group in steering the reactants by hydrogen bonding.113 
In contrast to the great success in the field of aldehyde-ketone reactions, the selective ketone-
ketone reactions are more rare. With non-symmetrical ketones, four possible enamines can be 
generated in the equilibrium, which can form four possible products, each one then in a form 
of different stereoisomers. A successful and selective reaction between two ketone partners 
must be then designed in a way where one of the components in non enolizable (i.e., has no α 
protons) and reacts as an electrophilic acceptor. Furthermore, to prevent the self aldolization 
of the nucleophilic partner, the non enolizable ketone should be much more reactive, i.e., 
should contain an activated carbonyl group.   
 For example, Maruoka reported on high enantio- and diastereoselectivities for the 
reaction of aromatic α-ketoesters with cyclohexanone (96-99% ee, ≥20:1 dr), catalysed by L-
proline (30 mol% loading) (Scheme 155).114 Gong has shown that the related reaction of 
acetone with the free α-ketoacids, catalysed by the N-(α-pyridyl)proline amide (20-30 mol%) 
at 0 oC, can give the aldol products with ≤98% ee.115  Zhao has found the reaction of acetone 
with α-diketones, catalysed by L-proline (50 mol%), affords the corresponding aldol products 
in ≤85% ee.116  
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Scheme 155: Examples of enantioselective aldol reactions. 
 
Besides ketoesters and diketones, ketones with α-CCl3 and CF3 group are also suitable 
candidates for the selective ketone-ketone aldol reaction. α-Trifluoromethyl tertiary alcohols 
and their derivatives are vital structural motifs in anticonvulsants, anaesthetics, Merck’s anti-
HIV agent Efavirenz and other pharmaceuticals, some also find application in LCD 
materials.117 Amino acid-catalysed asymmetric aldol reaction between methyl ketones and 
aryl trifluoromethyl ketones was reported by Zhang and co-workers but only moderate 
enantioselectivities were obtained.118 Wang and co-workers were using proline-derived N-
sulfonamides for the reaction of methyl ketones with α,β-unsaturated trifluoromethyl ketones 
(with 59-94% ee for various sulfonamide-based catalysts) but otherwise this field remains 
largely unexplored.119  
O
H
N O
CF3
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 Aldol reaction provides an easy access to chiral tertiary alcohols, and in particular, the 
utilization of isatins (see Scheme 156) as electrophiles has drawn much attention. This 
reaction affords chiral 3-hydroxy-2-oxyindole derivatives, an important structural motif in a 
number of biologically active compounds (Scheme 156).120  
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Scheme 156: Some of the nature products derived from the isatine. 
 
 Aldol  reaction of isatins with, e.g., acetone fulfils the criteria for a selective reaction 
described above. Isatins cannot enolize, C-3 isatin carbonyl is activated and much more 
reactive than that of acetone, and acetone as a symmetrical ketone can form only one type of 
enamine. 
 Convolutamydines are a family of alkaloids that were isolated from the marine 
bryozoan Amathia Convulata in 1995. All of them bear a common 4,6-dibromo-3-
hydroxyindole skeleton and contain a tertiary alcohol at C-3; the individual 
Convolutamydines (A-E) then differ in the side chain moiety at this center. All of them 
exhibit interesting biological activities, Convolutamydine A for an example has a potent 
inhibitory activity towards the differentiation of the human HL-60 promyelocytic leukaemia 
cells.121 
The first enantioselective synthesis of Convolutamydine A was reported in 2006 by 
Tomasini, through a direct aldol reaction of 4,6-dibromoisatine with acetone, using peptidic 
catalysts, having proline at the N-terminus (94% ee), proline itself gave only inferior results 
(Scheme 157).122 Shortly after that, Stazi published a longer but more selective synthesis of 
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enantiopure Convolutamydine A.123 The key steps of the latter synthesis were the In-catalysed 
diastereoselective allylation72 of the ketoester 355 and Wacker oxidation of 35.123  
 
Scheme 157: Synthesis of Convolutamydine A by Tomasini. 
 
In 2007, Xiao reported another aldol reaction of isatin with acetone, this time 
catalysed by the chiral bisamide 360, derived from a chiral diamine and L-proline (64% 
ee).124 
  
Scheme 158: Synthesis of Convolutamydine A from 4,6-dibromoisatine. 
 
Hao showed that simple proline can catalyse the aldol reaction of N-substituted isatins 
with acetone with moderate to good enantioselectivities, however with poor results for 
unsubstituted isatin.125 Interestingly, substitution at position 4 of the isatin, reverses the 
enantioselectivity of the reaction and the opposite enantiomer becomes the major product.  
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Our group reported on the synthesis of Convolutamydine A, using D-leucinol as a 
catalyst (94 % ee).94 We have demonstrated that the simple vicinal aminoalcohols, derived 
from common α-amino acids act as superior catalysts in the cross-aldol reaction of isatins 
with ketones and leucinol was identified as the catalyst of a choice. However, although 
readily available from α-amino acids and therefore relatively cheap, high loading (20 mol % 
of the catalyst) was still needed. High catalyst loading is in general a common problem of 
organocatalysed aldol reactions, typically over 10 mol % and sometimes even up to 50 mol % 
of the catalyst is needed. Therefore the design and development of new organocatalysts 
aimed at lowering the loading and improving the turnover and recovery of the catalyst is 
required. 
In 2008, Nakamura and co-workers reported on the sulfonamide catalysts 360, which 
they used in the synthesis of convolutamydines, using 2 mol % and lower loading.126 The 
most active of  the sulfonamide catalysts screened were those with 2-thienyl 360 and 2-
benzothienyl moiety 361 (Scheme 159). 
N
H
N
H
S
OOO
S
N
H
N
H
S
OOO
S
360 361  
 
Scheme 159: Nakamura's catalysts. 
 
Prior to this, sulfonamide derivates were known already to catalyse the aldol reaction, 
Ley and co-workers in 2004 developed the proline-based catalysts 362 and 363,127 Berkessel 
and co-workers reported that acylsulfonamides, such as 364 or 365, catalysed the aldol 
reaction between acetone and p-nitrobenzaldehyde with enantioselectivity up to 98% and 
with just 5 mol % of catalyst loading.128 The improved selectivity of these acylsulfonamide 
catalyst was attributed to a better shielding of one of the enantiotopic faces of the aldehyde by 
the aryl ring or by tighter hydrogen bonding in the List-Houk transition state.129   
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Scheme 159: Ley's and Berkessel's sulfonamide catalysts. 
 
To overcome the difficulty of the enantioselective reaction between isatins as the 
ketone acceptors and acetone, Nakamura and co-workers designed 
heteroarylsulfonylprolinamides, where the transition state 367 is controlled by the 
intramolecular hydrogen bonding between the NH group of the sulfonamide and the 
heteroatom (sulfur or oxygen) of the heteroaryl group (Scheme 161). The NH proton is quite 
acidic (with pKa similar to that of carboxylic acids) and coordinates strongly to the carbonyl 
group of the electrophile.  
 
 
Scheme 161: Proposed transition state. 
 
In accordance with the conclusions made by Tomasini and co-workers and based on 
DFT calculations, Nakamura suggested two plausible transition states: anti-trans and syn-
trans (Scheme 162).130  
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Scheme 162: Proposed transition states. 
 
The reaction using the thienyl catalyst 366 preferentially proceeds through the anti-
trans TS to give (R)-349, because the other transition state, i.e., syn-trans (which naturally 
would give the opposite enantiomer) is destabilized by the steric repulsion between the 4-
bromo and 2-thienyl groups. Experiments clearly showed that the organocatalyst bearing 
thienyl (366) or furyl (369) moiety were superior to those with aryl (370), where such 
hydrogen bonding and thus this case of steric repulsion do not exist.  
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Scheme 163: Examples of the sulfonamide catalysts. 
 
Nakamura's catalyst 360 exhibited high activity even at loading as low as 0.5%. This 
catalyst is now commercially available but very expensive. Solubility of these catalysts in 
common organic solvents is also an issue. Efficient recovery of the homogenous catalyst is 
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still a practical problem and there has not been much success in the development of aldol 
reaction organocatalysts anchored to a solid support, without a dramatic loss of their 
reactivity. However, Toru recently managed to entrap the N-sulfonamides in Montmorillonite 
by a cation exchange method. Although the reactivity slightly decreased, the catalyst still 
afforded convolutamydines with >90% ee even at 2 mol % loading.131   
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4.2 Results and Discussion 
4.2.1 The Sulfonamide Catalysts   
 
 Inspired by Toru and Nakamura's N-sulfonamide methodology, we aimed at applying 
their catalysts and their analogues in the total synthesis of Speranskatine A, a natural product 
we prepared (vide infra), using the leucinol as a catalyst in the enantioselective step. We 
proved earlier that valine- and leucine-derived catalysts can often produce similar or even 
higher enantioselectivities than their proline-derived congeners or the more complex 
analogues with additional chiral centres.132 Therefore, it was of interest to find out if this was 
the case here as well, by employing the valine analogues of Nakamura's proline N-
sulfonamide catalysts. Hence, besides making the analogue of the original 371, we set out to 
investigate the efficiency of sulfonamides 372 and 373. Since Nakamura and Toru have 
shown that the additional substituent of the thiophene moiety of the catalysts 360 did not 
affect the catalytic capability, we resolved to use α-halogenated (Cl or Br) thiophene unit, 
partly because the starting material was considerably cheaper and partly because the halogen 
represents a handle for possible future anchoring of the catalyst to a polymeric support or 
polyfluorinated tag. 
 
 
 
Scheme 164: Our analogues of the Nakamura's catalyst. 
 
The new catalysts were synthesized in a straightforward manner from proline, valine, 
and N-methylvaline respectively, via Boc protection of the amino group and amidation with 
the corresponding sulfonamide, followed by Boc deprotection (Scheme 165).  
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Scheme 165: Synthesis of the sulfonamide catalysts. 
 
We first applied the catalyst in the aldol reaction of isatins. Both the original proline catalyst 
360 (or its halogenated analogue) 371 and its valine analogue 372 worked well, giving 94% 
and 95% ee, respectively, in the reaction of isatins with acetone (Scheme 166 and Table 23). 
The N-methyl catalyst 373 gave only 35% ee and interestingly of the opposite enantiomer (in 
spite of the fact that, like the proline derivatives, the N-methyl valine catalyst is a secondary 
amine). This behaviour indicates fundamental differences in the transitions state.  
 
 
Scheme 166: Aldol reaction of isatins with acetone, catalysed by the sulfonamide 
catalysts. 
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Table 23:  Results of the aldol reaction of isatins with acetone, catalysed by the 
sulfonamide catalysts. 
Entry Catalyst Isatin Conversion (%) Product (% ee)a 
1 371•TFA 381 99 (R)-(+)-383   (94) 
2 371•TFA 382 98 (R)-(+)-384   (95) 
3 372•TFA 382 99 (R)-(+)-384   (94) 
4 373•TFA 382 53 (S)-(–)-384   (35) 
 
aDetermined by chiral HPLC. 
4.2.2 Synthesis of Speranskatine A    
 
 We then applied this methodology in the final step of the synthesis of Speranskatine 
A, an alkaloid isolated in 1995 from Speranskia tuberculata,133 a Chinese plant, whose 
extracts are being used for the treatment of rheumatic arthritis, and inflammatory diseases,134 
and whose synthesis has not been reported to date.  
 As seen in the Scheme 167, the stereogenic centre can be constructed by an aldol 
reaction of ketone 386 with acetone. It is obvious that the amidic part and the activated keto 
group of compound 386 are quite similar to the isatine system and therefore could be 
expected that the organocatalysts successfully employed in the synthesis of 
convolutamydines could also be effective here.   
 
 
Scheme 167: Speranskatine can be made by aldol reaction of 386 with acetone. 
 
The starting ketone 386 was synthesized as follows: dimethyl oxoglutarate 387 was 
treated with trimethyl orthoformate to produce the enol ether 388, and the ring was closed on 
by reaction with methylamine, according to the published procedure.134 The diketone 390 was 
prepared from 388 in a good yield (60% overall).  
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Scheme 168: Synthesis of the intermediate 390. 
 
The subsequent step required a great deal of optimization, as we run into difficulties 
trying to oxidize the diketone 390. Selenium dioxide, usually the catalyst of a choice for 
oxidation of allylic methylene groups did not seem to work at all at first, using published 
conditions for similar systems. Various other oxidizing reagents, such as KMnO4, HNO3, 
PhI(OAc)2, DMP, IBX, (AcO)4Pb, and K2S2O8, also failed to give the desired product too. 
Finally, it was discovered by serendipity that oxidation with SeO2, carried out at room 
temperature in chloroform acidified with a trace of concentrated hydrochloric acid, afforded 
the desired ketone in 73% yield after purification (Scheme 169).  
 
 
Scheme 169: Successful oxidation of 390. 
 
Not surprisingly, proline failed to catalyse the aldol reaction completely, and only the 
starting material was isolated. On the other hand, our first attempts to perform the aldol 
reaction of ketone 386 with acetone, using the conditions previously optimized for isatins (20 
mol% of L-leucinol as a catalyst, dichloromethane with a trace of water as a solvent, 20 °C) 
resulted in a complete conversion of the starting activated ketone into the aldol product with 
66% ee (Scheme 170). Upon decreasing the temperature, enantioselectivity did not improve 
and conversion dropped drastically. When the temperature was increased up to 37 oC, 72% ee 
was attained after 1 day. In the next attempt, rather than adding the catalyst to the solution of 
ketone 386 in the solvent, a solution of ketone 386 in CH2Cl2 was added dropwise over a 
period of 2 h to a mixture of L-leucinol, acetone, and CH2Cl2 in the presence of a trace 
amount of water and the results turned out to be rather surprising: One hour after the 
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dropwise addition, the analysis of an aliquot showed 28% ee (20% conversion). After 6 h, the 
ee increased to 58% (45% conversion) and finally reached 80% ee within 36 h (98% 
conversion). These observations are discussed in detail in the chapter 4.2.4. 
 
 
Scheme 170: The aldol reaction to form the Speranskatine A. 
 
Toru and Nakamura's sulfonamides, although being very enantioselective in the aldol 
reaction with isatins, catalysed the reaction of ketone 386 to afford Speranskatine A 
efficiently but exhibited much lower enantioselectivities (371 and 372 gave 30% ee each at 
room temperature, which was increased to 53% ee at –20 oC, at the expense of conversion). 
The N-methylvaline catalyst 373 then gave practically racemic product (3% ee). Further 
decreasing the temperature did not have any effect on the enantioselectivity.  
The tripeptide catalyst H-Pro-Pro-Asp-NH2, developed by Wennemers,135 afforded 
the non-natural enantiomer of Speranskatine A with 41% ee at room temperature. Upon 
lowering the temperature to 0 or -20 oC, respectively, no reaction took place.  
Finally, the salt of (S)-PicAm (417) and 3,5-dinitrobenzenesulfonic acid (DNBSA), 
recently developed by Nugent as a new organocatalyst with a primary amino group, 136 
catalysed the reaction of isatin with acetone, affording (S)-383 (62% ee), whereas the reaction 
of isatin with cyclohexanone, catalysed by 417•DNBSA, produced (3S,2’R)-(-)-418 (44% ee) 
as a single diastereoisomer (all at room temperature, Scheme 171). However, treatment of 
386 with acetone to afford the Speranskatine A did not give any notable conversion. 
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Scheme 171: Reaction of isatine with acetone and cyclohexanone catalysed by PicAm. 
 
These findings leave L-leucinol as a superior catalyst in the enantioselective step of 
synthesis of Speranskatine A, not only because it exhibited the highest enantioselectivity but 
also as one which promotes the formation of the natural (+)-Speranskatine A.  
The absolute configuration of Speranskatine A has been deduced to be (S)-(+)-385 
from the way of its formation in relation to Convolutamydine A. 
4.2.3 α­Trifluoromethyl Ketones in Aldol Reactions 
 
 As we stated at the beginning of the chapter, in a successful aldol reaction, one of the 
partners should be non-enolizable, and bear an activating group, such as CF3. And because of 
the medicinal importance of tertiary alcohols with CF3 substituents, and to further explore the 
applicability of aminoalcohols in this catalytic ketone-ketone aldol reaction, we screened the 
reactivity of acetone with a set of non-enolizable ketones bearing the activating 
trifluoromethyl group; in all cases, L-leucinol (20 mol%) was employed as a catalyst 
(Scheme 172). High yields and good enantioselectivities were attained, however, a slightly 
higher temperature (37 oC) was required to accelerate the reaction to a practical level. Under 
the same conditions, the thiophene derivative 403 underwent the reaction with good 
enantioselectivity, whereas the corresponding pyrrole analogue afforded only an a complex 
polymeric mixture. 3-Trifluoroacetyl indole did not react (~1% conversion). It  was therefore 
acetylated in order to further decrease the electron density and increase reactivity towards the 
nucleophilic attack. Indeed, the corresponding acetyl derivative 404 afforded the tertiary 
alcohol 407 with 46% ee.  
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  By contrast, enolizable aromatic ketones ArCOMe (Ar = Ph and 4-NO2C6H4) proved 
practically inert, whereas the PhCH2COCF3 was fully converted into the corresponding aldol 
product, which however turned out to be racemic.  
 The absolute configuration of the tertiary alcohols 397-402 and 406-408, has not been 
established by X-ray crystallography, it has only been deduced to be as drawn in the Scheme 
172, from the way of their formation in relation to the analogous reaction of acetone with 
isatins.  
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Scheme 172: α-Trifluoromethyl ketones in aldol reactions. 
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4.2.4 The Unusual Enantioselectivity Build­up During Leucinol­
Catalysed Aldol Reactions   
 
This part of the project was completed with the assistance of Dr. Mikhail Kabeshov, who 
performed the quantum calculations. 
 
 Intrigued by the unusual enantioselectivity build-up in the aldol reaction of acetone 
with isatins (in the synthesis of  Convolutamydine A) and ketone 386 (in the synthesis of 
Speranskatine A) we set to investigate this transformation in more detail, using isatin and 
acetone as model substrates  (Scheme 173).  
 
Scheme 173: Model reaction for the mechanistic studies. 
 
At the initial stage of the reaction, the both enantiomers were formed approximately 
with the same rate, only after 20-30 minutes, one of the enantiomers began to dominate, 
whereas the concentration of the other one remained unchanged from that point (Figure 1). 
 
 
Figure 1: Relative concentration of R and S enantiomer of 383, depending on the 
reaction time. 
 
129 
 
 The aldol reaction of isatin 381 with acetone in the presence of L-leucinol (409) (20 
mol%) has been found by us to be first-order in 381.132  We have also demonstrated the key 
importance of the primary amino group and the hydroxyl and have shown the linear 
correlation between the enantiopurity of leucinol and that of the product 383 (after full 
conversion), which indicates that only one molecule of the catalyst is likely to be involved in 
the stereo-discriminating step.132 Furthermore, formation of species 410-412 was proposed by 
us as a result of mixing acetone and leucinol in CDCl3 and monitoring the mixture by NMR 
(Scheme 174).132  This study revealed a gradual disappearance of leucinol at the expense of a 
concomitant build-up of oxazolidine 412, reaching completion within 2 h at 37 oC; no other 
species could be detected during this process. 
 
 
Scheme 174: Possible products of the reaction of leucinol with acetone. 
 
Isatin 381 was found to catalyze the latter formation of oxazolidine 412, which was 
then complete within several minutes at room temperature. On the other hand, the isolated 
oxazolidine 412 proved to be unstable in the absence of an excess of acetone, as its solution 
in wet CDCl3 slowly decomposed back to acetone and leucinol, presumably via enamines 411 
and/or imine 410 (ca 50 % conversion within 24 h). 
 Oxazolidine 412 was found to catalyze the aldol reaction of isatin 381 with acetone in 
CHCl3 at 37 °C as effectively as leucinol, with the same rate constant (at 20 mol% catalyst 
loading). This observation is in a full agreement with the Gschwind study,137 in which she 
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showed that the analogous oxazolidinone (derived from proline) generates the reactive 
enamine.  
 In CH2Cl2, the reaction catalysed by oxazolidine 412 proved to be 10 times slower 
than that in CHCl3, and 3 times slower when catalyzed by leucinol 409. This effect was 
attributed to the dependence of the rate of the equilibration 411 ' 412, which is apparently 
higher in CHCl3 than that in CH2Cl2.132 Nevertheless, the final enantiomeric excess of the 
product turned out to be unaffected.   
 Autocatalysis by the product 383 was ruled out by a control experiment, carried out in 
the presence of (S)-(-)-383 (20 mol%), added at the onset of the reaction. The latter additive 
neither catalysed the reaction nor it altered the enantiomeric ratio of the gradually produced 
383 when L-leucinol was also added to the mixture.132  
 To further corroborate experimental observation and obtain a complementary 
information, we studied the mechanism of the latter aldol reaction by DFT calculations using 
Gaussian 09.138,139 The quantum chemical calculations revealed the energies of the individual 
molecules involved along the multistep sequence (Scheme 175): thus, oxazolidine 412 was 
identified as the most stable species, whereas imine 410 was predicted to be less stable by   
~5 kcal mol-1. Most significantly, the syn-enamine 411b was found be more stable than the 
anti-rotamer 411a by ~2 kcal mol-1.* 
 
Scheme 175: Relative stability of the species formed from the reaction of leucinol and 
acetone. 
 
The calculations further suggested that a molecule of water is required for the 
formation of the enamine 411, as no energetically accessible transition state could be found in 
                                                 
*Geometries  of  all  structures  were  optimized  in  vacuum  at  the  B3LYP/6‐31g(d,p)  level.  IRC  analysis  was 
performed  to  unambiguously  assign  located  transition  states  to  the  reaction  pathways  studied.  Electronic 
energies were obtained by performing single point calculations at the TPSSh/cc‐PVTZ  level with CPCM/UAKS 
solvation model. Enthalpies  are  reported  as  ΔE  +  zero point  vibrational  energy  (ZPVE)  corrections  at 0 K  + 
thermal corrections at 298 K and Gibbs free energies were obtained as ΔG = ΔH – TΔS at 298 K (Kabeshov, M. 
unpublished results). 
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its absence (see Scheme 176, transition states 414 and 415). Thus, transition states 414 and 
415 were identified for the conversion of oxazolidine 412 into enamines 411b and 411a, 
respectively, where the former species (syn rotamer) is lower in energy by 1.8 kcal mol-1 
(Scheme 174). Furthermore, the transitions state 414, leading to 6, is preferred kinetically, as 
the activation energy for its formation is lower by 2.9 kcal mol-1 than that of 415.  
Based on these results, enamine formation can be expected to proceed with very high 
selectivity in favour of 411b. Furthermore, the reaction of 411b with isatin (381) should 
proceed via TS 416, giving rise to (S)-383, since the pathway toward its enantiomer from the 
same enamine would require overcoming an activation barrier that is higher by 8.5 kcal mol-1.  
By contrast, the anti-enamine 411a (disfavoured both kinetically and 
thermodynamically) would predominantly produce (R)-383, as the corresponding transition 
state is preferred by 2.1 kcal mol-1 over that generating (S)-383. In other words, the syn-
enamine 411b should produce mainly (S)-383, whereas its anti-rotamer 411a would 
predominantly afford (R)-2a. This shows that selective formation of syn-enamine 411b over 
its counterpart 411a plays a crucial role in the catalytic system.  
Furthermore, the temperature effect, observed for the analogous formation of 
Speranskatine A (+)-385 from ketone 386 also supports this scenario: here, at 20 oC, the 
enantioselectivity was lower (66% ee) than that at the optimal 37 oC (72% ee; vide supra), 
which is compatible with the faster established equilibration at higher temperature (a 
prerequisite for the thermodynamic control).    
This analysis can also account for the experimentally observed initial formation of a 
nearly racemic product, resulting from a different catalytic process (possibly using free 
leucinol as an amine base). As soon as all the leucinol is consumed by conversion into 
oxazolidine 412, the reaction follows the scenario shown in Scheme 176, and (S)-383 is 
produced almost exclusively.  
A substantial kinetic isotope effect140 (kH/kD = 2.7) was observed for the reaction of 
isatin 381 with d6-acetone, implying that the enamine formation is featured in the kinetic law. 
This is in line with the calculations, which predict a significantly higher activation energy for 
the formation of the syn/anti-enamines 411 than that for their subsequent reaction with isatine 
381 (24.4 kcal mol-1  and 27.3 kcal mol-1 vs 16.9 kcal mol-1 and 14.6 kcal mol-1, respectively; 
see Scheme 176). 
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Scheme 176: Proposed mechanism for the formation of 383. 
 
In conclusion, L-leucinol 409, a primary amino alcohol, has been shown to serve as an 
efficient, enantioselective organocatalyst for the cross-aldol reaction of isatin 381 (an 
activated, non-enolizable ketone) with acetone (an enolizable, less electrophilic ketone). The 
reaction proceeds at room temperature with a trace of water in CH2Cl2, at 10-20 mol% 
catalyst loading. Mechanistic and computational studies allowed to identify oxazolidine 412 
as the resting state of the catalyst and demonstrated the key role of water in its conversion 
into the reactive enamine. Calculations further suggest that the syn-enamine 411b is 
generated preferentially and then reacts with isatin (381) to afford the aldol product (S)-
(-)-383 via TS 416.  
It is pertinent to note that the preferential formation of the syn-enamine 411a stands in 
sharp contrast to the well established anti-enamine generation from proline and could thus be 
regarded as a characteristic feature of primary amino alcohols.  
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5 Experimental Part 
5.1 General Methods.  
 
 Melting points were determined on a Kofler block and are uncorrected. Optical 
rotations were recorded in CHCl3 unless otherwise indicated, with an error of ≤±0.1. The [α]D 
values are given in 10-1 deg cm3
 
g-1. The NMR spectra were recorded in CDCl3, 1H at 400 
MHz, 19F at 377 MHz and 13C at 101 MHz with chloroform-d1 (δ 7.26, 
1H; δ 77.16, 13C) and 
chlorotrifluoromethane (δ 0.00, 19F) as internal standards, unless stated otherwise. Various 
2D-techniques, DEPT and NOE experiments were used to establish the structures and to 
assign the signals. The IR spectra were recorded in NaCl disc, the mass spectra (EI, CI or 
FAB) were measured on a dual sector mass spectrometer using direct inlet and the lowest 
temperature enabling evaporation unless otherwise indicated. All reactions were performed 
under an atmosphere of dry argon in oven-dried glassware. Yields are given for isolated 
products showing one spot on a TLC plate and no impurities detectable in the NMR 
spectrum. The identity of the products prepared by different methods was checked by 
comparison of their NMR spectra. The enantiomeric excesses were determined by HPLC 
equipped with diode array detector, or by GC. The chiral GC and HPLC methods were 
calibrated with the corresponding racemic mixtures.  
All solvents and reagents for the reactions were of reagent grade and were dried and 
distilled under argon immediately before use as follows: chloroform from phosphorus 
pentoxide, Hünig’s base and acetonitrile from calcium hydride, THF and diethyl ether from 
sodium. Petroleum ether refers to the fraction boiling in the range 40-60 °C. Dichloromethane 
was obtained from the Pure-Solv™ Solvent Purification System (Innovative Technology).  
 
Individual NMR spectra of substituted 
tetrahydrofurans were obtained from the mixture of 
syn and anti forms in CDCl3 using a selective 1D 
TOCSY experiment, which, together with a 
traditional 2D COSY and HMQC, provided an unambiguous assignment of the NMR signals.  
Of particular interest was the stereochemistry of the protons H1, H2 and H4 and H1’, H2’ and 
H4’, in each molecule. A series of selective 1D NOESY experiment identified clear through-
space NOE correlations which allowed assignment of the relative stereochemistry.  
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A clear NOE from H1’ to H4’ and H5’(alkene) showed that H1’ and H4’ are syn-
orientated, and that H1’ and the alkene are also syn, a small asymmetric signal for H2’ 
indicated an indirect NOE to H2’, thus H2’ must be anti to both H1’ and H4’. This 
arrangement was confirmed by selective irradiation of H2’, which produced an asymmetric 
indirect NOE response for H4’. A clear NOE from H2 to H1 showed that H2 and H1 are syn-
configured. A clear NOE from H4 to H1 showed that H4 and H1 are syn-related. 
The chemical shift differences of H1/H1’ and H2/H2’ in the syn and anti forms are 
larger than for any other protons in the molecules and this provides circumstantial evidence 
that suggests that the difference in stereochemistry may be located in this part of the 
molecule. The multiplets of each proton in the two forms are remarkably similar, which 
indicates a particularly well known difficulty of applying the Karplus curve to 5-membered 
rings, where the pseudo-trans(H1’-H2’) and pseudo-gauche(H1-H2) arrangement of protons 
can produce similar couplings.  
 
Selective 1D TOCSY. Using the “selmlgp” pulse program, the NMR signal of H2 was 
selectively irradiated using a 40 ms 180° Gauss1.1 shaped-pulse of 70 dB, a M-LEV-17 
mixing time of 200 ms was sufficient to allow the propagation of the 3JH-H couplings to all 
multiplets within the molecule.  The NMR signal of H2’ was selectively irradiated using a 40 
ms Gauss1.1 pulse of 70 dB, a M-LEV-17 mixing time of 200 ms was sufficient to allow the 
propagation of the 3JH-H couplings to all multiplets within the molecule. Zero-quantum 
coherences were suppressed.  
 
Selective 1D NOESY. The “selnogp” pulse program was used, with a selective Gauss5 
profile, using a 40 ms 180° pulse of 70 dB with single pulsed-field-gradient echo, a mixing 
time of 0.4 s allowed NOE transfer, with purge gradients used to remove transverse 
magnetisation. 
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5.2 Asymmetric Allylations 
 
  
(223). Propargyl alcohol (40.79 g, 0.73 mol) was added in 
one portion to 3,4-dihydro-2H-pyran (64.20 g, 0.73 mol) at 0 °C, 
followed by p-toluenesulfonic acid (4.31 g, 0.02 mol) in small 
portions over the period of 20 min while stirring vigorously. The 
reaction mixture was stirred at 0 °C for 2h, then diluted with petroleum ether (100 mL), and 
washed with a saturated NaHCO3 solution (2 x 50 mL) and brine (2 x 50 mL) and dried 
(MgSO4). Petroleum ether was evaporated in vacuo and the crude product was purified by 
distillation at a reduced pressure (88-92 °C / 60 torr) to give 223 (73.43 g, 72%) as a 
colourless oil:  1H NMR (400 MHz, CDCl3) δ 1.40-1.82 (m, 6H, H-1, H-5, H-6 ), 2.35 (s, 1H, 
H-10), 3.42-3.52 (m, 1H, H-2), 3.74-3.82 (m, 1H, H-2), 4.16 (d, 2JH-H = 15.4 Hz, 1H, H-8), 
4.24 (d, 2JH-H = 15.4 Hz, 1H, H-8), 4.74-4.78 (m, 1H, H-4); 13C NMR (100 MHz, CDCl3) δ 
18.0 (CH2, C-6), 24.3 (CH2, C-1), 29.2 (CH2, C-5), 53.0 (CH2, C-6), 61.0 (CH2, C-2), 73.0 
(CH, C-10), 78.8 (C, C-9), 95.83 (CH, C-4) consistent with the literature data.141  
 
 (225). (Chloromethyl)trimethylsilane (4.54 g, 37.03 mmol) was 
added in one portion to a solution of sodium iodide (15.00 g, 100.1 mmol) in 
a freshly distilled acetone (100 mL) an the reaction mixture was stirred at 
ambient temperature for 24 h under Ar. Almost immediately, a white precipitate of NaCl was 
formed that thickened over time, eventually hindering agitation. The cooled mixture was 
filtered through a medium-porosity fritted funnel and the solid material was washed with 
acetone (200 mL). Acetone was then removed from the filtrate by fractionation through a 20 
cm Vigreaux column. The apparatus was then cooled and pentane (50 mL) and water (100 
mL) were poured down the Vigreaux column into the distillation flask. The mixture was 
transferred into a separating funnel, using 100 mL of water and 200 mL of pentane, shaken 
and separated. The aqueous layer  was extracted with pentane (3 x 50 mL) and the combined 
organic layers were washed with 10 % aqueous sodium thiosulfate (1 x 50 mL) to remove 
free iodine, and then with brine  (1 x 50 mL). The pentane solution was dried (MgSO4), 
filtered, and concentrated in vacuo using a room-temperature bath. The residue was distilled 
(20 cm Vigreaux column, b.p. 138–140 °C) to give 225 (5.18 g, 65%) as colourless oil: 1H 
NMR (400 MHz, CDCl3) δ 0.15 (s, 9H, H-1), 2.00 (s, 2H, H-2); 13C NMR (100 MHz, CDCl3) 
δ -18.3 (CH2, C-1), 2.0 (CH3, C-2) consistent with the literature data.142   
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 (227). An oven-dried 250 mL round bottom flask 
was charged with 2-(2-propynyl)tetrahydro-2H-pyran (9) 
(1.49 g, 10.61 mmol) and dry THF (50 mL) and the 
mixture was cooled to -30 °C under argon. n-BuLi (1.6M 
solution in hexane, 7.30 mL, 11.68 mmol) was then added 
dropwise over a period of 30 min while stirring and the mixture was stirred at the same 
temperature for an additional 15 min and then at 0 °C for another 20 min. 
(Iodomethyl)trimethylsilane (2.50 g, 11.68 mmol) was then added slowly via cannula over a 
period of 5 min and the mixture was stirred at 0 °C for another 10 minutes. The reaction 
vessel was then wrapped in an aluminium foil and heated to 55 °C for 3 h under reflux under 
an argon atmosphere. The mixture was then diluted with hexane (150 mL) and ethyl acetate 
(50 mL) and washed with water (1 × 50 mL) and brine (1 × 50 mL). The solvents were 
evaporated to give crude 227 (2.00 g, 83%) as a yellow oil, which was submitted to the next 
step without further purification: 1H NMR (400 MHz, CDCl3) δ 0.09 (s, 9H, H-6), 1.50 (t, 
5JH-H = 2.5 Hz, 2H, H-5), 1.50-1.64 (m, 4H, H-10, H-11), 1.68-1.88 (m, 2H, H-12), 3.47-3.56 
(m, 1H, H-9), 3.81-3.87 (m, 1H, H-9), 4.21 (dt, 2JH-H =  15.5 Hz, 5JH-H = 2.5 Hz, 1H, H-3), 
4.28 (dt, 2JH-H =  15.5 Hz, 5JH-H = 2.5 Hz, 1H, H-3), 4.84 (t, 3JH-H =  3.5 Hz, 1H, H-7); 13C 
NMR (100 MHz, CDCl3) δ -1.9 (CH3, C-6), 7.4 (CH2, C-5), 19.4 (CH2, C-11), 25.6 (CH2, C-
10), 30.5 (CH2, C-12), 54.9 (CH2, C-3), 62.2 (CH2, C-9), 74.7 (C, C-2), 84.7 (C, C-1), 96.5 
(CH, C-7) consistent with the literature data.80  
 
 (228). A solution of PTSA (22.7 mg, 0.12 mmol) and 
pyridine (9.4 mg, 0.12 mmol) in ethanol (4 mL) was added in one 
portion to a solution of  trimethyl(4-tetrahydro-2H-pyran-2-
yloxy-2-butynyl)silane (228) (135 mg, 0.60 mmol) in a mixture 
of ethanol (2 mL) and water (1.2 mL) while stirring and the reaction mixture was stirred at 55 
°C for 24 h. Ethanol was then evaporated in vacuo, the residue was diluted with petroleum 
ether (20 mL) and thoroughly washed with half-saturated brine (4 × 10 mL) and then with 
brine (1 × 10 mL). The organic solution was dried (Na2SO4) and evaporated to afford 4-
(trimethylsilyl)-2-butyn-1-ol (83 mg, 98%) as a viscous yellowish oil: 1H NMR (400 MHz, 
CDCl3) δ 0.08 (s, 9H, H-6), 1.48 (t,   5JH-H= 2.7 Hz, 2H, H-5), 4.22 (t, 5JH-H= 2.7 Hz, 2H, H-
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3); 13C NMR (100 MHz, CDCl3) δ -2.0 (CH3, C-6), 6.5 (CH2, C-5), 52.0 (CH2, C-3), 77.0 (C, 
C-2), 82.6 (C, C-3) consistent with the literature data.143 
 
 
(229). A solution of 4-(trimethylsilyl)-2-butyn-1-ol 
(1.90 g, 13.35 mmol) in dry THF (10 mL) was added 
dropwise to a stirred suspension of lithium aluminium hydride 
(1.52 g, 40.05 mmol) in dry THF (10 mL) at 0 °C under argon 
and the resulting mixture was stirred for another 10 min and 
then refluxed for 3 h. The mixture was then cooled with an ice-water bath, cold water (5 mL) 
was added dropwise, and then a 20 % NaOH aqueous solution (5 mL) and another portion of 
water (15 mL). The mixture was filtered through a short plug of sand and Celite, diluted with 
water (20 mL) and extracted with dichloromethane (5 × 50 mL). The organic phase was 
washed with brine (1 × 50 mL), dried (MgSO4), and evaporated in vacuo to furnish a 
yellowish oil. The crude product was purified by distillation at reduced pressure (89-92 °C / 
26 torr) to afford 229 (923 mg, 48 %) as a colourless oil:  1H NMR (400 MHz, CDCl3) δ 0.00 
(s, 9H, H-1), 1.49 (d, 3JH-H = 8.0 Hz, 2H, H-2), 4.06 (d, 3JH-H = 5.1 Hz, 2H, H-5), 5.44-5.56 
(m, 1H, H-3), 5.64-5.74 (m, 1H, H-4); 13C NMR (100 MHz, CDCl3) δ -1.9 (CH3, C-1), 22.9 
(CH2, C-2), 64.1 (CH2, C-5), 127.7 (CH, C-3), 130.3 (CH, C-4) consistent with the literature 
data.144  
 
 (230). A suspension of N-chlorosuccinimide (1.95 g, 14.6 
mmol) in dichloromethane (10 mL) was added to a solution of 4-
(trimethylsilyl)-2-buten-1-ol (11) (1.39 g, 12.2 mmol) and 
triphenylphosphine (3.20 g, 12.2 mmol) in dry dichloromethane 
(20 mL) at 0 °C and the mixture was stirred at 5 °C under Ar and monitored by TLC (the 
reaction typically took several hours). The reaction mixture was then allowed to warm up to 
ambient temperature and then passed through a short plug of sand and Celite. 
Dichloromethane was carefully evaporated from the filtrate in vacuo without heating and the 
residue was diluted with dry ether (10 mL). This process induced the formation of a white 
precipitate, which was removed by filtration through a short plug of sand and Celite, and the 
filtrate was evaporated, again without heating. The crude product was purified by distillation 
at a reduced pressure (50-54 °C / 10 torr) to afford 229 (851 mg, 80%) as a colourless oil: 1H 
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NMR (400 MHz, CDCl3) δ -0.05 (s, 9H. H-1), 1.44 (d,  3JH-H = 8.2 Hz, 2H, H-2), 3.97 (d, 3JH-
H = 7.3 Hz, 2H, H-5), 5.35-5.44 (m, 1H, H-3), 5.66-5.76 (m, 1H, H-4); 13C NMR (100 MHz, 
CDCl3) δ -2.12 (CH3, C-1), 22.8 (CH2, C-2), 46.1 (CH2, C-5), 124.1 (CH, C-3), 130.9 (CH, 
C-4); MS (CI-isobutane) m/z (%) 163/165 (M+H+, 100/32), 127 (20); HRMS (CI-isobutane) 
m/z 162.0630 (C7H1535ClSi, M+H+, requires 162.0630). 
 
(1). A suspension of CuCl (1.00 g, 10.00 mmol) and 
powdered 4Å molecular sieves (2.00 g) in a mixture of dry 
Hünig’s base (1690 mg, 13.1 mmol) and dry ether (200 mL) in 
an oven-dried flask was cooled to 0 °C under argon. (E)-1-
Chloro-4-(Trimethylsilyl)-2-buten (230) (850 mg, 5.2 mmol) was added as a solution in 
diethyl ether (100 mL) via cannula in one portion, followed by a dropwise addition of 
trichlorosilane (1330 mg, 10.0 mmol) over a period of 20-30 min with vigorous stirring. The 
reaction mixture was stirred at 0 °C for 30 min and then at room temperature until completion 
(ca 2 h). The progress of the reaction was monitored by 1H NMR spectroscopy.† After 
completion, the precipitate was removed by filtration under argon, the filtrate was transferred 
into a micro-distillation apparatus, and ether was distilled off under an inert atmosphere. The 
distillation residue was usually dissolved in an appropriate solvent and used in the next step 
as such immediately. Alternatively, the crude product was purified by distillation under 
reduced pressure (90-92 °C / 8 torr) to give 1 as a colourless liquid (860 mg, 63%): 1H NMR 
(400 MHz, CDCl3) δ 0.01 (s, 9H, H-1), 1.49 (dd, 3JH-H = 8.1 Hz, 4JH-H = 0.9 Hz, 2H, H-2), 
2.26 (dd,    3JH-H = 7.6 Hz, 4JH-H = 1.0 Hz, 2H, H-5), 5.18 (dtt, 3JH-H = 15.2 and 7.6 Hz, 4JH-H = 
1.0 Hz, 1H, H-3), 5.57 (dtt, 3JH-H = 15.1 and 8.2 Hz, 4JH-H = 1.0 Hz, 1H, H-4); 13C NMR (100 
MHz, CDCl3) δ -1.8 (CH3, C-1), 23.6 (CH2, C-2), 29.4 (CH2, C-5), 115.9 (CH, C-3), 132.4 
(CH, C-4); MS (FAB-NOBA) m/z (%) 261 (M+H+, 18), 228 (60), 226 (100), 221 (45); 
HRMS (FAB-NOBA) m/z 260.9849 (C7H1635Cl3Si2, M+H+, requires 260.9856).  
 
 
 
 
                                                 
† The conversion was checked using the following procedure: 0.05‐0.1 mL of the crude reaction mixture was 
transferred via cannula into an oven dried NMR tube under a stream of argon, dry CDCl3 was added and the 
1H 
NMR spectrum was recorded immediately.   
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(36j). Hünig's base (8.11 g, 110 mmol) was added to a solution 
of vanillin (7.61g, 50 mmol) in dry DMF (30 mL) and the resulting 
orange solution was stirred at room temperature for 5 min. TBDMSCl 
(8.29 g, 55 mmol) was added portion-wise in the course of 30 min and 
the mixture was stirred for another hour. The lemon-yellow reaction 
mixture was then cooled to 0° C and ice-cold water (100 mL) was 
added slowly and then diethyl ether (200 mL) and the mixture was stirred for 5 min. The 
organic layer was separated and the aqueous phase was extracted with diethyl ether (2×50 
mL). The organic phases were combined and washed with a 10% aqueous solution of lithium 
chloride (2×50mL), saturated NaHCO3 solution (2×50 mL) and finally brine (1×100 mL). 
The organic phase was dried (MgSO4) and the solvent was evaporated in vacuo to afford the 
product 36j as an yellowish oil, which was used without further purification (12.77 g, 96%): 
1H NMR (400 MHz, CDCl3) δ 0.19 (s, 6H, H-12, 14), 0.95 (s, 9H, H-15, 16, 17), 3.86 (s, 3H, 
H-7), 6.95 (d, 3JH-H = 7.7Hz, 1H, H-3), 7.35 (dd, 3JH-H = 7.8, 1.9 Hz, 1H, H-4), 7.40 (d, 4JH-H 
= 1.9 Hz, 1H, H-6), 9.89 (s, 1H, H-9); 13C NMR (400 MHz, CDCl3) δ -4.7 (CH3,   C-12, 14), 
18.50 (C, C-11), 25.59 (CH3, C-15, 16, 17), 55.44 (CH3, C-7), 110.10 (CH, C-6), 120.71 
(CH, C-3), 126.23 (CH, C-4), 130.94 (C, C-5), 151.34 (C, C-2), 151.63(C, C-1), 191.01 (C, 
C-8) in accordance with the literature data.145 
 
 Method A: General procedure for the synthesis of 
racemic homoallylic alcohols 4a-k. DMF (280 mg, 3.8 mmol), 
Hünig’s base (150 mg, 1.2 mmol), and the corresponding aldehyde 
(0.5 mmol) were added consecutively in this order to a solution of 
(E)-trimethyl[4-(trichlorosilyl)-2-butenyl]silane (1) (100 mg, 0.4 
mmol) in MeCN (10 mL) at –20 °C and the reaction mixture was stirred at the same 
temperature overnight. The reaction was quenched with a saturated aqueous NaHCO3 
solution (1 mL) at -20 °C and left to warm up to room temperature. The solid residue was 
filtered off, MeCN was evaporated, and the residue was dissolved in ether (40 mL) and the 
solution was washed with a saturated NaHCO3 solution (1 × 30 mL) and brine  (1 × 30 mL) 
and dried (Na2SO4) and evaporated. The crude product was purified by chromatography on a 
column of silica gel (2 × 25 cm) with a mixture of petroleum ether and AcOEt (98:2).  
 
R1
OH
Me3Si
4
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 Method B: General procedure for the synthesis of enantio-
enriched homoallylic alcohols 4a-4k. A solution of the chiral catalyst 
in an appropriate solvent (1 mL, see Table 12 for details), Hünig’s 
base (300 mg, 2.4 mmol), and the corresponding aldehyde  (0.5 mmol) 
were added consecutively in this order to a solution of allyldisilane 1 
(100 mg, 0.4 mmol) in the appropriate solvent (10 mL) at -78 °C.  The reaction mixture was 
then transferred to a freezer (-35 °C). Upon reaching the full conversion (monitored by NMR 
spectroscopy), the reaction was quenched with a saturated aqueous NaHCO3 solution (1 mL) 
and left to warm up to room temperature. The solid residue was removed by filtration, the 
solvent was evaporated, and the residue was dissolved in ether (40 mL) and the solution was 
washed with a saturated NaHCO3 solution (1 × 30 mL) and brine (1 × 30 mL) and dried 
(Na2SO4) and evaporated. The crude product was purified by chromatography on a column of 
silica gel (2 × 25 cm) with a mixture of petroleum ether and AcOEt (98:2).  
 
 4a was prepared by method A / B. The crude 
product was purified by chromatography on a column of silica 
gel with a mixture of petroleum ether and AcOEt (98:2) (TLC in 
a petroleum ether-AcOEt 95:5 mixture; RF  = 0.18, stains 
visualized by UV and PMA) to afford 4a (88%, >99% of anti 
diastereoisomer) as a colourless oil: [α]D −52.5 (c 1.2, CHCl3); 
1H 
NMR (400 MHz, CDCl3) δ -0.09 (s, 9H, H-8), 0.43 (dd, 2JH-H = 14.6 Hz, 3JH-H = 4.0 Hz, 1H, 
H-7), 0.49 (dd, 2JH-H = 14.6 Hz, 3JH-H = 10.5 Hz, 1H, H-7), 2.25 (d, 3JH-H = 2.2 Hz, 1H, H-6), 
2.37-2.47 (m, 1H, H-3), 4.30 (dd, 3JH-H = 7.8 Hz, 2JH-H = 2.1 Hz, 1H, H-2), 5.20 (dd, 3JH-H = 
6.2 Hz, 2JH-H = 1.8 Hz, 1H, H-5), 5.22-5.25 (m, 1H, H-5), 5.63 (ddd, JH-H = 15.7, 9.3, and 6.2 
Hz, 1H, H-4), 7.27-7.38 (m, 5H, H-9, 10, 11, 12, 13); 13C NMR (100 MHz, CDCl3) δ -0.7 
(CH3, C-8), 18.2 (CH2, C-7), 49.0 (CH,C-3), 78.8 (CH, C-2), 118.2 (CH2, C-5), 127.4 (CH, 
C-11), 127.8 (CH, C-9, 13), 128.3 (CH, C-10, 12), 141.3 (C, C-1), 142.3 (CH, C-4); IR ν 
3548, 3019, 2955, 2895, 2401, 1248, 1216 cm-1; MS (CI-isobutane) m/z (%) 217 (M+H+-
H2O, 100), 187 (10), 179 (18), 149 (5), 128 (10); HRMS (CI-isobutane) m/z 217.1414 
(C14H21Si, M+H+-H2O, requires 217.1413); chiral HPLC (Chiracel IB column, hexane/2-
propanol = 99.5:0.5, 1 mL/min) showed 93% ee (tmajor = 13.5 min, tminor = 15.9 min). 
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 4b was prepared by method A / B. The crude product 
was purified by chromatography on a column of silica gel with a 
mixture of petroleum ether and AcOEt (98:2) (TLC in a 
petroleum ether-AcOEt 95:5 mixture;  RF = 0.23, stains 
visualized by UV and PMA) to afford 4b (92%, >99% of anti 
diastereoisomer) as a colourless oil: 1H NMR (400 MHz, CDCl3) δ -0.09 (s, 9H, H-8), 0.40-
0.51 (m, 2H, H-7), 2.20 (s, 1H, H-6),  2.35 (s, 3H, H-14), 2.37-2.47 (m, 1H, H-3), 4.25 (d, 
3JH-H = 7.3 Hz, 1H, H-2), 5.17-5.21 (m, 1H, H-5), 5.23 (dd, 3JH-H = 7.2 Hz, 2JH-H = 2.7 Hz, 1H, 
H-5), 5.63 (ddd, 3JH-H = 17.6, 9.4, and 7.3 Hz, 1H, H-4), 7.14 (d, 2H, 3JH-H = 7.8 Hz, 2H, H-
10, 12), 7.20 (d, 3JH-H = 7.8 Hz, 2H, H-9, 13); 13C NMR (100 MHz, CDCl3) δ -0.6 (CH3,      
C-8), 18.2 (CH2, C-7), 21.3 (CH3, C-14), 48.9 (CH, C-3), 78.7 (CH, C-2), 118.1 (CH2, C-5), 
127.3 (CH, C-10, 12), 129.0 (CH, C-9, 13), 137.3 (C, C-11), 139.3 (C, C-1), 141.5 (CH, C-
4); IR ν 3550, 3020, 2954, 2895, 2401, 1248 cm-1; MS (CI-isobutane) m/z (%) 231 (M+H+-
H2O, 100), 159 (42), 141 (17), 121(14); HRMS (CI-isobutane) m/z 231.1574 (C15H23Si, 
M+H+-H2O, requires 231.1569). 
 
 4c was prepared by method A / B. The crude 
product was purified by chromatography on a column of 
silica gel with a mixture of petroleum ether and AcOEt 
(98:2) (TLC in a petroleum ether-AcOEt 96:4 mixture;  RF 
= 0.11, stains visualized by UV and PMA) to afford 4c 
(85%, >99% of anti diastereoisomer) as a colourless oil: [α]D +44.1 (c 1.0, CHCl3); 
1H NMR 
(400 MHz, CDCl3) δ -0.08 (s, 9H, H-14), 0.39 (dd, 2JH-H = 14.5 Hz, 3JH-H = 3.4 Hz, 1H, H-7), 
0.47 (dd, 2JH-H = 14.5 Hz, 3JH-H = 11.1 Hz, 1H, H-7), 2.36 (d, 3JH-H = 2.0 Hz, 1H, H-6), 2.32-
2.42 (m, 1H, H-3), 4.27 (dd, 3JH-H = 7.9 and 2.0 Hz, 1H, H-2), 5.21 (dd, 3JH-H = 16.7 Hz, 2JH-H 
= 1.8 Hz, 1H, H-5), 5.25 (dd, 3JH-H = 10.4 Hz, 2JH-H = 1.8 Hz, 1H, H-5), 5.62 (ddd, 3JH-H = 
16.7, 10.4, and 9.4 Hz, 1H, H-4), 7.03 (m, 2H, H-8, 12), 7.29 (dd, 3JH-F = 8.7 Hz, 3JH-H = 8.4 
Hz, 2H, H-9, 11); 13C NMR (100 MHz, CDCl3) δ -0.7 (CH3, C-14), 18.2 (CH2, C-7), 49.3 
(CH, C-3), 78.1 (CH, C-2), 115.1 (d, 2JC-F = 21.3 Hz, CH, C-9, 11), 118.6 (CH2, C-5), 129.0 
(d, 3JC-F = 8.2 Hz, CH, C-8, 12), 137.9 (d, 4JC-F = 3.2 Hz, C, C-1), 141.2 (CH, C-4), 162.4 (d, 
1JC-F = 245.2 Hz, C, C-10); 19F NMR (377 MHz, CDCl3) δ -115.0 (tt, 3JH-F = 8.7 Hz, 4JH-F = 
5.5 Hz, 1F); IR ν 3547, 3019, 2952, 2896, 2400, 1249, 1217 cm-1; MS (CI-isobutane) m/z (%) 
235 (M+H+-H2O, 100), 205 (10), 125 (15), 113 (20); HRMS (CI-isobutane) m/z 235.1319 
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(C14H20FSi, M+H+-H2O, requires 235.1318); chiral HPLC (Chiracel IB column, hexane/2-
propanol = 99.5:0.5, 0.75 mL/min) showed 97% ee (tmajor = 16.6 min, tminor = 17.4 min). 
 
 4d was prepared by method A / B. The crude 
product was purified by chromatography on a column of 
silica gel with a mixture of petroleum ether and AcOEt 
(98:2) (TLC in a petroleum ether-AcOEt 95:5 mixture;  RF 
= 0.13, stains visualized by UV and PMA) to afford 4d 
(90%, >99% of anti diastereoisomer) as a colourless oil: 
[α]D +32.8 (c 1.0, CHCl3); 
1H NMR (400 MHz, CDCl3) δ -0.08 (s, 9H, H-14), 0.41 (dd, 2JH-H 
= 14.5 Hz, 3JH-H = 3.3 Hz, 1H, H-7), 0.51 (dd, 2JH-H = 14.5 Hz, 3JH-H = 11.4 Hz, 1H, H-7), 
2.32 (d, 3JH-H = 2.1 Hz, 1H, H-6), 2.35-2.46 (m, 1H, H-3), 4.36 (dd, 3JH-H = 7.5 Hz, 3JH-H = 2.1 
Hz, 1H, H-2), 5.23 (dd, 3JH-H = 17.1 Hz, 2JH-H = 1.7 Hz, 1H, H-5), 5.23-5.25 (m, 1H, H-5), 
5.63 (ddd, 3JH-H = 17.1, 10.1, and 7.3 Hz, 1H, H-4), 7.44 (d, 3JH-H = 8.3 Hz, 2H, H-8, 12), 7.60 
(d, 3JH-H = 8.3 Hz, 2H, H-9, 11); 13C NMR (100 MHz, CDCl3) δ -0.7 (CH3, C-14), 18.1 (CH2, 
C-7), 49.1 (CH, C-3), 78.2 (CH, C-2), 118.9 (CH2, C-5), 124.3 (q, 1JC-F = 272.0 Hz, CF3,      
C-13), 125.2 (q, 3JC-F = 3.7 Hz, CH, C-9, 11), 127.7 (CH, C-8, 12), 129.9 (q, 2JC-F = 32.3 Hz, 
C, C-10), 140.6 (CH, C-4), 146.3 (C, C-4); 19F NMR (377 MHz, CDCl3) δ -62.4 (s, 3F); IR ν 
3548, 3020, 2956, 2897, 1250, 1216 cm-1; MS (CI-isobutane) m/z (%) 285 (M+H+-H2O, 42), 
193 (100), 175 (10), 113 (25); HRMS (CI-isobutane) m/z 285.1282 (C15H20F3Si, M+H+-H2O,  
requires 285.1286); chiral GC (Supelco β-DEX 120 column, oven for 1 min at 80 oC, then 
increase at 0.5 deg min-1) showed 90% ee (tmajor = 105.6 min, tminor = 106.7 min). 
 
 4e was prepared by method A / B. The crude 
product was purified by chromatography on a column of 
silica gel with a mixture of petroleum ether and AcOEt 
(gradient of 98:2 and 90:10) (TLC in a petroleum ether-
AcOEt 96:4 mixture;  RF = 0.05, stains visualized by UV 
and PMA) to afford 4e (91%, >99% of anti 
diastereoisomer) as a white crystalline solid: mp 64-67 °C; 
[α]D -45.2 (c 1.0, CHCl3); 
1H NMR (400 MHz, CDCl3) δ -0.08 (s, 9H, H-14), 0.40 (dd, 2JH-H 
= 14.4 Hz, 3JH-H = 3.2 Hz, 1H, H-7), 0.55 (dd, 2JH-H = 14.4 Hz, 3JH-H = 11.5 Hz, 1H, H-7), 
2.33-2.48 (m, 1H, H-3), 2.46 (d, 3JH-H = 2.0 Hz, 1H, H-6), 4.42 (dd, 3JH-H = 7.2 Hz, 3JH-H = 2.0 
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Hz, 1H, H-2), 5.17 (dd, 3JH-H = 17.1 Hz, 2JH-H = 1.6 Hz, 1H, H-5), 5.23 (dd, 3JH-H = 10.0 Hz, 
2JH-H = 1.6 Hz, 1H, H-5), 5.58 (ddd, 3JH-H = 17.1, 10.0, and 10.0 Hz, 1H, H-4), 7.49 (d, 3JH-H = 
8.8 Hz, 2H, H-8, 12), 8.19 (d, 3JH-H = 8.8 Hz, 2H, H-9, 11);  13C NMR (100 MHz, CDCl3) δ -
0.7 (CH3, C-14), 18.2 (CH2, C-7), 49.3 (CH, C-3), 77.9 (CH, C-2), 119.2 (CH2, C-5), 123.5 
(CH, C-9, 11), 128.2 (CH, C-8,12), 140.0 (CH, C-4), 149.7 (C, C-10), 149.8 (C, C-1); IR ν 
3549, 3020, 2954, 2896, 1523, 1348, 1250, 1216 cm-1; MS (CI-isobutane) m/z (%) 280 
(M+H+, 25), 262 (35), 250 (30), 232 (100) 122 (80); HRMS (CI-isobutane) m/z 280.1365 
(C14H22NO3Si, M+H+, requires 280.1369); chiral HPLC (Chiracel OD-H column, hexane/2-
propanol = 99.5:0.5, 1 mL/min) showed 94% ee (tminor =35.3 min, tmajor = 42.8 min). 
 
 4f was prepared by method A / B. The crude 
product was purified by chromatography on a column of 
silica gel with a mixture of petroleum ether and AcOEt 
(gradient of 98:2 and 96:4) (TLC in a petroleum ether-
AcOEt 90:10 mixture; RF = 0.29, stains visualized by UV 
and PMA) to afford 4f (91%, >99% of anti 
diastereoisomer) as a colourless oil: [α]D -41.4 (c 1.4, CHCl3); 
1H NMR (400 MHz, CDCl3) δ 
-0.08 (s, 9H, H-13), 0.44-0.52 (m, 2H, H-7), 2.23 (d, 3JH-H= 2.2 Hz, 1H, H-6), 2.43 (dddd, 
3JH-H = 9.3, 7.7, 7.5 and 4.8 Hz, 1H, H-3), 3.82 (s, 3H, H-14), 4.27 (dd, 3JH-H = 7.7 and 2.2 
Hz, 1H, H-2), 5.20 (dd, 3JH-H = 5.3, 2JH-H = 1.6, 1H, H-5), 5.23-5.26 (m, 1H, H-5), 5.59-5.70 
(m, 1H, H-4), 6.83 (d, 3JH-H = 7.8 Hz, 1H, H-12), 6.89-6.93 (m, 2H, H-10, 11), 7.25 (m, 1H, 
H-8); 13C NMR (100 MHz, CDCl3) δ -0.6 (CH3, C-13), 18.2 (CH2, C-7), 48.8 (CH, C-3), 55.4 
(CH3, C-14), 78.8 (CH, C-2), 112.9 (CH2, C-5), 113.3 (CH, C-10), 118.2 (CH, C-8), 119.9 
(CH, C-12), 129.3 (CH, C-11), 141.3 (CH, C-4), 144.0 (C, C-1), 159.7 (C, C-9); IR ν 3551, 
3018, 2954, 2894, 2400, 1248, 1216 cm-1; MS (FAB-NOBA) m/z (%) 247 (M+H+-H2O, 65), 
226 (62), 209 (20), 137 (135), 109 (10), 74 (100); HRMS (FAB-NOBA) m/z 247.1517 
(C15H23OSi, M+H+-H2O, requires 247.1518); chiral HPLC (Chiralpak IB-3 column, 
hexane/2-propanol = 98:2, 1 mL/min) showed 96% ee (tmajor =15.0 min, tminor = 25.7 min). 
 
 4g was prepared by method A / B. The 
crude product was purified by chromatography on a 
column of silica gel with a mixture of petroleum ether and 
AcOEt (99:1) (TLC in a petroleum ether-AcOEt 9:1 
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mixture; RF  = 0.40, stains visualized by PMA) to afford 4g (79%, >99% of anti 
diastereoisomer) as a colourless oil: [α]D  -9.4 (c 1.0, CHCl3); 
1H NMR (400 MHz, CDCl3) δ -
0.04 (s, 9H, H-8), 0.61 (dd, 2JH-H = 14.5 Hz, 3JH-H = 10.6 Hz, 1H, H-7), 0.70 (dd, 2JH-H = 14.5 
Hz, 3JH-H = 4.0 Hz, 1H, H-7), 0.89 (t, 3JH-H  = 6.9 Hz, 3H, H-12), 1.25-1.36 (m, 6H, H-9, 10, 
11), 1.41-1.54 (m, 2H, H-1), 1.61 (d, 3JH-H = 3.8 Hz, 1H, H-6), 2.10-2.19 (m, 1H, H-3), 3.29-
3.36 (m, 1H, H-2), 5.09 (dd, 3JH-H = 17.2 Hz, 2JH-H = 2.1 Hz, 1H, H-5), 5.13 (dd, 3JH-H = 10.5 
Hz, 2JH-H = 2.0 Hz, 1H, H-5), 5.13 (ddd, JH-H = 17.11, 10.1 and 9.4 Hz, 1H, H-4); 13C NMR 
(100 MHz, CDCl3) δ -0.53 (CH3, C-8), 14.2 (CH3, C-12), 18.6 (CH2, C-11), 22.8 (CH2, C-7), 
25.6 (CH2, C-9), 32.1 (CH2, C-10), 34.2 (CH2, C-1), 46.7 (CH, C-3), 75.8 (CH, C-2), 117.2 
(CH2, C-5), 140.9 (CH, C-4); IR ν 3555, 3023, 2921, 2895, 1263, 1215 cm-1; MS (CI-
isobutane) m/z (%) 211 (M+H+-H2O, 100), 185 (8), 173 (9), 128 (10), 85 (10); HRMS (CI-
isobutane) m/z 211.1887 (C13H27OSi, M+H+-H2O, requires 211.1877); chiral GC (Supelco β-
DEX 120 column, oven for 1 min at 80 oC, then increase at 0.25 deg min-1) showed 73% ee 
(tmajor = 91.0 min, tminor = 92.3 min). 
 
 4h was prepared by method A / B. The 
crude product was purified by chromatography on a 
column of silica gel with a mixture of petroleum ether and 
AcOEt (99:1) (TLC in a petroleum ether-AcOEt 9:1 
mixture; RF  = 0.34, stains visualized by PMA) to afford 
4h (90%, >99% of anti diastereoisomer) as a colourless oil: [α]D +13.1 (c 1.0, CHCl3); 
1H 
NMR (400 MHz, CDCl3) δ -0.02 (s, 9H, H-8), 0.48 (dd, 2JH-H = 14.6 Hz, 3JH-H = 11.3 Hz, 1H, 
H-7), 0.73 (dd, 2JH-H = 14.6 Hz, 3JH-H = 3.9 Hz, 1H,     H-7), 0.91 (t, 3JH-H  = 7.6 Hz, 3H, H-
12), 1.42 (ddq, 3JH-H  = 9.7, 9.5, and 7.6 Hz, 2H, H-11), 1.80 (s, 1H, H-6), 1.98-2.10 (m, 2H, 
H-10), 2.11-2.20 (m, 1H, H-3), 3.72 (dd, 3JH-H = 7.7 and 7.7 Hz, 1H, H-2), 5.14 (dd, 3JH-H = 
9.8 Hz, 2JH-H = 1.7 Hz, 1H, H-5), 5.16-5.18 (m, 1H, H-5), 5.38 (ddd, 3JH-H = 15.4, 7.7 and 1.5 
Hz, 1H, H-4), 5.58 (dd, 3JH-H = 15.7 and 9.2 Hz, 1H, H-1), 5.66 (ddd, 3JH-H = 15.0, 9.8 and 9.4 
Hz, 1H, H-9); 13C NMR (100 MHz, CDCl3) δ -0.58 (CH3, C-8), 13.8 (CH3, C-12), 18.1 (CH2, 
C-11), 22.4 (CH2, C-7), 34.6 (CH2, C-10), 47.4 (CH, C-3), 77.4 (CH, C-2), 117.6 (CH2, C-5), 
130.7 (CH, C-1), 134.5 (CH, C-9), 141.3 (CH, C-4);  IR ν 3599, 3019, 3030, 2947, 2409, 
1300, 1199 cm-1; MS (CI-isobutane) m/z (%) 209 (M+H+-H2O, 100), 171 (8), 135 (6), 99 
(12); HRMS (CI-isobutane) m/z 209.1723 (C13H25Si, M+H+-H2O,  requires 209.1720); chiral 
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GC (Supelco β-DEX 120 column, oven for 1 min at 80 oC, then increase at 0.5 deg min-1) 
showed 98% ee (tmajor = 73.9 min, tminor = 76.8 min). 
 
 4i was prepared by method A / B. The crude 
homoallylic alcohol was purified by chromatography on a 
column of silica gel (15g) with a mixture of petroleum ether and 
AcOEt (98:2 to 80:20) (TLC in a petroleum ether-AcOEt 80:20 
mixture; RF  = 0.29, stains visualized by UV and PMA) to afford 
4i (810 mg, 75%, >99% of anti diastereoisomer) as a colourless 
oil: 1H NMR (400 MHz, CDCl3) δ -0.05 (s, 9H, H-16), 0.43 (dd, 2JH-H = 14.6 Hz, 3JH-H = 4.2 
Hz, 1H, H-15), 0.47 (dd, 2JH-H = 14.6 Hz, 3JH-H = 10.3 Hz, 1H, H-15), 2.41 (d, 3JH-H = 2.0 Hz, 
1H, H-14), 2.35-2.46 (m, 1H, H-11), 3.84 (s, 3H, H-8), 3.87 (s, 6H, H-7, H-9), 4.20 (dd, 3JH-H 
= 8.1 Hz, 2JH-H = 1.4 Hz, 1H, H-10), 5.22-5.29 (m, 2H, H-13), 5.65 (ddd, JH-H = 16.8, 10.6, 
and 9.3 Hz, 1H, H-12), 6.56 (s, 2H, H-4, 6); 13C NMR (100 MHz, CDCl3) δ -0.7 (CH3), 18.0 
(CH2, C-15), 48.7 (CH, C-11), 56.0 (CH3, C-7, 9), 60.8 (CH3, C-8), 78.9 (CH, C-10), 104.3 
(CH, C-4, 6), 106.7 (CH, C-12), 118.2 (CH2, C-13), 137.7 (C), 141.5 (C), 153.1 (C); IR ν 
3550, 3022, 2895, 2786, 2418, 1190 cm-1; MS (CI-isobutane) m/z (%) 325 (M+H+, 50), 307 
(65), 197 (100); HRMS (CI-isobutane) m/z 325.1833 (C17H29O4Si, M+H+, requires 
325.1830). 
 
 4j was prepared by method A / B. The 
crude homoallylic alcohol was purified by chromatography 
on a column of silica gel (20g) with a mixture of petroleum 
ether and AcOEt (98:2 to 92:8) (TLC in a petroleum ether-
AcOEt 90:10 mixture; RF  = 0.30, stains visualized by UV 
and PMA) to afford 4j (990 mg, 75%, >99% of anti 
diastereoisomer) as a colourless oil: 1H NMR (400 MHz, 
CDCl3) δ -0.08 (s, 9H, H-15), 0.16 (s, 3H, H-17), 0.17 (s, 3H, H-19),  0.39 (dd, 2JH-H = 14.6 
Hz, 3JH-H = 3.3 Hz, 1H, H-14), 0.45 (dd, 2JH-H = 14.6 Hz, 3JH-H = 10.9 Hz, 1H, H-14), 1.02 (s, 
9H, H-21, 22, 23); 2.32 (d, 3JH-H = 1.4 Hz, 1H, H-13), 2.35-2.44 (m, 1H, H-10), 3.84 (s, 3H, 
H-7), 4.21 (dd, 2JH-H = 8.2.6 Hz, 2JH-H = 1.6 Hz, 1H, H-9), 5.21-5.24 (m, 1H, H-12), 5.26 (dd, 
3JH-H = 9.3 Hz, 2JH-H = 1.5 Hz, 1H, H-12), 5.67 (ddd, JH-H = 17.0, 10.2, and 9.4 Hz, 1H, H-11), 
6.78 (dd, 3JH-H = 8.1 Hz, 4JH-H = 2.2 Hz, 1H, H-4), 6.83 (d, 3JH-H = 8.3 Hz, 1H, H-3), 6.87 (d, 
146 
 
3JH-H = 1.9 Hz, 1H, H-6); 13C NMR (100 MHz, CDCl3) δ -4.6 (C, C-16), -0.85 (CH3, C-15), 
0.5 (CH3, C-17, 19), 18.1 (CH2, C-14), 25.7 (CH3, C-20, 21, 22), 49.0 (CH, C-10), 55.5 (CH3, 
C-7), 78.6 (CH, C-9), 110.7 (CH2, C-12), 117.9 (CH, C-6), 120.1 (CH, C-4), 120.4 (CH, C-
3), 135.6 (CH, C-11), 141.6 (C, C-5), 144.4 (C, C-2), 150.9 (C, C-1); IR ν 3549, 3025, 2890, 
2795, 2435, 1248, cm-1; MS (CI-isobutane) m/z (%) 395 (M+H+, 30), 377 (M+H+-H2O, 92), 
267 (100), 209 (10), 127 (8); HRMS (CI-isobutane) m/z 395.2440 (C21H39O3Si2, M+H+, 
requires 395.2432). 
 
  4k was prepared by method A / B. The 
crude homoallylic alcohol was purified by chromatography on 
a column of silica gel (35g) with a mixture of petroleum ether 
and AcOEt (98:2 to 92:8) (TLC in a petroleum ether-AcOEt 
90:10 mixture; RF  = 0.22, stains visualized by UV and PMA) 
to afford 4k (1.91g, 71%, >99% of anti diastereoisomer) as a 
colourless oil: 1H NMR (400 MHz, CDCl3) δ -0.05 (s, 9H, H-15), 0.43-0.49 (m, 2H, H-14), 
2.34 (d, 3JH-H = 1.6 Hz, 1H, H-14), 2.35-2.44 (m, 1H, H-10), 4.22 (dd, 3JH-H = 8.0 Hz, 4JH-H = 
1.0 Hz, 1H, H-9), 5.21-5.24 (m, 1H, H-12), 5.25-5.28 (m, 1H, H-12), 5.65 (ddd, 3JH-H = 16.3, 
10.0, and 9.5 Hz, 1H, H-11), 5.98 (s, 1H, H-16), 5.99 (s, 1H, H-16), 6.78-6.82 (m, 2H, H-3, 
4), 6.85-6.88 (m, 1H, H-6); 13C NMR (100 MHz, CDCl3) δ -0.8 (CH3, C-15), 18.1 (CH2, C-
14), 49.0 (CH, C-10), 78.5 (CH, C-9), 100.9 (CH2, C-16), 107.4 (CH, C-6), 107.8 (CH, C-3), 
118.1 (CH2, C-12), 120.9 (CH, C-4), 136.1 (CH, C-11), 141.2 (C, C-5), 146.9 (C, C-1), 147.6 
(C, C-2); IR ν 3558, 3015, 2799, 2442, 1198, cm-1; MS (CI-isobutane) m/z (%) 261 (M+H+-
H2O, 35), 151 (100), 81 (5); HRMS (CI-isobutane) m/z 261.1312 (C15H21O2Si, M+H+-H2O, 
requires 261.1305). 
 
 A 1:1 mixture of syn-4a and anti-4a was 
prepared by method A from the 1:1 mixture of the corresponding E 
and Z disilane. The crude mixture was purified by chromatography 
on a column of silica gel (2g) with a mixture of petroleum ether and 
AcOEt (98:2) (TLC in a petroleum ether-AcOEt 90:10 mixture; RF  
= 0.46, stains visualized by UV and PMA) to afford syn-4a as a colourless oil (55 mg, 45%): 
1H NMR (400 MHz, CDCl3) δ -0.02 (s, 9H, H-8), 0.53 (dd, 2JH-H = 14.5 Hz, 3JH-H = 11.7 Hz, 
1H, H-7), 0.81 (dd, 2JH-H = 14.5 Hz, 3JH-H = 2.8 Hz, 1H, H-7), 2.09 (d, 3JH-H = 5.0 Hz, 1H,    
147 
 
O R2R1
H-6), 2.54-2.65 (m, 1H, H-3), 4.58 (t, 3JH-H = 5.1 Hz, 1H, H-2), 5.01-5.11 (m, 2H, H-5), 5.57 
(ddd, JH-H = 17.0, 10.3, and 9.2 Hz, 1H, H-4), 7.25-7.45 (m, 5H, H-9, 10, 11, 12, 13); 13C 
NMR (100 MHz, CDCl3) δ -6.0 (CH3, C-8), 11.5 (CH2, C-7), 42.1 (CH, C-3), 73.4 (CH,      
C-2), 111.3 (CH2, C-5), 121.5 (CH, C-11), 122.0 (CH, C-9, 13), 122.6 (CH, C-10, 12), 135.0 
(CH, C-4), 136.9 (C, C-2); IR ν 3543, 3010, 2960, 2480, 1260 cm-1; MS (CI-isobutane) m/z 
(%) 217 (M+H+-H2O, 100), 187 (22), 179 (25), 128 (10); HRMS (CI-isobutane) m/z 
217.1420 (C14H21Si, M+H+-H2O, requires 217.1413). 
 
  Method C: General method for the intramolecular cascade 
allylation (intramolecular allyl  transfer).  The aldehyde (0.05 mmol) 
was added via a Hamilton syringe to a solution of the corresponding homoallylic 
alcohol 4  (0.04 mmol) in dry THF (1 mL) at room temperature under argon. The solution 
was stirred at -90 °C for 10 min, then a suspension of tin(II) triflate (8 mg, 0.02 mmol) in 
THF (0.5 mL) was added slowly via cannula on the wall of the reaction vessel (in order to 
cool it to -90 °C before reaching the reactants) while stirring vigorously. The reaction mixture 
was stirred at –90 °C overnight and then allowed to warm to room temperature over 4-5 h. 
The solvent was evaporated at reduced pressure and the crude product was purified by 
chromatography on a column of silica gel (0.4 × 5 cm) with a mixture of petroleum ether and 
AcOEt (99:1).  
 
7aa was prepared by method C. The crude product 
was purified by chromatography on a column of silica gel 
(0.4 × 5 cm) with a mixture of petroleum ether and AcOEt 
(99:1) (TLC in a petroleum ether-AcOEt 90:10 mixture; RF 
= 0.23, stains visualized by UV and PMA) to afford 7aa 
(95%, >25:1 de) as a colourless oil: [α]D −50.1 (c 1.0, 
CHCl3); 1H NMR (400 MHz, CDCl3) δ 1.92 (ddd, 2JH-H = 12.5 Hz, 3JH-H = 9.4 and 9.2 Hz, 
1H, H-2), 2.57 (ddd, 2JH-H = 12.6 Hz, 3JH-H = 7.9, and 6.0 Hz, 1H, H-2), 3.30-3.41 (m, 1H,    
H-1), 4.78 (dd, 3JH-H = 10.2 Hz, 2JH-H = 1.6, 1H, H-19), 4.92 (ddd, 3JH-H = 17.0 Hz, 2JH-H = 1.7 
Hz, 4JH-H = 0.8 Hz, 1H, H-19), 5.10 (dd, 3JH-H = 9.6 and 5.9 Hz, 1H, H-3), 5.23 (ddd, 3JH-H = 
17.2, 10.1 and 8.2 Hz, 1H, H-18), 5.24 (d, 3JH-H = 8.2 Hz, 1H, H-5), 7.25-7.52 (m, 10H, H-13-
17 and 8-12); 13C NMR (100 MHz, CDCl3) δ 40.8 (CH2, C-2), 49.2 (CH, C-1), 80.5 (CH,    
C-3), 83.8 (CH, C-5), 115.9 (CH2, C-19), 126.0 (CH, C-10), 127.0 (CH, C-15), 127.2 (CH, 
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C-9, 10), 127.5 (CH, C-14, 16), 128.1 (CH, C-8,12), 128.6 (CH, C-13,17), 138.4 (CH, C-18), 
140.3 (C, C-3), 142.0 (C, C-5); IR ν 3019, 2399, 2361, 1510, 1216 cm-1; MS (CI-isobutane) 
m/z (%) 251 (M+H+, 42), 233 (25), 137 (100), 121 (54), 69 (50); HRMS (CI-isobutane) m/z 
251.1440 (C18H19O, M+H+, requires 251.1436); (Chiralpak IA-3 column, hexane/2-propanol 
= 95:5, 0.5 mL/min) showed 90% ee (tminor = 10.0 min, tmajor = 13.5 min). 
 
7ab was prepared by method C. The crude product was 
purified by chromatography on a column of silica gel (0.4 × 5 
cm) with a mixture of petroleum ether and AcOEt (99:1) (TLC 
in a petroleum ether-AcOEt 95:5 mixture; RF = 0.49, stains 
visualized by UV and PMA) to afford 7ab (90%, de > 25:1) as 
a colourless oil: 1H NMR (400 MHz, CDCl3) δ 1.91 (ddd, 2JH-H = 12.5 Hz, 3JH-H = 9.3 and 9.3 
Hz, 1H, H-2), 2.38 (s, 3H, H-20), 2.57 (ddd, 2JH-H = 12.6 Hz, 3JH-H = 7.9 and 6.1 Hz, 1H, H-
2), 3.51-3.65 (m, 1H, H-1), 4.79 (dd, 3JH-H = 10.2 Hz, 2JH-H = 1.6, 1H, H-19), 4.90 (ddd, 3JH-H 
= 16.9 Hz, 2JH-H = 1.7 Hz, 4JH-H = 0.8 Hz, 1H, H-19), 5.11 (dd, 3JH-H = 9.5 and 5.9 Hz, 1H,   
H-3), 5.24 (ddd, 3JH-H = 17.2, 10.1, and 8.2 Hz, 1H, H-18), 5.24 (d, 3JH-H = 8.2 Hz, 1H, H-5), 
7.25-7.52 (m, 9H, H-13-17 and 8-12); 13C NMR (100 MHz, CDCl3) δ 20.6 (CH3, C-20), 40.8 
(CH2, C-2), 49.2 (CH, C-1), 80.6 (CH, C-3), 83.9 (CH, C-5), 116.0 (CH2, C-19), 126.2 (CH, 
C-9,11), 127.1 (CH, C-15), 127.2 (CH, C-14, 16), 128.1 (CH, C-8,12), 128.6 (CH, C-13, 17), 
134.0 (C, C-10), 138.4 (CH, C-18), 140.3 (C, C-6), 142.0 (C, C-7); IR ν 3019, 2399, 2375, 
2362, 1510, 1216, 1014 cm-1; MS (CI-isobutane) m/z (%) 265 (M+H+, 45), 247 (58), 151 
(100); HRMS (CI-isobutane) m/z 265.1570 (C19H21O, M+H+, requires 265.1592). 
 
7ad was prepared by method C. The crude 
product was purified by chromatography on a column of 
silica gel (0.4 × 5 cm) with a mixture of petroleum ether 
and AcOEt (99:1) (TLC in a petroleum ether-AcOEt 
90:10 mixture; RF = 0.25, stains visualized by UV and 
PMA)  to afford 7ad (80%,  20:1 de) as a colourless oil: 
1H NMR (400 MHz, CDCl3) δ 1.86 (ddd, 2JH-H = 12.5 Hz, 3JH-H = 9.4 and 8.9 Hz, 1H, H-2), 
2.60 (ddd, 2JH-H = 12.6 Hz, 3JH-H = 7.3 Hz and 6.2 Hz, 1H, H-2), 3.30-3.39 (m, 1H, H-1), 4.76 
(ddd, 3JH-H = 10.1 Hz, 2JH-H = 1.7, 4JH-H = 0.6, 1H, H-19), 4.90 (ddd, 3JH-H = 17.0 Hz, 2JH-H = 
1.7 Hz, 4JH-H = 0.9 Hz, 1H, H-19), 5.12 (dd, 3JH-H = 9.5 and 6.3 Hz, 1H, H-3), 5.19 (ddd, 3JH-H 
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= 17.0, 10.0 and 8.9, 1H, H-18), 5.24 (d, 3JH-H = 8.1, 1H, H-5), 7.20-7.38 (m, 5H, H-
13,14,15,16,17), 7.54-7.68 (m, 4H, H-8,9,11,12); 13C NMR (100 MHz, CDCl3) δ 40.6 (CH2, 
C-2), 49.1 (CH, C-1), 79.7 (CH, C-5), 83.9 (CH, C-3), 115.7 (CH2, C-19), 125.5 (q, 3JC-F = 
3.9 Hz, CH, C-9,11), 124.1 (q, 1JC-F = 271.0 Hz, CF3, C-20), 126.1 (CH, C-8,12), 126.9 (CH, 
C-14,16), 127.4 (CH, C-15), 128.1 (CH, C-13.17), 129.6 (q, 2JC-F = 32.3 Hz, C, C-10), 137.9 
(CH, C-18), 139.9 (C, C-7), 146.3 (C, C-6); 19F NMR (377 MHz, CDCl3) δ -62.3 (s, 3F); IR ν 
3019, 2400, 2361, 1510, 1250, 1217, 1015 cm-1; MS (CI-isobutane) m/z (%) 319 (M+H+, 
100), 301 (60), 205 (35), 129 (37); HRMS (CI-isobutane) m/z 319.1305 (C19H18F3O, M+H+, 
requires 319.1310). 
 
 7ag was prepared by method C. The crude 
product was purified by chromatography on a column of 
silica gel (0.4 × 5 cm) with a mixture of petroleum ether 
and AcOEt (99:1) (TLC in a petroleum ether-AcOEt 
90:10 mixture;  RF = 0.49, stains visualized by UV and 
PMA) to afford 7ag (94%, >25:1 de) as a colourless oil: 
1H NMR (400 MHz, CDCl3) δ 1.87 (ddd, 2JH-H = 12.4 Hz, 3JH-H = 10.1 and 6.2 Hz, 1H, H-2), 
2.57 (ddd, 2JH-H = 12.6 Hz, 3JH-H = 7.3 and 6.1 Hz, 1H, H-2), 3.28-3.40 (m, 1H, H-1), 4.78 
(dd, 3JH-H = 10.0 Hz, 2JH-H = 1.7, 1H, H-19), 4.91 (ddd, 3JH-H = 17.0 Hz, 2JH-H = 1.7 Hz, 4JH-H = 
0.7 Hz, 1H, H-19), 5.06 (dd, 3JH-H = 9.7 Hz, 3JH-H = 6.9 Hz, 1H, H-3), 5.15-5.26 (m, 1H, H-5), 
5.20 (d, 3JH-H = 8.1 Hz, 1H, H-18), 7.22-7.46 (m, 9H, H-13-17 and 8,9,11,12); 13C NMR (100 
MHz, CDCl3) δ 40.7 (CH2, C-2), 49.1 (CH, C-1), 79.8 (CH, C-5), 83.9 (CH, C-3), 115.6 
(CH2, C-19), 126.9 (CH, C-15), 127.4 (CH, C-14, 16), 127.5 (CH, C-8,12), 128.1 (CH, C-9, 
11), 128.7 (CH, C-13, 17), 133.2 (C-10), 138.1 (CH, C-18), 140.1 (C-7), 140.7 (C, C-6); IR ν 
3020, 2398, 2361, 1510, 1215, 1199 cm-1; MS (CI-isobutane) m/z (%) 285/287, 285 (M+H+, 
48/17), 269 (13), 267 (20), 178 (10), 137 (80), 69 (100); HRMS (CI-isobutane) m/z 285.1042 
(C18H1835ClO, M+H+, requires 285.1046).  
 
7ah was prepared by method C. The crude 
product was purified by chromatography on a 
column of silica gel (0.4 × 5 cm) with a mixture of 
petroleum ether and AcOEt (99:1) (TLC in a 
petroleum ether-AcOEt 90:10 mixture;  RF = 0.43, 
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stains visualized by UV and PMA) to afford 7ah (87%, >25:1 de) as a colourless oil: 1H 
NMR (400 MHz, CDCl3) δ 1.87 (ddd, 2JH-H = 12.5 Hz, 3JH-H = 9.1 and 9.1 Hz, 1H, H-2), 2.58 
(ddd, 2JH-H = 12.6 Hz, 3JH-H = 8.0, and 6.1 Hz, 1H,     H-2), 3.32 (m, 1H, H-1), 4.78 (dd, 3JH-H 
= 10.1 Hz, 2JH-H = 1.9, 4JH-H = 0.5 Hz, 1H, H-19), 4.91 (ddd, 3JH-H = 17.0 Hz, 2JH-H = 1.8 Hz, 
4JH-H = 0.8 Hz, 1H, H-19), 5.05 (dd, 3JH-H = 9.2 and 6.1 Hz, 1H, H-3), 5.21 (dd, 3JH-H = 17.0, 
10.0, and 8.3 Hz, 1H, H-18), 5.22 (d, 3JH-H = 8.1 Hz, 1H, H-5), 7.22-7.38 (m, 7H, H-13-17 
and 11,12), 7.44 (dd, 3JH-H = 7.7 Hz, 4JH-H = 1.5 Hz, 1H, H-10), 7.64 (t, 4JH-H= 1.4 Hz, 1H, H-
8); 13C NMR (100 MHz, CDCl3) δ 40.6 (CH2, C-2), 49.1 (CH, C-1), 79.7 (CH, C-5), 83.9 
(CH, C-3), 115.6 (CH2, C-19), 122.7 (C, C-9), 124.6 (CH, C-10), 126.9 (CH, C-15), 127.4 
(CH, C-14, 16), 128.1 (CH, C-13, 17), 129.0 (CH, C-10), 130.2 (CH, C-11), 130.5 (CH, C-8), 
138.0 (CH, C-18), 139.9 (C, C-7), 144.5 (C, C-6); IR ν 3019, 2400, 2361, 1515, 1253, 1215, 
1199 cm-1; MS (CI-isobutane) m/z (%) 331/329 (M+H+, 19/20), 313 (10), 311 (11), 187 (14), 
185 (15), 137 (45), 69 (100); HRMS (CI-isobutane) m/z 329.0534 (C18H1879BrO, M+H+, 
requires 329.0514). 
 
 7ai was prepared by method C. The crude 
product was purified by chromatography on a 
column of silica gel (0.4 × 5 cm) with a mixture of 
petroleum ether and AcOEt (99:1) (TLC in a 
petroleum ether-AcOEt 9:1 mixture; RF = 0.54, stains 
visualized by UV and PMA)  to afford 7ai (92%, 10:1 de) as a colourless oil: 1H NMR (400 
MHz, CDCl3) δ 0.91 (t, 3JH-H = 7.4, 3H, H-18), 1.29-1.55 (m, 8H), 1.80-1.91 (m, 1H, H-2), 
2.20 (ddd, 2JH-H = 12.6, 3JH-H = 7.3 and 5.5 Hz, 1H, H-2), 3.11-3.23 (m, 1H, H-1), 4.02 (dtd, 
3JH-H =  9.6, 6.3 and 5.7 Hz, 1H, H-3), 4.75 (ddd, 3JH-H = 10.1 Hz, 2JH-H = 2.0, 4JH-H = 0.5, 1H, 
H-14), 4.90 (ddd, 3JH-H = 17.0 Hz, 2JH-H = 2.0 Hz, 4JH-H = 0.8 Hz, 1H, H-14), 5.04 (d, 3JH-H = 
8.1 Hz, 1H, H-5), 5.17 (ddd, 3JH-H = 17.1, 10.0 and 9.0, 1H, H-13), 7.19-7.36 (m, 5H, H-8, 9, 
10, 11, 12); 13C NMR (100 MHz, CDCl3) δ 14.2 (CH3, C-18), 22.8 (CH2, C-17), 26.3 (CH2, 
C-15), 32.1 (CH2, C-16), 35.7 (CH2, C-6), 38.5 (CH2, C-2), 49.1 (CH, C-1), 79.8 (CH, C-3), 
83.3 (CH, C-5), 115.0 (CH2, C-14), 126.9 (CH, C-8, 12), 127.3 (CH, C-10), 127.9 (CH, C-9, 
11), 138.9 (CH, C-13), 140.7 (C-7); IR ν 3031, 2900, 1492, 1215, 1060, 1014 cm-1; MS (CI-
isobutane) m/z (%) 245 (M+H+, 100), 227 (10), 145 (23), 69 (48); HRMS (CI-isobutane) m/z 
245.1903 (C17H25O, M+H+, requires 245.1900). 
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 7aj was prepared by method C. The crude 
product was purified by chromatography on a column 
of silica gel (0.4 × 5 cm) with a mixture of petroleum 
ether and AcOEt (99:1) (TLC in a petroleum ether-
AcOEt 9:1 mixture; RF = 0.49, stains visualized by 
UV and PMA)  to afford 7aj (92%, 10:1 de) as a colourless oil: 1H NMR (400 MHz, CDCl3) 
1.05-1.39 (m, 6H, H-15, 16, 17, 18, 19), 1.60-1.81 (m, 5H, H-15, 6, 19), 2.05-2.15 (m, 1H, H-
2), 2.13 (ddd, 2JH-H = 12.6, 3JH-H = 7.3 and 5.5 Hz, 1H, H-2), 3.10-3.19 (m, 1H, H-1), 3.72 
(ddd, 3JH-H = 9.7,  7.8 and 5.5 Hz, 1H, H-3), 4.79 (dd, 3JH-H = 9.9 Hz, 2JH-H = 1.9 Hz, 1H, H-
14), 4.89 (ddd, 3JH-H = 17.0 Hz, 2JH-H = 2.0 Hz, 4JH-H = 0.8 Hz, 1H, H-14), 5.03 (d, 3JH-H = 8.2 
Hz, 1H, H-5), 5.17 (ddd, 3JH-H = 17.1, 10.0 and 9.1, 1H, H-13), 7.19-7.35 (m, 5H, H-8, 9, 10, 
11, 12); 13C NMR (100 MHz, CDCl3) δ 26.1 (CH2, C-17), 26.3 (CH2, C-16, 18), 26.7 (CH2, 
C-15, 19), 43.3 (CH, C-1), 48.9 (CH, C-6), 83.0 (CH, C-3), 84.2 (CH, C-5), 114.8 (CH2, C-
14), 126.9 (CH, C-8, 12), 127.0 (CH, C-10), 127.9 (CH, C-9, 11), 139.0 (CH, C-13), 140.8 
(C, C-7); IR ν 3007, 2919, 1485, 1208, 1069 cm-1; MS (CI-isobutane) m/z (%) 257 (M+H+, 
100), 239 (16), 145 (18), 69 (83); HRMS (CI-isobutane) m/z 257.1899 (C18H25O, M+H+, 
requires 257.1900). 
 
 
7bb was prepared by method C. The crude 
product was purified by chromatography on a 
column of silica gel (0.4 × 5 cm) with a mixture of 
petroleum ether and AcOEt (99:1) (TLC in a 
petroleum ether-AcOEt 95:5 mixture;  RF = 0.34, 
stains visualized by UV and PMA)  to afford 7bb 
(85%, 21:1 de) as a colourless oil: 1H NMR (400 MHz, CDCl3) δ 1.89 (ddd, 2JH-H = 12.5,  
3JH-H = 9.5 and 9.5 Hz, 1H, H-2), 2.33 (s, 3H, H-20), 2.37 (s, 3H, H-21), 2.51 (ddd, 2JH-H = 
12.6 Hz, 3JH-H = 7.3 and 5.8 Hz, 1H, H-2), 3.27-3.37 (m, 1H, H-1), 4.78 (ddd,  3JH-H = 10.1 
Hz,  2JH-H = 1.9, 4JH-H = 1.9  and 0.5 Hz, 1H, H-19), 4.92 (ddd,  3JH-H = 17.0 Hz, 2JH-H = 1.9,  
4JH-H = 1.9  and 0.9 Hz, 1H, H-19), 5.05 (dd, 3JH-H = 9.7 and 5.8 Hz, 1H, H-3), 5.19 (d, 3JH-H = 
8.0 Hz, 1H, H-5), 5.26 (ddd, 3JH-H = 17.0, 10.1, and 8.9 Hz, 1H, H-18), 7.11 (d, 3JH-H = 8.0 
Hz, 2H, H-14, 16), 7.14-7.25 (m, 4H, H-9, 11, 8, 12), 7.39 (d, 3JH-H = 8.0 Hz, 2H, H-13, 17); 
13C NMR (100 MHz, CDCl3) δ 21.3 (CH3, C-20), 21.4 (CH3, C-21), 40.8 (CH2, C-2), 49.3 
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(CH, C-1), 80.5 (CH, C-3), 83.6 (CH, C-5), 115.2 (CH2, C-19), 126.0 (CH, C-13, 17), 127.0 
(CH, C-8, 12), 128.7 (CH, C-14, 16), 129.2 (CH, C-9, 11), 136.7 (C, C-15), 137.1 (C, C-10), 
137.4 (C, C-7), 138.6 (CH, C-18), 139.0 (C, C-6); IR ν 3012, 2405, 2361, 1515, 1220, 1200 
cm-1; MS (CI-isobutane) m/z (%) 279 (M+H+, 100), 261 (90), 159 (28), 121(22); HRMS (CI-
isobutane) m/z 279.1746 (C20H23O, M+H+, requires 279.1749). 
 
  7bm was prepared by method C. 
Cinnamaldehyde (6 mg, 0.04 mmol) was 
added via Hamilton syringe to a solution of 
alcohol 2 (4 mg, 0.02 mmol) in dry THF (1 
mL) at room temperature under Ar. The 
solution was stirred at -90 °C for 10 min, 
then a suspension of tin(II) triflate (7 mg, 0.02 mmol) in THF (0.5 mL) was added slowly via 
cannula on the wall of the reaction vessel. The reaction mixture was stirred at –90 °C 
overnight and then allowed to warm to the room temperature over 4-5 h. The solvent was 
then evaporated at reduced pressure and the crude product was purified by chromatography 
on a column of silica gel (0.4 x 5 cm) with a mixture of petroleum ether and AcOEt (98:2) 
(TLC in a petroleum ether-AcOEt 95:5 mixture;  RF=0.42, stains visualised by UV and PMA)  
to afford 7bm (3.5 mg, 75%, 89% de ) as a colourless oil: 1H NMR (400 MHz, CDCl3) δ 
1.84-2.10 (m, 2H, H-2), 2.05-2.10 (m, 1H, H-1), 2.34 (s, 3H, H-15), 4.20-4.26 (m, 1H, C-3), 
4.77 (dd, 3JH-H = 10.1 Hz, 2JH-H = 1.9 Hz, 1H, H-14), 4.88-4.92 (m, 1H, H-6), 4.92-4.96 (m, 
1H, H-16), 4.97 (m, 1H, H-14), 5.19 (d, 3JH-H = 8.3 Hz, 1H, H-5), 5.25 (ddd, 3JH-H = 17.4, 9.5, 
and 8.3 Hz, 1H, H-13), 7.10-7.34 (m, 9H, H-8, 9, 11, 12 and 18-22); 13C NMR (100 MHz, 
CDCl3) δ 21.3 (CH3, C-15), 32.5 (CH2, C-2), 49.0 (CH, C-1), 78.8 (CH, C-3), 83.3 (CH, C-
5), 115.0 (CH2, C-14), 126.3 (CH, C-20), 126.8 (CH, C-8, 12), 128.5 (CH, C-9, 11), 128.6 
(CH, C-18, 22), 128.8 (CH, C-6), 129.0 (CH, C-19, 21), 129.2 (CH,    C-16), 138.1 (C, C-7), 
138.3 (C,C-10), 138.9 (CH, C-13), 142.2 (C, C-17); MS (EI) m/z (%) 292 (M+H+, 10), 222 
(15), 172 (15), 131 (40), 130 (50), 91 (100); HRMS (EI) m/z 292.1831 (C21H24O, M+H+, 
requires 292.1827). 
 
  7ca was prepared by method C. The crude 
product was purified by chromatography on a column 
of silica gel (0.4 × 5 cm) with a mixture of petroleum 
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ether and AcOEt (99:1) (TLC in a petroleum ether-AcOEt 96:4 mixture;  RF = 0.23, stains 
visualized by UV and PMA)  to afford 7ca (92%, >25:1 de) as a colourless oil: [α]D +45.0 (c 
1.0, CHCl3); 1H NMR (400 MHz, CDCl3) δ 1.91 (ddd, 2JH-H = 12.5 Hz, 3JH-H = 9.6 and 9.6 
Hz, 1H, H-2), 2.57 (ddd, 2JH-H = 12.5 Hz, 3JH-H = 7.3 and 6.0 Hz, 1H, H-2), 3.27-3.39 (m, 1H, 
H-1), 4.79 (dd, 3JH-H = 9.8 Hz, 2JH-H = 1.8, 1H, H-19), 4.93 (dd, 3JH-H = 16.9 Hz, 2JH-H = 1.8 
Hz, 1H, H-19), 5.08 (dd, 3JH-H = 9.7 and 5.9 Hz, 1H, H-3), 5.16-5.26 (m, 1H, H-18), 5.22 (d, 
3JH-H = 8.2 Hz, 1H, H-5), 6.9-7.02 (m, 2H, H-14, 16), 7.26-7.54 (m, 7H, H-13, 17 and 8-12); 
13C NMR (100 MHz, CDCl3) δ 40.6 (CH2, C-2), 49.2 (CH, C-1), 80.6 (CH, C-3), 83.2 (CH, 
C-5), 114.9 (d, 2JC-F = 21.3 Hz, CH, C-14, 16), 116.0 (CH2, C-19), 125.9 (CH, C-10), 126.1 
(CH, C-9, 11), 127.6 (CH, C-8, 12), 128.5 (d, 3JC-F = 10.5 Hz, CH), C-13, 17) 136.0 (C, C-7), 
138.2 (CH, C-18), 141.8 (C, C-6), 162.1 (d, 1JC-F = 248.1 Hz, C, C-15); 19F NMR (377 MHz, 
CDCl3) δ -115.8 (tt, 3JH-F = 8.8 Hz, 4JH-F = 5.6 Hz, 1F); IR ν 3019, 2400, 2361, 1510, 1215 
cm-1; MS (CI-isobutane) m/z (%) 269 (M+H+, 100), 251 (65), 233 (15), 163 (15); HRMS (CI-
isobutane) m/z 269.1338 (C18H18FO, M+H+, requires 269.1342); (Chiralpak IA-3 column, 
hexane/2-propanol = 98:2, 0.5 mL/min) showed 87 % ee (tmajor = 18.3 min, tminor = 23.6 min). 
 
 7cb was prepared by method C. The crude 
product was purified by chromatography on a 
column of silica gel (0.4 × 5 cm) with a mixture of 
petroleum ether and AcOEt (99:1) (TLC in a 
petroleum ether-AcOEt 96:4 mixture;  RF = 0.26, 
stains visualized by UV and PMA) to afford 7cb 
(91%, 15:1 de) as a colourless oil: 1H NMR (400 MHz, CDCl3) δ 1.87  (ddd, 2JH-H = 12.5 Hz, 
3JH-H = 9.6 and 9.6 Hz, 1H, H-2), 2.38 (s, 3H, H-21), 2.53 (ddd, 2JH-H = 12.9 Hz, 3JH-H = 8.6 
and 5.9 Hz, 1H, H-2), 3.32 (m, 1H, H-1), 4.79 (dd, 3JH-H = 10.1 Hz, 2JH-H = 1.5, 1H, H-19), 
4.92 (ddd, 3JH-H = 17.0 Hz, 2JH-H = 1.5 Hz, 4JH-H = 0.8 Hz, 1H, H-19), 5.05 (dd, 3JH-H = 9.6 and 
5.9 Hz, 1H, H-3), 5.15-5.30 (m, 1H, H-18), 5.19 (d, 3JH-H= 7.4 Hz, 1H, H-5), 6.97-7.31 (m, 
4H, H-9, 11, 14, 16), 7.20 (d, 3JH-H = 7.5 Hz, 2H, H-8, 12), 7.35-7.42 (m, 2H, H-13, 17); 13C 
NMR (100 MHz, CDCl3) δ 21.3 (CH3, C-21), 40.5 (CH2, C-2), 49.2 (CH, C-1), 80.6 (CH,    
C-3), 83.1 (CH, C-5), 114.9 (d, 2JC-F = 21.4 Hz, CH, C-14, 16), 115.5 (CH2, C-19), 126.0 
(CH, C-8, 12), 128.5 (d, 3JC-F = 10.5 Hz, CH, C-13, 17), 129.3 (CH, C-9, 11), 136.1 (d, 4JC-F = 
3.3 Hz, C, C-7), 137.3 (C, C-10), 138.3 (CH, C-18), 138.7 (C, C-6), 162.1 (d, 1JC-F = 244.6 
Hz, C, C-15); 19F NMR (377 MHz, CDCl3) δ -115.9 (tt, 4JH-F = 8.7 Hz, 3JH-F = 5.5 Hz, 1F); IR 
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ν 3015, 2399, 2356, 1524, 1200, 1187 cm-1; MS (CI-isobutane) m/z (%) 283 (M+H+, 55), 265 
(20), 190 (25), 79 (100); HRMS (CI-isobutane) m/z 283.1502 (C19H20FO, M+H+, requires 
283.1498).  
 
 7cg was prepared by method C. The crude 
product was purified by chromatography on a column of 
silica gel (0.4 × 5 cm) with a mixture of petroleum ether 
and AcOEt (99:1) (TLC in a petroleum ether-AcOEt 
90:10 mixture; RF = 0.34, stains visualized by UV and 
PMA) to afford 7cg (90%, 23:1 de) as a colourless oil: 1H 
NMR (400 MHz, CDCl3) δ 1.84 (ddd, 2JH-H = 12.5, 3JH-H 
= 9.5 and 8.4 Hz, 1H, H-2), 2.56 (ddd, 2JH-H = 12.5 Hz, 3JH-H = 8.3 and 6.1 Hz, 1H, H-2), 3.32 
(m, 1H, H-1), 4.80 (dd, 3JH-H = 10.1 Hz, 2JH-H = 1.5, 1H, H-19), 4.92 (dd, 3JH-H = 17.0 Hz, 2JH-
H = 1.5 Hz, H-19), 4.98 (dd, 3JH-H = 9.4 and 8.3 Hz, 1H, H-3), 5.05-5.26 (m, 1H, H-18), 5.13 
(d, 3JH-H = 8.2 Hz, 1H, H-5), 6.91-6.97 (m, 2H, H-14, 16), 7.14-7.22 (m, 2H, H-8, 12), 7.29 
(d, 3JH-H = 8.5 Hz, 2H, H-13, 17), 7.35 (d, 3JH-H = 8.5 Hz, 2H, H-9, 11); 13C NMR (100 MHz, 
CDCl3) δ 40.5 (CH2, C-2), 49.0 (CH, C-1), 79.8 (CH, C-3), 83.2 (CH, C-5), 115.0 (d, 2JC-F = 
21.4 Hz, CH, C-14, 16), 115.8 (CH2, C-19), 127.3 (CH, C-8, 12), 128.4 (d, 3JC-F = 8.0 Hz, 
CH, C-13, 17), 128.7 (CH, C-9, 11), 133.2 (C, C-10), 137.7 (d, 4JC-F = 2.9 Hz, C, C-7), 137.9 
(CH, C-18), 140.4 (C, C-6), 162.1 (d, 1JC-F = 244.9 Hz, C, C-15); 19F NMR (377 MHz, 
CDCl3) δ -115.6 (tt, 4JH-F = 8.8 Hz, 3JH-F = 5.4 Hz, 1F); IR ν 3020, 2390, 2361, 1590, 1518, 
1219 cm-1; MS (CI-isobutane) m/z (%) 305/303 (M+H+, 31/100), 285 (27), 178 (20), 81 (72); 
HRMS (CI-isobutane) m/z 303.0939 (C18H1735ClFO, M+H+, requires 303.0952). 
 
 
  7da was prepared by method C. The crude 
product was purified by chromatography on a column of 
silica gel (0.4 × 5 cm) with a mixture of petroleum ether 
and AcOEt (99:1) (TLC in a petroleum ether-AcOEt 
90:10 mixture;  RF = 0.40, stains visualized by UV and 
PMA)  to afford 7da (79%, >25:1 de) as a colourless oil: 
[α]D +40.3 (c 1.0, CHCl3); 
1H NMR (400 MHz, CDCl3) δ 1.90 (ddd, 2JH-H = 12.6 Hz, 3JH-H = 
9.6 and 8.6 Hz, 1H, H-2), 2.60 (ddd, 2JH-H = 12.6 Hz, 3JH-H = 7.4 and 6.0 Hz, 1H, H-2), 3.31-
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3.42 (m, 1H, H-1), 4.8 (ddd, 3JH-H = 10.1 Hz, 2JH-H = 1.8, 4JH-H = 0.4, 1H, H-19), 4.94 (ddd, 
3JH-H = 16.9 Hz, 2JH-H = 1.9 Hz, 4JH-H = 0.9 Hz, 1H, H-19), 5.12 (dd, 3JH-H = 9.7 and 6.0 Hz, 
1H, H-3), 5.17 (ddd, 3JH-H = 17.0, 10.0, and 9.1, 1H, H-18), 5.27 (d, 3JH-H = 8.2, 1H, H-5), 
7.30-7.61 (m, 9H, H-13,14,16,17 and 8-12); 13C NMR (100 MHz, CDCl3) δ 40.5 (CH2, C-2), 
49.2 (CH, C-1), 80.7 (CH, C-3), 83.0 (CH, C-5), 116.1 (CH2, C-19), 125.5 (q, 3JC-F = 3.6 Hz, 
CH, C-14, 16), 125.0 (q, 1JC-F = 269.0 Hz, CF3, C-20), 126.0 (CH, C-13, 17), 127.2 (CH, C-
10), 127.7 (CH, C-8, 12), 128.7 (CH, C-9, 11), 130.5 (q, 2JC-F = 31.6 Hz, C, C-15), 137.8 
(CH, C-18), 141.6 (C, C-7), 144.4 (C, C-6); 19F NMR (377 MHz, CDCl3) δ -62.4 (s, 3F); IR ν 
3014, 2392, 2370, 1523, 1218, 1201 cm-1; MS (CI-isobutane) m/z (%) 319 (M+H+, 29), 301 
(100), 223 (34), 205 (45), 197 (78), 129 (21); HRMS (CI-isobutane) m/z 319.1302 
(C19H18F3O, M+H+, requires 319.1310); chiral GC (Supelco γ-DEX 120 column, oven for 1 
min at 130 oC, then increase to 170 oC at 0.5 deg.min-1) showed 90% ee (tminor = 95.5 min, 
tmajor = 96.4 min). 
 
 7ea was prepared by method C. The crude 
product was purified by chromatography on a 
column of silica gel (0.4 × 5 cm) with a mixture of 
petroleum ether and AcOEt (99:1) (TLC in a 
petroleum ether-AcOEt 96:4 mixture; RF = 0.14, 
stains visualized by UV and PMA)  to afford 7ea (90%, >25:1 de) as a colourless oil: 1H 
NMR (400 MHz, CDCl3) δ 1.91 (ddd, 2JH-H = 12.6, 3JH-H = 9.5 and 8.5 Hz, 1H, H-2), 2.64 
(ddd, 2JH-H = 12.7 Hz, 3JH-H = 8.0 and 6.2 Hz, 1H, H-2), 3.42 (m, 1H, H-1), 4.81 (dd, 3JH-H = 
10.0 Hz, 2JH-H = 1.4, 1H, H-19), 4.95 (ddd, 3JH-H = 17.0 Hz, 2JH-H = 1.5 Hz, 4JH-H = 0.7 Hz, 1H, 
H-19), 5.05-5.26 (m, 2H, H-3, 18), 5.30 (d, 3JH-H = 8.2 Hz, 1H, H-5), 7.31-7.32 (m, 7H, H-13, 
17 and 8-12), 8.17-8.21 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 40.5 (CH2, C-2), 49.2 (CH, 
C-1), 80.9 (CH, C-3), 82.8 (CH, C-5), 116.4 (CH2, C-19), 123.4 (CH, C-13, 17), 126.0 (CH, 
C-8, 12), 127.7 (CH, C-10), 127.9 (CH, C-13, 17), 128.7 (CH, C-9, 11), 137.5 (CH, C-18), 
141.3 (C, C-6), 147.2 (C, C-7), 147.8 (C, C-15); IR ν 3016, 2927, 1492, 1454, 1215, 1090, 
1060, 1014 cm-1; MS (CI-isobutane) m/z (%) 296 (M+H+, 70), 266 (100), 173 (10), 122 (38); 
HRMS (CI-isobutane) m/z 296.1283 (C18H18NO3, M+H+, requires 296.1287). 
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 7eb was prepared by method C. The crude 
product was purified by chromatography on a 
column of silica gel (0.4 × 5 cm) with a mixture of 
petroleum ether and AcOEt (99:1) (TLC in a 
petroleum ether-AcOEt 96:4 mixture; RF = 0.10, 
stains visualized by UV and PMA) to afford 7eb 
(89%, >25:1 de) as a colourless oil: 1H NMR (400 MHz, CDCl3) δ 1.89 (ddd, 2JH-H = 12.7 Hz, 
3JH-H = 9.7 and 8.6 Hz, 1H, H-2), 2.60 (ddd, 2JH-H = 12.8 Hz, 3JH-H = 7.6 and 6.1 Hz, 1H, H-2), 
3.41 (m, 1H, H-1), 4.80 (ddd, 3JH-H = 9.9 Hz, 2JH-H = 1.7 Hz, 4JH-H = 0.4 Hz, 1H, H-19), 4.95 
(ddd, 3JH-H = 17.0 Hz, 2JH-H = 1.7 Hz, 4JH-H = 0.7 Hz, 1H, H-19), 5.09 (dd, 3JH-H = 9.7 and 6.1 
Hz, 1H, H-3), 5.15 (ddd, 3JH-H = 17.0, 9.8, and 8.6 Hz, 1H, H-18), 5.28 (d, 3JH-H = 8.2 Hz, 1H, 
H-5), 7.23 (d, 3JH-H = 8.0 Hz, 2H, H-9, 11), 7.38 (d, 3JH-H = 8.0 Hz, 2H, H-8, 12), 7.47 (m, 2H, 
H-13, 17), 8.18 (dd, 3JH-H = 8.8 Hz, 4JH-H = 2.3 Hz, 2H, H-14, 16); 13C NMR (100 MHz, 
CDCl3) δ 21.3 (CH3, C-21), 40.4 (CH2, C-2), 49.2 (CH, C-1), 80.9 (CH, C-3), 82.8 (CH, C-
5), 116.4 (CH2, C-19), 123.4 (CH, C-14, 16), 126.0 (CH, C-8, 12), 127.7 (CH, C-9, 11), 
129.4 (CH, C-13, 17), 137.6 (CH, C-18), 137.7 (C, C-10), 138.2 (C, C-6), 147.2 (C, C-7), 
147.9 (C, C-15); IR ν 3016, 2927, 1495, 1457, 1220, 1090, 1069 cm-1; MS (CI-isobutane) m/z 
(%) 310 (M+H+, 66), 292 (100), 187 (14), 122 (27); HRMS (CI-isobutane) m/z 310.1439 
(C19H20NO3, M+H+, requires 310.1443). 
  
 7eg was prepared by method C. The crude 
product was purified by chromatography on a column 
of silica gel (0.4 × 5 cm) with a mixture of petroleum 
ether and AcOEt (99:1) (TLC in a petroleum ether-
AcOEt 90:10 mixture; RF = 0.20, stains visualized by 
UV and PMA)  to afford 7eg (92%, 10:1 de) as a colourless oil: 1H NMR (400 MHz, CDCl3) 
δ 1.85 (ddd, 2JH-H = 12.7, 3JH-H = 9.4 and 8.3 Hz, 1H, H-2), 2.64 (ddd, 2JH-H = 12.7 Hz, 3JH-H = 
7.5 and 6.3 Hz, 1H, H-2), 3.40 (m, 1H, H-1), 4.81 (dd, 3JH-H = 10.0 Hz, 2JH-H = 1.5, 1H, H-19), 
4.94 (ddd, 3JH-H = 16.7 Hz, 2JH-H = 1.5 Hz, 4JH-H = 0.6 Hz, 1H, H-19), 5.06-5.18 (m, 2H, H-3, 
18), 5.35 (d, 3JH-H = 8.5 Hz, 1H, H-5), 7.44-7.54 (m, 6H, H-8,9,11,12,13,17), 8.24-8.28 (m, 
2H, H-14, 16); 13C NMR (100 MHz, CDCl3) δ 40.5 (CH2, C-2), 49.1 (CH, C-1), 80.2 (CH, C-
3), 82.9 (CH, C-5), 116.6 (CH2, C-19), 123.4 (CH, C-14, 16), 127.3 (CH, C-8, 12), 127.6 
(CH, C-9, 11), 128.9 (CH, C-13, 17), 136.6 (C, C-10), 137.2 (CH, C-18), 139.9 (C, C-6), 
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147.3 (C, C-7), 147.5 (C, C-15); IR ν 3014, 2965, 1494, 1454, 1215, 1058, 1013 cm-1; MS 
(CI-isobutane) m/z (%) 332/330 (M+H+, 12/39), 302 (40), 300 (100), 266 (10), 122 (75); 
HRMS (CI-isobutane) m/z 330.0899 (C18H1735ClNO3, M+H+, requires 330.0897). 
 
 7ek was prepared by method C. The crude 
product was purified by chromatography on a column 
of silica gel (0.4 × 5 cm) with a mixture of petroleum 
ether and AcOEt (99:1) (TLC in a petroleum ether-
AcOEt 9:1 mixture; RF = 0.46, stains visualized by 
UV and PMA)  to afford 7ek (95%, >25:1 de) as a colourless oil: 1H NMR (400 MHz, 
CDCl3) δ 0.94 (t, 3JH-H = 7.4, 3H, H-1), 1.41-1.53 (m, 2H, H-18), 1.67 (ddd,   2JH-H = 12.6, 
3JH-H = 10.0 and 9.3 Hz, 1H, H-2), 2.05-2.15 (m, 2H, H-17), 2.27 (ddd, 2JH-H = 12.8 Hz,   3JH-
H = 7.1 and 5.9 Hz, 1H, H-2), 3.25-3.33 (m, 1H, H-1), 4.49 (td, 3JH-H = 9.4 and 6.5 Hz, 1H, H-
3), 4.81 (dd, 3JH-H = 10.0 Hz, 2JH-H = 1.7, 1H, H-14), 4.95 (ddd, 3JH-H = 16.9 Hz, 2JH-H = 1.8 
Hz, 4JH-H = 0.5 Hz, 1H, H-14), 5.10 (ddd, 3JH-H = 17.0, 9.9 and 9.2, 1H, H-13), 5.15 (d, 3JH-H = 
8.17 Hz, 1H, H-5), 5.68 (tdd, 3JH-H = 14.0 and 6.7, 4JH-H = 1.4, 1H, H-16), 5.84 (td, 3JH-H = 
13.8 and 6.7, 1H, H-6), 7.35 (d, 3JH-H = 8.6 Hz, 2H, H-9, 11), 8.11 (d, 3JH-H = 8.6 Hz, 2H, H-8, 
12); 13C NMR (100 MHz, CDCl3) δ 13.9 (CH3, C-1), 22.4 (CH2, C-18), 34.5 (CH2, C-17), 
38.7 (CH2, C-2), 49.2 (CH, C-1), 80.8 (CH, C-3), 82.5 (CH, C-5), 116.4 (CH2, C-14), 123.3 
(CH, C-9, 11), 127.6 (CH, C-8, 12), 134.5 (CH, C-6), 136.9 (CH, C-16), 137.4 (CH, C-13), 
147.1 (C, C-7), 148.2 (C, C-10); IR ν 3020, 2931, 1492, 1488, 1447, 1216, 1088, 1060, 1011 
cm-1; MS (CI-isobutane) m/z (%) 288 (M+H+, 19), 258 (41), 240 (8), 113 (20), 97 (21), 69 
(100); HRMS (CI-isobutane) m/z 288.1601 (C17H22NO3, M+H+, requires 288.1594). 
 
 7el was prepared by method C. The crude 
product was purified by chromatography on a column 
of silica gel (0.4 × 5 cm) with a mixture of petroleum 
ether and AcOEt (99:1) (TLC in a petroleum ether-
AcOEt 9:1 mixture; RF = 0.40, stains visualized by 
UV and PMA)  to afford 7el (91%, 7:1 de) as a colourless oil: 1H NMR (400 MHz, CDCl3) δ 
1.69 (td, 2JH-H = 12.6, 3JH-H = 6.8, 1H, H-2), 1.79 (dd, 3JH-H = 6.7, 4JH-H = 1.1, 3H, H-19), 2.30 
(ddd, 2JH-H = 12.6, 3JH-H = 7.1 and 6.5 Hz, 1H, H-2), 3.25-3.34 (m, 1H, H-1), 4.56 (td, 3JH-H = 
9.1 and 6.5 Hz, 1H, H-3), 4.82 (dd, 3JH-H = 9.9 Hz, 2JH-H = 1.8, 1H, H-14), 4.95 (ddd, 3JH-H = 
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17.0 Hz, 2JH-H = 1.8 Hz, 4JH-H = 0.6 Hz, 1H, H-14), 5.09 (ddd, 3JH-H = 17.0, 9.9 and 9.2, 1H,  
H-13), 5.17 (d, 3JH-H = 8.3 Hz, 1H, H-7), 5.73-5.82 (m, 2H, H-6, 18), 6.13 (ddd, 3JH-H = 15.0, 
10.5 and 1.4 Hz, 1H, H-16), 6.33 (dd, 3JH-H = 15.2 and 10.4, 1H, H-17), 7.41 (d, 3JH-H = 8.1 
Hz, 2H, H-8, 12), 8.18 (d, 3JH-H = 8.1 Hz, 2H, H-9, 11); 13C NMR (100 MHz, CDCl3) δ 18.3 
(CH3, C-19), 38.7 (CH2, C-2), 49.3 (CH, C-1), 80.4 (CH, C-3), 82.6 (CH, C-5), 116.5 (CH2, 
C-14), 123.3 (CH, C-9, 11), 127.6 (CH, C-18), 129.5 (CH, C-8, 12), 130.7 (CH, C-17), 131.0 
(CH, C-16), 132.8 (CH, C-6), 137.3 (CH, C-13), 147.2 (C, C-7), 148.1 (C, C-10); IR ν 3010, 
2920, 1490, 1472, 1095, 1049, 1024 cm-1; MS (CI-isobutane) m/z (%) 286 (M+H+, 100), 243 
(8), 238 (10), 69 (80); HRMS (CI-isobutane) m/z 286.1432 (C17H20NO3, M+H+, requires 
286.1438). 
 
 7ka was prepared by method C. The crude 
product was purified by chromatography on a 
column of silica gel (0.4 × 5 cm) with a mixture of 
petroleum ether and AcOEt (99:1) (TLC in a 
petroleum ether-AcOEt 9:1 mixture; RF = 0.62, stains 
visualized by PMA)  to afford 7ka (70%, 9:1 de) as a colourless oil: 1H NMR (400 MHz, 
CDCl3) δ 0.88 (t, 3JH-H = 7.3, 6H, H-15, 17), 1.22-1.52 (m, 10H, H-6, 12, 13, 14, 16), 1.65-
1.73 (m, 1H, H-1), 1.95-2.06 (m, 2H, H-8), 2.12 (ddd, 2JH-H = 12.7, 3JH-H = 7.0 and 5.8 Hz, 
1H, H-2), 2.88-2.97 (m, 1H, H-2), 3.86 (tdd, 3JH-H = 9.7, 9.4 and 6.8 Hz, 1H, H-3), 4.33 (t, 
3JH-H = 7.7 Hz, 1H, H-5), 5.00 (dd, 3JH-H = 9.0 Hz, 2JH-H = 1.5 Hz, 1H, H-11), 5.37 (tdd, 3JH-H = 
15.3 and 7.8 Hz, 4JH-H = 1.3 Hz, 1H, H-11), 5.62 (td, 3JH-H = 15.3 and 6.7 Hz, 1H, H-10), 5.65-
5.70 (m, 1H, H-7), 5.70 (ddd, 3JH-H = 17.1, 9.4 and 8.6, 1H, H-9);  13C NMR (100 MHz, 
CDCl3) δ 13.8 (CH3, C-15), 14.2 (CH3, C-17), 22.4 (CH2, C-14), 22.7 (CH2, C-16), 26.2 
(CH2, C-12), 32.1 (CH2, C-13), 34.5 (CH2, C-6), 36.4 (CH2, C-2), 38.5 (CH2, C-8), 48.1 (CH, 
C-1), 79.4 (CH, C-3), 82.6 (CH, C-5), 115.0 (CH2, C-11), 128.1 (CH, C-9), 133.5 (CH, C-7), 
138.6 (CH, C-10); IR ν 2998, 2941, 1450, 1210, 1090, 1001 cm-1; MS (CI-isobutane) m/z (%) 
237 (M+H+, 28), 219 (22), 123 (35), 97 (23), 85 (66), 69 (100); HRMS (CI-isobutane) m/z 
237.2213 (C16H29O, M+H+, requires 237.2213); chiral GC (Supelco β-DEX 120 column, 
oven for 1 min at 60 oC, then increase at 0.5 deg min-1) showed 98% ee (tminor = 135.9 min, 
tmajor = 136.5 min). 
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 (267c). The homoallylic alcohol 4c (20 mg, 0.079 mmol) 
was dissolved in dry methanol (10 mL) and cooled to -90°C. Stream 
of ozone was bubbled through the mixture, while stirring vigorously. 
Samples of the reaction mixture were then checked by the TLC 
frequently, until the reaction reached the full conversion (typically 
several minutes). The reaction was then immediately quenched with DMS (2 mL) and the 
mixture was left stirring for another hour at room temperature. A solution of semi-saturated 
potassium iodide (10 mL) was added and the mixture was extracted with diethyl ether (3×10 
mL). The organic layer was washed with brine (1×30), dried (Na2SO4), and evaporated in 
vacuo to afford the pure product 276c (19 mg, 95%): 1H NMR (400 MHz, CDCl3) δ -0.05 (s, 
9H, H-13), 0.39 (dd, 2JH-H = 14.9 Hz, 3JH-H = 3.6 Hz, 1H, H-7), 0.76 (dd, 2JH-H = 14.9 Hz, 3JH-
H = 10.8 Hz, 1H, H-7), 2.45 (d, 3JH-H = 3.4 Hz, 1H, H-3), 2.69-2.78 (m, 1H, H-6), 4.79 (dd, 
3JH-H = 7.8 and 3.2 Hz, 1H, H-2), 7.07 (m, 2H, H-9, 11), 7.33 (dd, 3JH-F = 8.7 Hz, 3JH-H = 8.1 
Hz, 2H, H-8, 12), 9.74 (dd, 3JH-H = 3.0 Hz, 4JH-H = 0.8 Hz, 1H, H-4); 13C NMR (100 MHz, 
CDCl3) δ 0.3 (CH3, C-13), 14.5 (CH2, C-7), 56.2 (CH, C-3), 77.2 (CH, C-2), 116.7 (d, 2JC-F = 
22.4 Hz, CH, C-9, 11), 129.7 (d, 3JC-F = 7.8 Hz, CH, C-8, 12), 138.4 (d, 4JC-F = 2.9 Hz, C,    
C-1), 162.5 (d, 1JC-F = 245.0 Hz, C, C-10), 205.5 (CH, C-4); 19F NMR (377 MHz, CDCl3) δ -
113.8 (tt, 3JH-F = 8.6 Hz, 4JH-F = 5.4 Hz, 1F); IR ν 3027, 2866, 2754, 1725, 1249, 1217 cm-1; 
MS (CI-isobutane) m/z (%) 237 (M+H+-H2O, 12), 125 (100), 115 (52), 85 (64); HRMS (CI-
isobutane) m/z 237.1110 (C13H18FOSi, M+H+, requires 237.1105). 
 
(38a). Ethyl acrylate (1 ml, 9.2 mmol) was added in 
one portion to the racemic homoallylic alcohol 37a (100 
mg, 0.62 mmol, anti:syn = 3:1) in CH2Cl2 (10 mL) under 
Ar at room temperature. The mixture was stirred for 5 min, 
a solution of Grubs 2nd generation catalyst (13 mg, 15 
µmol) in CH2Cl2 (1 mL) was added. The mixture was 
stirred at 40 °C for 2 days, then it was allowed to cool to room temperature, and diluted with 
CH2Cl2 (10 mL) and water (10 mL). The organic phase was separated and washed with water 
(2×10 mL) and brine (1×10 mL), and dried (Na2SO4). The drying agent was filtered off and 
the solvent was evaporated in vacuo. The crude product was purified by chromatography on a 
column of silica gel (2 g), using petroleum ether-AcOEt (4:1) as an eluent to afford the 
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unreacted starting alcohol 37a (26 mg, 26%) and the desired ester 38a as a colourless oil (48 
mg, 33%, anti:syn = 3:1). (TLC in PE:EtOAc 4:1, RF = 0.21, visualized by PMA): Major 
diastereoisomer (anti) 1H NMR (400 MHz, CDCl3) δ 0.93 (d, 3JH-H = 6.9 Hz, 3H, H-5), 1.30 
(t, 3JH-H = 7.1 Hz, 3H, H-17), 1.95 (bs, 1H, H-3), 2.61–2.71 (m, 1H, H-4), 4.19 (q, 3JH-H = 7.1 
Hz, 2H, H-16), 4.51 (d, 3JH-H = 7.6 Hz, 1H, H-2), 5.91 (dd, 3JH-H = 15.8 Hz, 4JH-H = 1.0 Hz, 
1H, H-7), 7.04 (dd, 3JH-H = 15.7 Hz, 3JH-H = 8.2 Hz, 1H, H-6), 7.27-7.38 (m, 5H, H-
9,10,11,12,13). Minor diastereoisomer (syn) 1H NMR (400 MHz, CDCl3) δ 1.07 (d, 3JH-H = 
6.7 Hz, 3H, H-5), 1.26 (t, 3JH-H = 7.1 Hz, 3H, H-17), 1.95 (bs, 1H, H-3), 2.69–2.76 (m, 1H, H-
4), 4.12 (q, 3JH-H = 7.2 Hz, 2H, H-16), 4.71 (d, 3JH-H = 5.4 Hz, 1H, H-2), 5.79 (dd, 3JH-H = 15.8 
Hz, 4JH-H = 1.3 Hz, 1H, H-7), 6.95 (dd, 3JH-H = 15.8 Hz, 3JH-H = 7.4 Hz, 1H, H-6), 7.27-7.38 
(m, 5H, H-9,10,11,12,13) in accordance with the literature data.146 
 
(285j). DIBAL (260 µL, 0.260 mmol, 1M solution 
in cyclohexane) was added to a solution of ester 
273j (12 mg, 0.026 mmol) in dry dichloromethane 
(1 mL) at -90°C in one portion, while stirring 
vigorously. The solution was then further stirred at 
that temperature for another hour and then left to 
warm to 0 °C overnight. The reaction mixture was 
then cooled to approx. -60 °C and quenched with water. The mixture was extracted with 
dichloromethane (3×10 mL) and the organic phase was dried over Na2SO4 and evaporated in 
vacuo to yield crude 285, which was purified by chromatography on a column of silica gel 
(0.5×5cm) with diethyl ether as an eluent (TLC in diethyl ether, RF = 0.40, stains visualized 
by PMA) to afford pure 285 as a viscous colourless oil (9 mg, 83%): 1H NMR (400 MHz, 
CDCl3) δ -0.12 (s, 9H, H-13), 0.13 (s, 3H, H-19), 0.14 (s, 3H, H-20), 0.35 (dd, 2JH-H = 14.6 
Hz, 3JH-H = 3.2 Hz, 1H, H-7), 0.41 (dd, 2JH-H = 14.6 Hz, 3JH-H = 11.0 Hz, 1H, H-7), 0.98 (s, 
9H, H-22, 23, 24), 1.70 (br s, 1H, H-17), 2.02 (br s, 1H, H-6), 2.32-2.45 (m, 1H, H-3), 3.80 
(s, 3H, H-14), 4.13 (d, 3JH-H = 5.5 Hz, 2H, H-16), 4.19 (d, 3JH-H = 8.2 Hz, 1H, H-2), 5.51 (dd, 
3JH-H = 15.4 and 9.4 Hz, 1H, H-4), 5.78 (dt, 3JH-H = 15.4 and 5.7 Hz, 1H, H-5), 6.72 (dd, 3JH-H 
= 8.0 Hz, 4JH-H = 1.8 Hz, 1H, H-12), 6.78-6.83 (m, 2H, H-8, 11); 13C NMR (100 MHz, 
CDCl3) δ -4.5 (CH3, C-19, 20), -0.6 (CH3, H-13), 18.5 (C, C-21), 18.6 (CH2, C-7), 25.9 (CH3, 
C-22, 23, 24), 47.3 (CH, C-3), 55.6 (CH, C-2), 63.5 (CH2, C-16), 79.3 (CH3, C-14), 110.7 
(CH, C-8), 120.1 (CH, C-12), 120.6 (CH, C-11), 132.1 (CH, C-5), 135.2 (CH, C-6), 136.0 (C, 
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C-1), 144.7 (C. C-10), 151.1 (C, C-9); IR ν 3520, 2995, 2832, 2856, 2221, 1254, 1215 cm-1; 
MS (CI-isobutane) m/z (%) 407 (M+H+-H2O, 28), 391 (11), 317 (8), 267 (100); 209 (9); 
HRMS (CI-isobutane) m/z 407.2435 (C22H39O3Si2, M+H+-H2O, requires 407.2432). 
 
277 was formed as an undesired byproduct of the Wittig-
Horner reaction (95 mg, 42%): 1H NMR (400 MHz, 
CDCl3) δ -0.00 (s, 9H, H-10), 0.61-0.67 (m, 2H, H-9), 
1.28 (t, 3JH-H = 7.1 Hz, 3H, H-5), 2.15-2.22 (m, 2H, H-8), 
4.18 (q, 3JH-H = 7.1, 2H, H-4), 5.80 (dt, 3JH-H = 15.5 Hz, 
4JH-H = 1.6 Hz, 1H, H-1), 7.02 (dt, 3JH-H = 15.5 Hz, 3JH-H = 6.6 Hz, 1H, H-7); 13C NMR (100 
MHz, CDCl3) δ -1.6 (CH3, C-10), 14.4 (CH3, C-5), 15.1 (CH2, C-9), 26.8 (CH2, C-8), 60.2 
(CH2, C-4), 120.1 (CH, C-1), 152.0 (CH, C-7), 167.1 (CO, C-2); IR ν 3005, 2984, 2954, 
1740, 1222 cm-1; MS (CI-isobutane) m/z (%) 201 (M+H+, 100), 181 (10), 121 (12), 85 (30); 
HRMS (CI-isobutane) m/z 200.1200 (C10H20O2Si, M+H+, requires 200.1233). 
 
 (275). PdCl2 (1 mg, 5.6 µmol), Cu(OAc)2.H2O (17.1 mg, 
86 µmol) and MeOH (100 µL) were added to a solution of the 
homoallylic alcohol 37a (6.7 mg, 29 µmol) in dry MeCN (5 mL). 
The reaction flask was flushed with CO for 30 min and then 
stirred under atmospheric pressure of CO at 60 °C for 3 days 
(while monitoring by TLC). The reaction mixture was allowed to 
cool to room temperature, AcOEt (15 mL) was added, and the mixture was washed with 
saturated aqueous solution of NaHCO3 (1×10 mL) and brine (1×10 mL). The organic phase 
was separated and dried (Na2SO4). The solids were filtered off and solvent was evaporated in 
vacuo to afford the crude product, which was purified by chromatography on a column of 
silica gel (0.2 g) using petroleum ether-AcOEt (7:1) as an eluent to afford 275 as a colourless 
oil (3.1 mg, 34%) (TLC in PE/EtOAc = 4:1, RF = 0.50, visualized by KMnO4): 1H NMR (400 
MHz, CDCl3) δ 1.00 (d, 3JH-H = 7.2 Hz, 3H, H-5), 1.95 (dd, 2JH-H  = 17.0 Hz, 3JH-H  = 9.1 Hz, 
1H, H-8), 2.65-2.70 (m, 1H, H-8), 2.76–2.84 (m, 1H, H-4), 3.14-3.18 (m, 1H, H-6), 3.70 (s, 
3H, H-18), 5.25 (d, 3JH-H  = 2.4 Hz, 1H, H-2), 7.30-7.43 (m, 5H, H-11, 12, 13, 14, 15).  
 
 
 
162 
 
   (36m). A solution of DMSO (8 mL, 112.6 mmol) in CH2Cl2 (20 mL) 
was added dropwise to a solution of oxalylchloride (4.8 mL, 56.7 
mmol) in CH2Cl2 (30 mL) at -78° C while stirring vigorously. 3-
(Trimethylsilyl)-1-propanol (5g, 37.8 mmol) in CH2Cl2 (20 mL) was 
then added dropwise and the reaction mixture was stirred at -78° C for 30 min. Hünig's base 
(38.3 mL, 213.3 mmol) was added portionwise, the reaction mixture was stirred at -78° C for 
20 minutes and then left to warm to 0° C during 1 h and then poured into an ice-cold 
saturated aqueous solution of NH4Cl (200 mL). The organic layer was separated, the aqueous 
layer was extracted with CH2Cl2 (2×50 mL), the organic phases were combined, washed with 
water (3×50mL) and brine (1×50mL), dried (Na2SO4), and evaporated in vacuo to afford the 
product in a form of an yellowish oil, which was used without further purification (4.0 g, 
82%): 1H NMR (400 MHz, CDCl3) δ 0.02 (s, 9H, H-1), 0.80 (t, 3JH-H = 9.0 Hz, 2H, H-2), 2.43 
(dt, 3JH-H = 8.7 Hz, 3JH-H = 2.0, 2H, H-3), 9.79 (t, 3JH-H = 1.8 Hz, 1H, H-4); 13C NMR (100 
MHz, CDCl3) δ -0.6 (CH3, C-1), 11.9 (CH2, C-2), 36.2 (CH2, C-3), 198.0 (CO, C-4) in 
accordance with the literature data.147 
 
   (256). A round bottom flask was charged with the Lindlar 
catalyst (240 mg), evacuated, and filled with Ar three times. A 
solution of alkyne 228 (1.200 g, 8.4 mmol) in MeOH (10 mL) was 
added and the reaction vessel was flushed with the hydrogen gas for 
30 min and then kept under an atmospheric pressure of hydrogen overnight while stirring 
vigorously. Lindlar catalyst was filtered off on a short plug of Celite and the filtrate was 
concentrated in vacuo giving 256 as a viscous yellowish oil (1.144 g, 94%):  1H NMR (400 
MHz, CDCl3) δ 0.00 (s, 9H, H-1), 1.52 (d, 3JH-H= 8.6 Hz, 2H, H-2), 4.13 (d, 3JH-H= 6.5 Hz, 
2H, H-5), 5.49 (dt, 3JH-H= 10.2 and 6.7 Hz, 1H, H-3), 5.58 (dt, 3JH-H = 10.0 and 8.7 Hz, 1H, 
H-4) in accordance with the literature data.144  
 
 (299). n-BuLi (1.6M solution in hexane, 54 mL, 86.22 
mmol) was added to a solution of 2-(2’-propynyl)tetrahydro-2H-
pyran (12.09 g, 86.22 mmol) in dry THF (150 mL) at -78 °C over 
1 h while stirring vigorously. The mixture was then stirred at the 
same temperature for an additional 15 min and then at -20 °C for 
another 20 min. Then the reaction mixture was cooled to -78 °C and a solution of 
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chlorotrimethylsilane (10.9 mL, 86.22 mmol) in dry THF (40 mL) was added slowly via 
cannula over a period of 1 h and the reaction mixture was then stirred at 0 °C for 5 h. The 
reaction was then quenched with a saturated solution of ammonium chloride (150 mL) and 
the mixture was extracted with ether (50 mL). The aqueous layer was extracted with ether 
(3×150 mL) and the combined organic extracts were dried (MgSO4) overnight. MgSO4 was 
filtered off and the solvents were evaporated in vacuo to give crude 299 as a pale yellow 
liquid, which was used in the next step without further purification (17.76 g, 97%): 1H NMR 
(400 MHz, CDCl3) δ 0.16 (s, 9H, H-5), 1.48-1.84 (m, 6H, H-9, 10, 11), 3.51 (dddd, 2JH-H = 
11.1 Hz, 3JH-H = 8.5 and 4.4 Hz, 4JH-H = 1.7 Hz, 1H, H-8), 3.82 (ddd, 2JH-H = 11.7 Hz, 3JH-H = 
9.2 and 3.1 Hz, 1H, H-8), 4.20 (d, 2JH-H = 15.9 Hz, 1.7 Hz, 1H, H-2), 4.28 (d, 2JH-H = 15.9 Hz, 
1.7 Hz, 1H, H-2), 4.80 (t, 4JH-H = 3.4 Hz, 1H, H-6); 13C NMR (100 MHz, CDCl3) δ -0.2 (CH3, 
C-5), 18.9 (CH2, C-10), 25.3 (CH2, C-9), 30.2 (CH2, C-11), 54.8 (CH2, C-8), 61.9 (CH2, C-3), 
90.8 (C, C-1), 96.7 (CH, C-6), 101.4 (C, C-2) in accordance with the literature data.148  
 
 (300). A solution of PTSA (3.16 g, 16.73 mmol) and pyridine 
(1.34 mL, 16.73 mmol) in ethanol (120 mL) was added in one portion 
to a solution of the THP protected alcohol 300 (17.76 g, 83.63 mmol) 
in a mixture of ethanol (120 mL) and water (40 mL) and the reaction 
mixture was stirred at 60 °C for 24 h. Ethanol was then evaporated  in 
vacuo, the residue was diluted with petroleum ether (150 mL) and washed with saturated 
NaHCO3 (1×150 mL) and brine (3×150 mL). Combined organic layers were dried (Na2SO4) 
overnight and evaporated in vacuo to afford 300 (10.28 g, 95%) as a yellow liquid: 1H NMR 
(400 MHz, CDCl3) δ 0.18 (s, 9H, H-5), 1.7 (t, 3JH-H = 6.1 Hz , 1H, H-4), 4.27 (d, 3JH-H = 6.1 
Hz, 2H, H-3); 13C NMR (100 MHz, CDCl3) δ -0.2 (CH3, C-5), 51.6 (CH2, C-3), 90.6 (C,     
C-1), 103.8 (C, C-2) in accordance with the literature data.149  
 
 (301). A solution of alkyne 300 (10.29 g, 79.48 mmol) in 
dry THF (50 mL) was added dropwise to a stirred suspension of 
lithium aluminium hydride (6.03 g, 158.96 mmol) in THF (50 mL) 
at 0 °C under Ar. The resulting mixture was stirred for another 10 min and then heated at 
reflux for 1 h. The mixture was cooled in an ice-water bath and cold water (50 mL) was 
added dropwise until the gas stopped evolving, and then a 20% aqueous NaOH solution (50 
mL). The mixture was filtered through a short plug of sand and Celite, the filtrate was diluted 
with water (50 mL) and extracted with dichloromethane (5×150 mL). Combined organic 
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extracts were dried (MgSO4) and the solvents were evaporated in vacuo to afford the alkene 
301 in a form as a yellow liquid (9.73 g, 94%): 1H NMR (400 MHz, CDCl3) δ 0.08 (s, 9H, H-
5), 1.47 (t, 3JH-H = 6.0 Hz, 1H, H-3), 4.18 (ddd, 3JH-H = 6.0 and 4.5 Hz, 4JH-H = 1.7 Hz, 2H, H-
2), 5.92 (dt, 3JH-H = 18.8 Hz, 4JH-H = 1.7 Hz, 1H, H-4), 6.18 (dt, 3JH-H = 18.8 and 4.5 Hz, 1H, 
H-1); 13C NMR (100 MHz, CDCl3) δ -1.4 (CH3, C-5), 65.5 (CH2, C-2), 129.5 (CH, C-4), 
144.7 (CH, C-1), consistent with the literature data.150  
 
                                  (302). DMF (13.3 mL, 171.65 mmol) was added dropwise to a 
stirred solution of oxalyl chloride (14.73 mL, 171.65 mmol) in 
dichloromethane (350 mL) at 0 oC and the resulting white suspension 
was allowed to warm to the room temperature and after a period of 10 
min was cooled to 0 oC again. Allylic alcohol 302 (22.36 g, 171.65 mmol) was added in one 
portion and the resulting solution was heated at reflux for 24 h. The reaction mixture was 
then left to cool to room temperature, brine (150 mL) was added, and the product was 
extracted into dichloromethane (2 × 150 mL). Combined organic extracts were washed with 
water (3×100 mL) and dried (MgSO4). MgSO4 was filtered off and the solvents were distilled 
off (bath temperature 60 °C). Ethyl acetate (20 mL) was added (to form an azeotrope with the 
residual dichloromethane) and distilled off again (bath temperature 90 °C) and this procedure 
was repeated once more to afford 302 (22.97 g, 90%) as a colourless oil: 1H NMR (400 MHz, 
CDCl3) δ 0.09 (s, 9H, H-5), 4.07 (dd, 3JH-H = 5.8 Hz, 4JH-H = 0.9 Hz, 2H, H-2), 5.98 (dt, 3JH-H 
= 18.3 Hz, 4JH-H = 0.9 Hz, 1H, H-4), 6.09 (dt, 3JH-H = 18.3 and 5.8 Hz, 1H, H-1); 13C NMR 
(100 MHz, CDCl3) δ -1.7 (CH3, C-5), 47.2 (CH2, C-2), 134.5 (CH, C-4), 140.3 (CH, C-1) 
consistent with the  literature data.151 
Alternative procedure: Allylic alcohol 301 (510 mg, 3.92 mmol) was added to a 
solution of triphenylphosphine (1.03 g, 3.92 mmol) in CCl4 (15 mL, 156 mmol) and heated to 
85 °C under argon while stirring for 1 h and then tetrachloromethane was distilled off (bath 
temperature 90 °C). Ethyl acetate (10 mL) was added and distilled off twice. Dry diethyl 
ether (20 mL) was added and the resulting suspension was filtered through a short plug of 
Celite, and the solvent was distilled off to afford the chloride 302 as a colourless oil (379 mg, 
65%).  
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(3). Hünig’s base (2.14 mL, 16.57 mmol) was added 
to a suspension of CuCl (2.63 g, 26.51 mmol) and powder 4Å 
molecular sieves (1 g) in dry ether (15 mL) in an oven-dried 
flask at 0 °C under Ar. A solution of allylic chloride 302 (982 
mg, 6.63 mmol) in diethyl ether (20 mL) was added  via cannula in one portion and the 
resulting mixture was stirred at 0 °C for 10 min. Trichlorosilane (3.54 g, 26.51 mmol) was 
added dropwise over a period of 10 min while stirring vigorously and the reaction mixture 
was stirred at 0 °C for another 10 min and then at the room temperature until reaching the full 
conversion, checked by NMR (typically 1-5 h). The reaction mixture was then filtered under 
Ar and the diethyl ether was distilled off under Ar. The crude product was purified by 
distillation under reduced pressure (120 -125 °C / 50 torr) to give the trichlorosilane 3 as a 
colourless liquid (1.10 g, 67%): 1H NMR (400 MHz, CDCl3) δ 0.07 (s, 9H, H-5), 2.43 (d, 3JH-
H = 6.3 Hz, 2H, H-2), 5.85 (d, 3JH-H = 18.5 Hz, 1H, H-4), 5.93 (td, 3JH-H = 18.5 and 6.3 Hz, 
1H); 13C MR (100 MHz, CDCl3) δ -1.4 (CH3, C-5), 33.8 (CH2, C-2), 134.1 (CH, C-4), 137.0 
(CH, C-1); MS (FAB+) m/z (%) 247 [(M+H)+, 40], 207 (100), 193 (75), 147 (50), 133 (60).     
 
 Method D: General procedure for the synthesis of 
racemic homoallylic alcohols 6. Hünig’s base (4 mmol), DMF (4 
mmol), and the corresponding aldehyde (2 mmol) were added 
consecutively to a solution of trimethyl[3-(trichlorosilyl)-2-
propenyl]silane 3 (2 mmol) in dry acetonitrile (8 mL) at 0 °C and 
the resulting mixture was stirred at this temperature for 48 h. The reaction was quenched with 
a saturated solution of NaHCO3 (10 mL), dichloromethane (20 mL) was added, and the 
resulting suspension was filtered through a short pad of Celite. The organic layer was 
separated and the aqueous layer was extracted with dichloromethane (3×40 mL). Combined 
organic layers were dried (Na2SO4) overnight, Na2SO4 was filtered off, and the solvent was 
evaporated in vacuo to furnish the crude product that was purified on a column of silica gel 
(2.0 × 25 cm) with a mixture of petroleum ether and AcOEt (98:2).  
 
 Method E: General procedure for the synthesis of enantio-
enriched homoallylic alcohols 6. A solution of the chiral catalyst in 
an appropriate solvent (MeCN, DCM or THF depending on the 
catalyst, see Table 19), Hünig’s base (300 mg, 2.4 mmol), and the 
R
OH
SiMe3
6
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corresponding aldehyde  (0.5 mmol) were added consecutively in this order to a solution of 
allyldisilane 3 (100 mg, 0.4 mmol) in the appropriate solvent (10 mL) at -78 °C.  The reaction 
mixture was then transferred to a freezer (-35 °C). Upon reaching the full conversion 
(monitored by NMR spectroscopy), the reaction was quenched with a saturated NaHCO3 
solution (1 mL) and left to warm up to room temperature. The solid residue was removed by 
filtration, the solvent was evaporated, and the residue was dissolved in ether (30 mL) and the 
solution was washed with a saturated NaHCO3 solution (2 × 20 mL) and brine (1 × 30 mL) 
and dried (Na2SO4) and evaporated. The crude product was purified by chromatography on a 
column of silica gel (2 × 25 cm) with a mixture of petroleum ether and AcOEt (98:2).  
 
6a was prepared by method D / E. The crude product was 
purified by chromatography on a column of silica gel (2.0×25 cm) 
with a mixture of petroleum ether and AcOEt (98:2) (TLC in a 
petroleum ether-AcOEt 7:1 mixture; RF = 0.37, stains visualized by 
UV and PMA) to afford 6a (51 mg, 9%) as a pale yellow oil: 1H 
NMR (400 MHz, CDCl3) δ -0.20 (s, 9H, H-7), 2.08 (dd, 3JH-H = 10.1 and 8.8 Hz, 1H, H-3), 
2.22 (d, 3JH-H = 2.2 Hz, 1H, H-6), 4.80 (dd, 3JH-H = 8.8 and 2.2 Hz, 1H, H-2), 5.03 (dd, 3JH-H = 
17.1 Hz, 2JH-H = 1.3 Hz, 1H, H-5), 5.11 (dd, 3JH-H = 10.3 Hz, 2JH-H = 1.8 Hz, 1H, H-5), 5.86 
(td, 3JH-H = 17.1, 10.3, and 10.1 Hz 1H, H-4), 7.27-7.34 (m, 5H, H-8, 9, 10, 11, 12); 13C NMR 
(100 MHz, CDCl3) δ -2.4 (CH3, C-7), 45.6 (CH, C-3), 74.5 (CH, C-2), 116.0 (CH2, C-5), 
126.9 (CH, C-10), 127.8 (CH, C-9, 11), 128.4 (CH, C-8, 12), 136.6 (CH, C-4), 143.6 (C, C-
1), consistent with the literature data.152 
 
6b was prepared by method D / E. The crude product was 
purified by chromatography on a column of silica gel (2.0×25 cm) 
with a mixture of petroleum ether and AcOEt (98:2) (TLC in a 
petroleum ether-AcOEt 7:1 mixture; RF = 0.40, stains visualized 
by UV and PMA) to afford 6b (102 mg, 17%) as a pale yellow 
oil: 1H NMR (400 MHz, CDCl3) δ -0.20 (s, 9H, H-7), 2.07 (dd, 3JH-H = 10.2 and 8.7  Hz, 1H, 
H-3), 2.19 (d, 3JH-H = 2.1 Hz, 1H, H-6), 2.34 (s, 3H, H-13), 4.76 (dd, 3JH-H = 8.7 and 2.1 Hz, 
1H, H-2), 5.02 (ddd, 3JH-H = 17.1 Hz, 2JH-H = 1.9 Hz, 4JH-H = 0.7 Hz, 1H, H-5), 5.1 (dd, 3JH-H 
= 10.3 Hz, 2JH-H = 1.9 Hz, 1H, H-5), 5.86 (td, 3JH-H = 17.1 and 10.2 Hz, 1H, H-4), 7.14 (d, 
3JH-H = 7.8 Hz, 2H, H-9, 11), 7.21-7.24 (m, 2H, H-8, 12); 13C NMR (100 MHz, CDCl3) δ -2.4 
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(CH3, C-7), 21.2 (CH3, C-13), 45.5 (CH, C-3), 74.3 (CH, C-2), 115.8 (CH2, C-5), 126.8 (CH, 
C-8, 12), 129.0 (CH, C-9, 11), 136.8 (CH, C-4), 137.5 (C, C-10), 140.6 (C,C-1).  
 
6d was prepared by method D / E. The crude product was 
purified by chromatography on a column of silica gel (2.0×25 cm) 
with a mixture of petroleum ether and AcOEt (98:2) (TLC in a 
petroleum ether-AcOEt 7:1 mixture; RF = 0.46, stains visualized by 
UV and PMA) to afford 31 (205 mg, 29%) as a pale yellow oil: 1H 
NMR (400 MHz, CDCl3) δ -0.13 (s, 9H, H-7), 2.00 (dd, 3JH-H = 10.4 
and 7.5 Hz, 1H, H-3), 2.34 (d, 3JH-H = 2.5, 1H, H-6), 4.87 (dd, 3JH-H = 7.5 and 2.5 Hz, 1H, H-
2), 4.96 (dd, 3JH-H = 17.1 Hz, 2JH-H = 1.5 Hz, 1H, H-5), 5.08 (dd, 3JH-H = 10.3 Hz, 2JH-H = 1.5 
Hz, 1H, H-5), 5.83 (td, 3JH-H = 17.1, 10.4, and 10.3 Hz, 1H, H-4), 7.43 (d, 3JH-H = 8.1 Hz, 2H, 
H-8, 12), 7.58 (d, 3JH-H = 8.1 Hz, 2H, H-9, 11); 13C NMR (100 MHz, CDCl3) δ -2.4 (CH3, C-
7), 45.4 (CH, C-3), 73.9 (CH, C-2), 116.4 (CH2, C-5), 124.3 (q, 1JC-F = 272 Hz, CF3, C-13), 
125.4 (q, 3JC-F = 3.7 Hz, CH, C-9, 11), 127.1 (CH, C-8, 12), 129.9 (q, 2JC-F = 32.3 Hz, C, C-
10), 135.6 (CH, C-4), 148.0 (C, C-1); 19F NMR (376 MHz, CDCl3) δ -62.4 (CF3).  
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5.3 The N,N'­Dioxide Catalyst 
 
 
 (10). o-Toluoyl chloride (46.38g, 0.3 mol) was added dropwise to 
a 40% aqueous solution of methylamine (78 mL, 0.9 mol) in water (50 
mL) at  0 °C during 30 min, while stirring vigorously. The mixture was 
then left to stand at room temperature for 30 min. The white precipitate 
was filtered off and left to dry in the air to give pure o-toluamide (43 g, 96%): mp = 74 - 75 
°C [lit.153 gives 74-75 °C]; 1H NMR (400 MHz, CDCl3) δ 2.44 (s, 3H, H-9), 2.98 (d, 3JH-H = 
3.6 Hz, 3H, H-11), 5.76 (bs, 1H, H-8), 7.17-7.35 (m, 4H, H-1, 2, 3, 6) in accordance with the 
literature data.10 
 
Method F: A 10M solution of n-BuLi in hexanes (0.40 mL 4.0 
mmol) was added dropwise during period of 5 min to a solution of N-
methyl-o-toluamide (2 mmol) in dry THF (5 mL) in an oven-dried flask 
under Ar at -20 °C. The reaction mixture turned red after addition of half 
of the n-BuLi solution. The mixture was stirred at -20 °C for 30 min and then it was allowed 
to warm up to 0 °C, and stirred for another 30 min. The reaction mixture was cooled to -50 
°C and a solution of the corresponding nitrile (2.2 mmol) in dry THF (5 mL) was added in 
one portion. The mixture was warmed rapidly to room temperature during a period of 10 min 
and then added dropwise to water or to a saturated aqueous solution of NH4Cl or to a mixture 
of water and THF (40 mL). The resulting suspension was diluted with CH2Cl2 (40 mL) and 
the organic phase was separated. Solid NaOH (0.4 g) was added to the aqueous phase and the 
aqueous phase was extracted again with CH2Cl2 (2×40 mL). Combined organic phases were 
washed with water (1×40 mL), and brine (1×40 mL), and dried (MgSO4). The drying agent 
was filtered off and the solvent was evaporated in vacuo. The resulting solid was purified by 
chromatography on a column of silica gel (15 g), using petroleum ether-AcOEt (7:1 to 1:1) as 
an eluent.  
 
Method G: A 10M solution of n-BuLi in hexanes (0.44 mL 4.4 mmol) was added 
dropwise during period of 5 min to a solution of N-methyl-o-toluamide (2 mmol) in dry THF 
(5 mL) in an oven-dried flask under Ar at -20 °C. The reaction mixture was stirred at -20 °C 
NH
O
Ar
11
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for 30 min and then it was allowed to warm up to 0 °C and stirred for another 30 min. The 
reaction mixture was cooled to -50 °C and a solution of the corresponding nitrile (2.2 mmol) 
in dry THF (1 mL) was added in one portion. The resulting mixture was warmed up rapidly 
to room temperature during a period of 10 min and then water (5 mL) was added. The 
resulting suspension was diluted with CH2Cl2 (40 mL) after 15 min, and the organic phase 
was separated. Solid NaOH (0.4 g) was added to the aqueous phase, and the aqueous phase 
was extracted with CH2Cl2 (1×40 mL). Combined organic phases were washed with water 
(3×40 mL) and brine (1×40 mL) and dried (MgSO4). The drying agent was filtered off and 
the solvent was evaporated in vacuo. The resulting solid was purified by chromatography on 
a column of silica gel (15 g), using petroleum ether-AcOEt (7:1 to 1:1) as an eluent. 
 
Method H: A 10M solution of n-BuLi in hexanes (0.44 mL 4.4 mmol) was added 
dropwise during period of 5 min to a solution of N-methyl-o-toluamide (2 mmol) in dry THF 
(5 mL) in an oven-dried flask under Ar at -20 °C. The reaction mixture was stirred for 30 min 
at -20 °C and then it was allowed to warm up to 0 °C and stirred for another 30 min. The 
reaction mixture was cooled to -50 °C and a solution of the nitrile (2.2 mmol) in dry THF (5 
mL) was added in one portion. The resulting mixture was warmed up rapidly to room 
temperature during a period of 10 min. Water (5 mL) was added slowly and dropwise at room 
temperature (the reaction was exothermic). The resulting suspension was diluted with CH2Cl2 
(40 mL) after 15 min and the organic phase was separated. Solid NaOH (0.4 g) was added to 
the aqueous phase and the aqueous phase was extracted with CH2Cl2 (40 mL). Combined 
organic phases were washed with water (1×40 mL) and brine (1×40 mL) and dried (MgSO4). 
The drying agent was filtered off and the solvent was evaporated in vacuo. The resulting solid 
was purified by chromatography on a column of silica gel (15 g), using petroleum ether-
AcOEt (7:1 to 1:1) as an eluent. 
 
(11a). Compound 11a was synthesized from benzonitrile 
according to method H and was further purified by crystallization 
from EtOAc to afford of 11a as white crystals (510 mg, 65%): mp 
= 203-205 °C [lit.154 gives 205 °C]; RF = 0.57 (PE:EtOAc 1:1, 
visualised by UV). 1H NMR (400 MHz, d6-DMSO) δ 6.77 (s, 1H, 
H-10), 7.42-7.52 (m, 4H, H-2, 14, 15, 16), 7.60 (d, 3JH-H = 7.7 Hz, 1H, H-6), 7.68-7.71 (m, 
3H, H-1, 13, 17), 8.41 (d, 3JH-H = 8.5 Hz, 1H, H-3) in accordance with the literature data.153  
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 (11b). Compound 11b was synthesized from 4-
trifluoromethylbenzonitrile according to method H and further 
purified by crystallization from EtOAc to afford 11b as white 
crystals (980 mg, 79%): mp > 250 °C; RF = 0.64 (PE:EtOAc 
1:1, visualized by UV); 1H NMR (400 MHz, d6-DMSO) δ 6.84 
(s, 1H, H-10), 7.54 (t, 3JH-H = 7.0 Hz, 1H, H-2), 7.63 (d, 3JH-H = 
7.7 Hz, 1H, H-6), 7.72 (t, 3JH-H = 7.5 Hz, 1H, H-1), 7.78 (d, 3JH-H = 8.4 Hz, 2H, H-13, 17), 
7.86 (d, 3JH-H = 8.2 Hz, 2H, H-14, 16) , 8.42 (d, 3JH-H = 8.0 Hz, 1H, H-3), 10.51 (bs, 1H, H-8); 
19F NMR (376.4 MHz, d6-DMSO) δ -61.1; 13C NMR (100 MHz, d6-DMSO) δ 104.7 (CH, C-
10), 124.1 (q, 1JC-F = 269.5 Hz, CF3, C-18), 128.1 (C, C-4), 128.9 (C, C-15), 129.8 (CH,      
C-14, 16), 131.0 (CH, C-13, 17), 133.5 (CH, C-3), 134.4 (CH, C-2), 134.9 (CH, C-6), 135.5 
(C, C-5), 137.0 (CH, C-1), 137.8 (C, C-9), 142.1 (C, C-12), 160.9 (CO, C-12); IR ν 3169, 
1638, 1620, 1325, 1112, 1072, 821 cm-1; HRMS (CI, isobutane) m/z 290.0795 (C16H11F3NO, 
M+H+, requires 290.0787). 
 
 Lactam (11c) was synthesized from 4-
methoxybenzonitrile according to method H and was further 
purified by crystallization from EtOAc to afford 11c as white 
crystals (1.1g, 65%): mp = 238-241° C [lit.153 gives 242 C]; 
RF = 0.5 (PE:EtOAc 1:1, visualized by UV). 1H NMR (400 
MHz, d6-DMSO) δ 3.88 (s, 3H, H-18), 6.77 (s, 1H, H-10), 
7.03 (d, 3JH-H = 8.8 Hz, 2H, H-14, 16), 7.45 (t, 3JH-H = 7.5 Hz, 1H, H-2), 7.57 (d, 3JH-H = 7.7 
Hz, 1H, H-6), 7.62-7.68 (m, 2H, H-1, 3), 8.39 (d, 2JH-H = 8.6 Hz, 2H) according to the 
literature;153 13C NMR (100 MHz, d6-DMSO) δ 55.3 (CH3, C-18), 102.0 (CH, C-10), 114.1 
(CH, C-14, 16), 124.5 (C, C-12), 126.0 (CH, C-6), 126.1 (C, C-4), 126.5 (CH, C-3), 126.6 
(CH, C-2),  128.0 (CH, C-13, 17), 132.5 (CH, C-1), 138.1 (C, C-9), 139.8 (C, C-5), 160.1 (C, 
C-15), 162.8 (CO, C-7); HRMS (CI, isobutane) m/z 252.1023 (C16H14NO2, M+H+, requires 
252.1019). 
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 (12a). Compound 12a was synthesized from benzonitrile 
according to method F and further purified by crystallization from 
EtOH to afford 12a in a form of white crystals (423 mg, 57%): mp = 
166-168 °C; RF = 0.20 (PE:EtOAc 1:1, visualized by UV); 1H NMR 
(400 MHz, d6-DMSO) δ 2.12 (bs, 2H,H-18), 2.97 (s, 3H, H-19), 
3.25 (d, 2JH-H = 16.0 Hz, 1H, H-10), 3.45 (d, 2JH-H = 16.0 Hz, 1H, H-
10), 7.05 (d, 3JH-H = 6.8 Hz, 1H), 7.20-7.40 (m, 6H, H-2, 13, 14, 15, 16, 17), 7.46-7.48 (m, 
2H, H-1, 3); 13C NMR (100 MHz, d6-DMSO) δ 28.9 (CH3, C-19), 45.4 (CH2, C-10), 75.8 (C, 
C-9), 126.3 (CH, C-15), 127.3 (CH, C-3), 127.4 (CH, C-6), 128.0 (CH, C-13, 17), 128.3 (CH, 
C-2), 128.5 (C, C-12), 128.3 (CH, C-14, 16), 132.1 (CH, C-1), 134.5 (C, C-5), 142.6 (C, C-
4), 165.6 (CO, C-11); IR ν 3395, 3316, 1636, 1491, 1443, 1375, 1325, 737 cm-1; HRMS (CI, 
isobutane) m/z 253.1345 (C16H17N2O, M+H+, requires 253.1335). 
 
    (12b). Compound 12b was synthesized from 4-
trifluoromethylbenzonitrile according to method F and further 
purified by crystallization from EtOH to afford orange crystals of 
12b (456 mg, 74%): mp = 142-145 °C; RF = 0.23 (PE:EtOAc 1:1, 
visualized by UV). 1H NMR (400 MHz, d6-DMSO) δ 2.15 (bs, 2H, 
H-18), 2.97 (s, 3H, H-19), 3.27 (d, 2JH-H = 16.0 Hz, 1H, H-10), 3.41 
(d, 2JH-H = 16.0 Hz, 1H, H-10), 7.05 (d, 3JH-H = 6.8 Hz, 1H, H-2), 7.35-7.42 (m, 2H, H-13, 
17), 7.57-7.62 (m, 4H, H-1, 6, 14, 16),  8.14 (dd, 3JH-H = 7.3 Hz, 4JH-H = 1.9 Hz, 1H, H-3); 19F 
NMR (376.4 MHz, d6-DMSO) δ -61.0; 13C NMR (100 MHz, d6-DMSO) δ 28.1 (CH3, C-19), 
44.6 (CH2, C-10), 75.7 (C-9), 125.5 (q, 1JC-F = 268.0 Hz, CF3, C-20), 127.9 (C-12), 128.6 
(CH, C-13, 17), 129.0 (CH, C-3), 129.1 (CH, C-6), 129.9 (CH, C-2), 130.5 (CH, C-14, 16), 
132.3 (C-5), 133.0 (CH, C-1), 135.0 (C, C-4), 165.8 (CO, C-7); IR ν 3387, 3281, 1640, 1325, 
1159, 1111, 1067, 839, 739 cm-1; HRMS (CI, isobutane) m/z 321.1217 (C17H16F3N2O, M+H+, 
requires 321.1209).  
 
     Aminal 12c was synthesized from 4-
methoxybenzonitrile according to method A and was 
further purified by crystallization from EtOH to afford 12c 
as white crystals (865 mg, 71%): mp = 141-143 °C; RF = 
0.21 (PE:EtOAc 1:1, visualized by UV); 1H NMR (400 
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MHz, d6-DMSO) δ 2.10 (bs, 2H, H-18), 2.97 (s, 3H, H-19), 3.23 (d, 2JH-H = 15.9 Hz, 1H, H-
10), 3.42 (d, 2JH-H = 16.0 Hz, 1H, H-10), 3.78 (s, 3H, H-20), 6.84 (d, 3JH-H = 8.9 Hz, 2H, H-
14, 16), 7.06 (d, 3JH-H = 6.9 Hz, 1H, H-2), 7.32-7.41 (m, 4H, H-1, 6, 13, 17), 8.13 (dd, 3JH-H = 
7.5 Hz, 4JH-H = 1.5 Hz, 1H, H-3); 13C NMR (100 MHz, d6-DMSO) δ 26.3 (CH3, C-19), 45.1 
(CH2, C-10), 57.6 (CH3, C-15), 75.2 (C, C-9), 126.1 (CH, C-14, 16), 126.9 (CH, C-3), 127.1 
(CH, C-6), 127.8 (CH, C-2), 128.1 (CH, C-13, 17), 128.9 (C, C-12), 129.2 (CH, C-1), 132.5 
(C, C-5), 133.4 (C, C-4), 159.1 (C, C-15), 166.8 (CO, C-7); IR ν 3397, 3298, 2967, 1634, 
1605, 1578, 1383, 1242, 1030, 833, 733 cm-1; HRMS (EI) m/z 282.1364 (C17H18N2O2, M+H+, 
requires 282.1368). 
 
 
 
 
(339a). Compound 339a was formed as a minor 
byproduct while utilizing method H. It was separated from 
the main products by a flash chromatography on a column of 
silica gel (5g) using PE/EtOAc (7:1) as an eluent to afford 
339a as a yellow solid (211 mg, 19%), which rapidly 
decomposes in a solution: RF = 0.9 (PE:EtOAc 1:1, 
visualized by UV); 1H NMR (400 MHz, d6-DMSO) δ 3.22 (d, 3JH-H = 4.2 Hz, 3H, H-18), 5.23 
(bs, 1H, H-11), 7.26-7.42 (m, 5H, H-13, 14, 15, 16, 17), 7.50 (ddd, 3JH-H = 8.1 Hz, 3JH-H = 7.0 
Hz, 4JH-H = 1.1 Hz, 1H, H-1), 7.64-7.69 (m, 2H, H-3, 10), 8.11-8.14 (m, 2H, H-2, 6) in 
accordance with the literature data.155  
 
 (339c). Compound 339c was formed as a minor 
byproduct while utilizing method H. It was separated 
from the main products by a flash chromatography on a 
column of silica gel (3g) using PE/EtOAc (7:1) as an 
eluent to afford 339c as a yellow solid (85 mg, 15%). It 
rapidly decomposes in a solution. RF = 0.86 (PE:EtOAc 
1:1, visualised by UV); 1H NMR (400 MHz, d6-DMSO) δ 3.21 (d, 3JH-H = 4.8 Hz, 3H, H-18), 
3.80 (s, 3H, H-19), 5.21 (bs, 1H, H-11), 6.93 (d, 3JH-H = 8.9 Hz, 2H, H-14, 16), 7.28 (s, 1H, 
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H-10), 7.32 (t, 3JH-H = 7.8 Hz, 1H, H-1), 7.49 (t, 3JH-H = 7.7 Hz, 1H, H-2), 7.75-7.79 (m, 1H, 
H-3), 7.80-7.85(m, 1H, H-6), 8.07 (d, 3JH-H = 8.8 Hz, 2H, H-13, 17).  
 
 
 
 
             From 3-(4-methoxyphenyl)isoquinolin-1(2H)-one (11b):  
 
 
(311b). Lactam 11b (6.00 g, 23.8 mmol) was dissolved 
in POCl3 (50 mL) and the reaction mixture was refluxed at 135 
°C for 4 h. Then it was allowed to cool to room temperature and 
poured slowly and portion-wise to a large excess of ice. The 
resulting mixture was allowed to warm to the room temperature, 
the solid product was filtered off and washed with plenty of 
water (until neutral reaction to litmus). The crude product was dried in the air and was further 
purified by crystallization from hexane to give pure chloride 311b (5.25 g, 82%) as white 
crystals. For the characterization data, vide infra. 
 
 
 
  (318b). 3-amino-3-(4-methoxyphenyl)-2-methyl-
3,4-dihydroisoquinolin-1(2H)-one (12b) (18.3 g, 64.8 mmol) was 
dissolved in glacial acetic acid (100 mL) and the solution was 
stirred at 80° C for 8h. The reaction mixture was allowed to cool to 
N
Cl
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room temperature and the acetic acid was evaporated in vacuo. The crude product was 
purified by crystallization from EtOAc to afford 318b as yellow crystals (11.8 g, 69%): mp = 
133-135 °C [lit.156  gives 136 °C]; RF = 0.5 (PE:EtOAc 1:1, visualized by UV); 1H NMR (400 
MHz, d6-DMSO) δ 3.36 (s, 3H, H-18), 3.80 (s, 3H, H-19), 6.36 (s, 1H, H-10), 6.92 (d, 3JH-H = 
8.7 Hz, 2H, H-14, 16), 7.25 (d, 3JH-H = 8.7 Hz, 2H, H-13, 17), 7.36-7.42 (m, 2H, H-1, 6),  
7.55 (ddd, 3JH-H = 8.2 Hz, 3JH-H = 6.9 Hz, 4JH-H = 1.3 Hz, 1H, H-2), 8.36 (d, 3JH-H = 7.9 Hz, 
1H, H-3) in accordance with the literature;157 13C NMR (100 MHz, d6-DMSO) δ 33.1 (CH3, 
C-18), 54.4 (CH3, C-19), 106.5 (CH, C-10), 113.0 (CH, C-14, 16), 123.8 (C, C-12), 124.7 
(CH, C-13, 17), 125.4 (CH, C-6), 126.8 (CH, C-2), 127.6 (C, C-9), 129.1 (CH, C-1), 131.2 
(CH, C-3), 135.4 (C, C-5), 142.7 (C, C-4), 159.0 (C, C-15), 162.4 (CO, C-7); IR ν 2999, 
2967, 2936, 1637, 1609, 1510, 1246, 1179, 1032, 822, 758 cm-1; HRMS (CI, isobutane) m/z 
266.1183 (C17H16NO2, M+H+, requires 266.1176). 
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From 3-(4-methoxyphenyl)-2-methylisoquinolin-1(2H)-one (318b):  
 
318b (11.8 g, 41.5 mmol) was dissolved in POCl3 (100 mL) and then same protocol 
as above was used to afford 311b as white crystals (6.10 g, 51%): mp = 84-87 °C [lit.156 gives 
88 °C]; RF = 0.50 (PE:EtOAc 7:1, visualized by UV); 1H NMR (400 MHz, d6-DMSO) δ 3.90 
(s, 3H, H-18), 7.04 (d, 3JH-H = 8.9 Hz, 2H, H-14, 16), 7.63 (ddd, 3JH-H = 8.2 Hz, 3JH-H = 6.9 
Hz, 4JH-H = 1.2 Hz, 1H, H-2), 7.73 (ddd, 3JH-H = 8.2 Hz, 3JH-H = 6.9 Hz, 4JH-H = 1.2 Hz, 1H, H-
1), 7.86 (d, 3JH-H = 8.2 Hz, 1H, H-6),  7.93 (s, 1H, H-10), 8.09 (d, 3JH-H = 8.9 Hz, 2H, H-13, 
17), 8.32 (dd, 3JH-H = 8.4 Hz, 4JH-H = 0.7 Hz, 1H, H-3) in accordance with the literature;158 13C 
NMR (100 MHz, d6-DMSO) δ 55.4 (CH3, C-18), 114.2 (CH, C-14, 16), 115.1 (CH, C-10), 
125.6 (C, C-12), 126.5 (CH, C-13, 17), 127.2 (CH, C-6), 127.8 (CH, C-3), 128.2 (CH, C-2), 
130.6 (C, C-5), 131.2 (CH, C-1), 138.8 (C-4), 150.2 (C, C-9), 151.2 (C, C-7), 160.5 (C, C-
15); IR ν 2936, 2836, 1606, 1560, 1516, 1249, 1173, 976, 824, 745 cm-1; HRMS (CI, 
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isobutane) m/z 270.0688 (C16H1335ClNO, M+H+, requires 270.0680); 272.0658 
(C16H1337ClNO requires 272.0651). 
 
 (312b). Zinc dust (855 mg, 13.1 mmol) and 
NiCl2.6H2O (3.11 g, 13.1 mmol) were added to a solution of 
triphenylphosphine (13.65 g, 52.1 mmol) in DMF (45 mL) and 
the mixture was left in an ultrasound bath for 30 min, while a 
steady stream of argon was bubbled through the suspension. 
The suspension was then heated to 65 °C and stirred for 1 h 
under argon while changing the colour from green to orange. A 
solution of chloride 311b (2.35 g, 8.70 mmol) in DMF (10 ml) 
was then added in one portion, the mixture was stirred at 65 °C 
for 3 h and then allowed to cool to room temperature. A 30% aqueous solution of ammonia 
(300 mL) was then added and the mixture was allowed to stand for a few hours in the fridge, 
while yellow crystals of product 312b were formed and filtered off (1.44 g, 71%): mp = 242-
245 °C; RF = 0.59 (PE:EtOAc 1:1, visualized by UV); 1H NMR (400 MHz, d6-DMSO) δ 3.86 
(s, 6H, H-18, 34), 7.00 (d, 3JH-H = 7.8 Hz, 4H, H-14, 16, 30, 32), 7.42 (t, 3JH-H = 7.5 Hz, 2H, 
H-1, 26), 7.68 (t, 3JH-H = 7.4 Hz, 2H, H-2, 25), 7.94-7.98 (m, 2H, H-6, 27), 7.95 (s, 2H, H-10, 
21), 8.09 (d, 3JH-H = 8.0 Hz, 4H, H-13, 17, 29, 33), 8.40-8.51 (m, 2H, H-3, 24); 13C NMR 
(100 MHz, d6-DMSO) δ 55.4 (CH3, C-18, 34), 114.1 (CH, C-14, 16, 30, 32), 115.8 (CH, C-
10, 21), 126.7 (CH, C-2, 6, 25, 27), 126.8 (C, C-19, 4), 127.6 (CH, C-3, 24), 128.4 (CH, C-
17, 13, 29, 33), 130.2 (CH, C-1, 26), 132.2 (C, C-5, 20), 138.1 (C, C-12, 28), 149.6 (C, C-9, 
22), 157.8 (C, C-15, 31), 160.1 (C, C-7, 11); IR ν 3052, 2830, 1607, 1514, 1244, 1175, 1028, 
835, 750 cm-1; HRMS (FAB, NOBA) m/z 469.1919 (C32H25N2O2, M+H+, requires 469.1911).  
 
 (13b). m-CPBA (75%, 1.0 g, 4.3 mmol) was added 
portion-wise to a solution of 3,3'-bis(4-methoxyphenyl)-1,1'-
biisoquinoline (312b) (200 mg, 0.43 mmol) in CH2Cl2 (10 mL) 
at the room temperature and the mixture was stirred for 5 days. 
The reaction mixture was then diluted with CH2Cl2 (40 mL) and 
washed with water (3×50 mL) and brine (1×50 mL). The 
organic phase was separated and dried (MgSO4). The solids 
were filtered off and the solvent was evaporated in vacuo to 
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afford a colourless oil. The crude product was purified by chromatography on a column of 
silica gel (2 g), using first a petroleum ether-AcOEt mixture (1:1) to elute the impurities and 
then CH2Cl2-MeOH (20:1) to afford the dioxide 13b as an orange solid (93 mg, 44%): mp > 
250 °C; RF = 0.20 (DCM:MeOH 50:1, visualised by UV); 1H NMR (400 MHz, d6-DMSO) δ 
3.84 (s, 6H, H-18, 34), 6.97 (d, 3JH-H = 8.9 Hz, 4H, H-14, 16, 30, 32), 7.17 (dd, 3JH-H = 8.4 Hz, 
4JH-H =0.7 Hz, 2H, H-6, 27), 7.41 (ddd, 3JH-H = 8.2 Hz, 3JH-H = 7.0 Hz, 4JH-H =1.1 Hz, 2H, H-1, 
26), 7.52 (ddd, 3JH-H = 8.1 Hz, 3JH-H = 7.1 Hz, 4JH-H =1.0 Hz, 2H, H-2, 25), 7.85-7.93 (m, 6H, 
H-3, 13, 17, 24),  7.97 (s, 2H, H-10, 21); 13C NMR (100 MHz, d6-DMSO) δ 55.4 (CH3, C-18, 
34), 113.4 (CH, C-14, 16, 30, 32), 123.4 (CH, C-1, 26), 124.8 (CH, C-3, 24), 124.9 (C, C-4, 
20), 127.1 (CH, C-2, 25), 128.4 (CH, C-6, 27), 129.1 (C, C-4, 19), 129.4 (CH, C-10, 21), 
131.6 (CH, C-13, 17, 29, 33), 138.9 (C, C-12, 28), 147.2 (C, C-9, 22), 160.5 (C, C-7, 11), 
171.2 (C, C-15, 31); IR ν 3052, 2830, 1607, 1514, 1244, 1175, 1028, 835, 750 cm-1; HRMS 
(FAB, NOBA) m/z 501.1812 (C32H25N2O4, M+H+, requires 501.1809).  
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5.4 Asymmetric Aldol Reactions 
 
(383). Solid isatine (43 mg, 0.292 mmol) was 
added to (S)-PicAm-DNBSA (8 mg, 0.015 mmol) or (R)-
PicAm-tart respectively (6 mg, 0.013 mmol) in brine (1.5 
mL) in a 10 mL round-bottom flask. Acetone (71 µL, 
0.970 mmol) was then added in one portion via a 
Hamilton syringe and the suspension was stirred at the 
room temperature for 24 h. The reaction mixture was extracted with diethylether (3 × 10 mL) 
and the organic phase was dried (Na2SO4) and evaporated in vacuo. The residue was purified 
by chromatography on a column of silica gel (0.5 × 7 cm) with diethyl ether as an eluent to 
afford (S)-(-)-383 as a white solid (48 mg, 87%): [α]D –25.9 (c 0.50, MeOH); 1H NMR (400 
MHz; CDCl3 and d6-DMSO, 4:1) δ 2.09 (s, 3H, H-13), 2.95 (d, 2JH-H = 16.2 Hz, 1H, H-10), 
3.13 (d, 2JH-H = 16.2 Hz, 1H, H-10), 5.55 (br s, 1H, H-15), 6.79 (d, 3JH-H = 7.3 Hz, 1H, H-1), 
6.86 (t, 3JH-H = 7.3 Hz, 1H, H-2), 7.10 (t, 3JH-H = 7.3 Hz, 1H, H-3), 7.17 (d, 3JH-H = 7.8 Hz, 
1H, H-6), 9.7 (s, 1H, H-7); 13C NMR (100 MHz; CDCl3 and d6-DMSO, 4:1) δ 35.8 (CH3,    
C-13), 54.8 (CH2, C-10), 78.0 (C, C-9), 114.6 (CH, C-3), 126.3 (CH, C-6), 127.4 (CH, C-1), 
133.9 (CH, C-2), 135.1 (C, C-5), 146.8 (C, C-4), 183.4 (CO, C-8), 210.7 (CO, C-12) 
consistent with the literature data;132 chiral HPLC (Chiracel OJ-H column, hexane/2-propanol 
= 4:1, 1 mL/min) showed 62% ee (tminor = 12.9 min, tmajor = 16.7 min) for the (S)-PicAm-
DNBSA catalyst. The reaction catalysed by (R)-PicAm-tart did not show any conversion 
even after a prolonged reaction time. 
 
 (418). Solid isatine (43 mg, 0.292 mmol) was 
added to (S)-PicAm-DNBSA (8 mg, 0.015 mmol) or (R)-
PicAm-tart respectively (6 mg, 0.013 mmol) in brine (1.5 
mL) in a 10 mL round-bottom flask. Cyclohexanone 
(102 µL, 0.987 mmol) was then added in one portion via 
a Hamilton syringe, followed by sodium 
dodecylbenzenesulfonate (102 mg, 0.293 mmol) as a 
phase-transfer catalyst and the suspension was stirred at 
room temperature for 24 h. The reaction mixture was extracted with ether (3 × 10 mL) and 
the organic phase was dried (Na2SO4) and evaporated in vacuo. The residue was purified by 
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chromatography on a column of silica gel (0.5 × 7 cm) with ether as an eluent, to afford 418 
as a white solid (65 mg, 90%): [α]D –9.2 (c 0.50, MeOH); 1H NMR (400 MHz; d6-DMSO) δ 
1.50-2.10 (m, 6H. H-13, 14, 15), 2.30-2.32 (m, 1H, H-10), 2.47-2.52 (m, 1H, H-16), 3.23 (dd, 
3JH-H = 7.9 and 5.9 Hz, 1H, H-16), 5.70 (br s, 1H, H-12), 6.80 (d, 3JH-H = 7.3 Hz, 1H, H-3), 
6.83 (t, 3JH-H = 7.3 Hz, 1H, H-2), 7.18 (t, 3JH-H = 7.3 Hz, 1H, H-1), 7.25 (d, 3JH-H = 7.7 Hz, 
1H, H-6), 9.7 (s, 1H, H-7); 13C NMR (100 MHz; d6-DMSO) δ 24.5 (CH2, C-13), 26.8 (CH2, 
C-14), 27.5 (CH2, C-15), 41.9 (CH2, C-16), 57.8 (CH, C-10), 73.7 (C, C-9), 110.4 (CH, C-3), 
121.5 (CH,   C-6), 124.3 (CH, C-1), 128.5 (CH, C-2), 130.1 (C, C-5), 143.2 (C, C-4), 178.7 
(CO, C-8), 209.0 (CO, C-17) consistent with the literature data.160 HPLC (Chiracel OJ-H 
column, hexane/2-propanol = 4:1, 1 mL/min) showed 44% ee (tminor = 13.3 min, tmajor = 17.4 
min) for the (S)-PicAm-DNBSA catalyst. The reaction catalysed by (R)-PicAm-tart did not 
show any conversion even after a prolonged reaction time. The absolute configuration was 
determined by comparison of the specific rotation with that of the literature value. 
 
General Method for the Aldol Reactions using (R)-(-)-Leucinol as a Catalyst 
(Method I). Acetone (4 mL) and water (0.5 mL) were added to a solution of the 
corresponding trifluoromethyl ketone (5 mmol) and (R)-(-)-leucinol (1 mmol) in CH2Cl2 (24 
mL) and the reaction mixture was stirred at 0 °C for 24 h. The mixture was then diluted with 
CH2Cl2 (20 mL) and washed with water (3×20 mL). The organic layer was dried (MgSO4) 
and the solvent was evaporated in vacuo. The crude product was purified by chromatography 
on a column of Al2O3 (30 g of alumina) pre-treated with Et3N. Racemic standards (for HPLC) 
were prepared in the same way, using aminoethanol (20 mol %) as a catalyst.   
 
 397 was prepared by the Method I. White solid (85%): mp 
50-55 oC; [α]D –7.7 (c 0.40, MeOH); 1H NMR (400 MHz; CDCl3) δ 
2.21 (s, 3H, CH3, H-12), 3.31 (d, 2JH-H = 17.2 Hz, 1H, H-3), 3.37 (d, 
2JH-H = 17.2 Hz, 1H, H-3), 5.45 (s, 1H, H-9), 7.35-7.43 (m, 3H, H-5, 
6, 7), 7.55-7.59 (m, 2H, H-4, 8); 13C NMR (100 MHz; CDCl3) δ 32.1 (CH3, C-12), 45.1 (CH2, 
C-3), 76.0 (q, 2JC-F = 29.2 Hz, C, C-2), 124.4 (q, 1JC-F = 284.9 Hz, CF3, C-10), 126.1 (q, 4JC-F 
= 0.8 Hz, CH, C-4, 8), 128.4 (CH, C-5, 7), 128.8 (CH, C-6), 137.4 (C, C-1), 208.9 (CO, C-
11); IR ν 3466, 1715, 1450, 1406, 1238, 1195, 1167, 1155, 1136, 994, 767, 710 cm-1; MS 
(EI) m/z (%) 232 (M+, 10), 175 (10), 163 (35), 105 (100); HRMS (EI) m/z: 232.0714 
(C11H11O2F3, M+•, requires 232.0711); chiral HPLC (Chiracel OJ-H hexane/2-propanol 4:1, 
0.75 mL min-1) showed 77% ee (tminor = 17.9 min, tmajor = 11.9 min). 
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 398 was prepared by the Method I. White solid (70%): mp 
43-46 oC; [α]D –9.8 (c 0.63, MeOH); 1H NMR (400 MHz; CDCl3) δ 
2.20 (s, 3H, CH3, H-12 ), 3.44 (d, 2JH-H = 17.0 Hz, H-3), 3.94 (d, 2JH-
H = 17.0 Hz, H-3), 5.69 (s, 1H, OH), 7.25-7.45 (m, 3H, Ar), 
7.70-7.80 (m, 2H, Ar); 13C NMR (100 MHz; CDCl3) δ 32.2 (CH3, C-
12), 46.9 (CH2, C-3), 83.9 (C-O), 105.4 (CCl3), 127.6 (CH, C-6), 128.6 (CH, C-4, 8), 128.8 
(CH, C-5, 7), 138.1 (C, C-1), 209.3 (CO, C-11); IR ν 3481, 1694, 1409, 1391, 1363, 1328, 
1317, 1180, 837, 802, 765, 711, 610 cm-1; MS (CI/isobutane) m/z (%) 281 (M+, 100), 185 
(10), 163 (30), 105 (5); HRMS (EI) m/z: 280.9893 (C11H11O2Cl3, M+•, requires 280.9903); 
chiral HPLC (Chiracel OJ-H hexane/2-propanol 4:1, 0.75 mL min-1) showed 64% ee (tminor = 
44.4 min, tmajor = 17.6 min). 
 
  399 was prepared by the Method I. White solid (86%): 
mp 38-41 oC; [α]D –11.2 (c 1.4, MeOH); 1H NMR (400 MHz; 
CDCl3) δ 2.21 (s, 3H, CH3), 3.21 (d, 2JH-H = 17.2 Hz, CHH’), 3.31 
(d, 2JH-H = 17.2 Hz, CHH’), 5.50 (s, 1H, OH), 7.05-7.11 (m, 2H, 
Ar), 7.52-7.57 (m, 2H, Ar); 13C NMR (100 MHz; CDCl3) δ 32.1 (CH3), 45.0 (CH2), 75.7 (q, 
2JC-F = 29.4 Hz, C-O), 115.4 (d, 2JC-F = 21.6 Hz, CH, C-5, 7), 124.3 (q, 1JC-F = 285.5 Hz, 
CF3), 128.1 (dq, 3JC,F = 8.3 Hz, 4JC-F = 0.8 Hz, CH, C-4, 8), 133.3 (d, 4JC-F = 3.3 Hz, C, C-1, 
8), 162.9 (d, 1JC-F = 248.2 Hz, CF, C-6), 208.9 (CO, C-11); IR (NaCl) ν 3475, 1714, 1511, 
1420, 1365, 1337, 1238, 1195, 1166, 1134, 837, 736 cm-1; MS (EI) m/z (%) 250 (M+, 5), 181 
(40), 123 (100); HRMS (EI) m/z: 250.0615 (C11H10O2F4, M+•, requires 250.0617); chiral 
HPLC (Chiracel OJ-H hexane/2-propanol 9:1, 1 mL min-1) showed 82% ee (tminor = 16.5 min, 
tmajor = 11.4 min). 
  
 400 was prepared by the Method I. Colourless liquid (87%): 
[α]D –6.6 (c 0.65, MeOH); 1H NMR (400 MHz; CDCl3) δ 2.22 (s, 
3H, CH3), 3.21 (d, 2JH-H = 17.3 Hz, CHH’), 3.31 (d, 2JH-H = 17.3 Hz, 
CHH’), 5.53 (s, 1H, OH), 7.03 – 7.09 (m, 1H, Ar), 7.29 – 7.40 (m, 
3H, Ar); 13C NMR (100 MHz; CDCl3) δ 32.0 (CH3), 45.0 (CH2), 
75.7 (qd, 2JC-F = 29.5 Hz, 4JC-F = 1.8 Hz, C-O), 113.8 (d, 2JC-F = 23.8 Hz, CH), 115.8 (d, 2JC-F 
= 21.1 Hz, CH), 121.5 – 121.7 (m, CH), 124.2 (q, 1JC-F = 285.0 Hz, CF3, C-10), 130.0 (d, 3JC-
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F = 8.2 Hz, CH, C-5), 140.1 (d, 3JC-F = 7.0 Hz, C, C-1), 162.8 (d, 1JC-F = 246.4 Hz, CF, C-7), 
208.7 (CO, C-11); IR (NaCl) ν 3455, 1714, 1593, 1491, 1444, 1420, 1365, 1344, 1275, 1240, 
1146, 1061, 865, 790, 726 cm-1; MS (EI) m/z (%) 250 (M+, 10), 181 (30), 123 (60); HRMS 
(EI) m/z: 250.0619 (C11H10O2F4, M+•, requires 250.0617); chiral HPLC (Chiracel OJ-H 
hexane/2-propanol 9:1, 1 mL min-1) showed 73% ee (tminor = 12.0 min, tmajor = 10.2 min). 
  
 401 was prepared by the Method I. White solid (84%): 
mp 42-45 oC; [α]D –9.0 (c 1.0, MeOH); 1H NMR (400 MHz; 
CDCl3) δ 2.22 (s, 3H, CH3), 3.20 (d, 2JH-H = 17.3 Hz, CHH’), 
3.30 (d, 2JH-H = 17.3 Hz, CHH’), 5.49 (s, 1H, OH), 7.35-7.39 (m, 
2H, Ar), 7.48-7.52 (m, 2H, Ar); 13C NMR (100 MHz; CDCl3) δ 32.1 (CH3), 44.9 (CH2), 75.8 
(q, 2JC-F = 29.5 Hz, C-O), 124.2 (q, 1JC-F = 284.9 Hz, CF3), 127.6 (d, 4JC-F = 0.8 Hz, CH, C-4, 
14), 128.7 (CH, C-5,7), 135.0 (C, C-1), 136.1 (C, C-6), 208.7 (C=O); IR ν 3478, 1713, 1494, 
1410, 1363, 1336, 1240, 1192, 1169, 1138, 1112, 1095, 1057, 915, 825, 734 cm-1; MS (EI) 
m/z (%) 266 (M+, 5), 197 (35), 139 (90); HRMS (EI) m/z: 266.0325 (C11H10O2F3Cl, M+•, 
requires 266.0321); chiral HPLC (Chiracel OJ-H hexane/2-propanol 9:1, 1 mL min-1) showed 
78% ee (tminor = 14.7 min, tmajor = 10.7 min). 
  
 402 was prepared by the Method I. White solid (72%): mp 
35-38 oC; [α]D –7.7 (c 0.34, MeOH); 1H NMR (400 MHz; CDCl3) δ 
2.21 (s, 3H, CH3), 3.41 (d, 2JH-H = 17.1 Hz, CHH’), 3.82 (s, 3H, 
CH3O), 3.91 (d, 2JH-H = 17.1 Hz, CHH’), 5.70 (s, 1H, OH), 6.88-6.92 
(m, 1H, Ar), 7.24-7.36 (m, 3H, Ar); 13C NMR (100 MHz; CDCl3) δ 
32.2 (CH3), 47.0 (CH2), 55.3 (CH3O), 83.8 (C-O), 105.2 (CCl3), 113.8 (CH, C-8), 115.6 (CH,     
C-6), 120.8 (CH, C-4), 128.5 (CH, C-5), 139.8 (C, C-1), 159.0 (C, C-7), 209.3 (CO, C-11); 
IR (NaCl) ν 3448, 1697, 1489, 1464, 1426, 1363, 1264, 1234, 1172, 1033, 801, 777, 728, 702 
cm-1; MS (CI/isobutane) m/z (%):  311 (80), 259.1 (80), 207.2 (100); HRMS (CI) m/z: 
310.9995 (C12H14O3Cl3, M+H+, required 311.0009); chiral HPLC (Chiracel OJ-H hexane/2-
propanol 9:1, 1 mL min-1) showed 66% ee (tminor = 25.1 min, tmajor = 21.1 min). 
 
 (404). 3-(Trifluoroacetyl)indole (543 mg, 2.55 mmol) was 
added to a solution of pyridine (0.21 mL, 2.55 mmol) and acetic 
anhydride (1.19 mL, 12.73 mmol) in dry THF (20 mL). The reaction 
1 2
3
4
5
6
7
14
HO
8
CF3
9
10 11
O
12
401 1Cl13
181 
 
mixture was refluxed for 5 h and then stirred at room temperature overnight. The solvent was 
evaporated, the residue was dissolved in CH2Cl2 (50 mL), washed with water (3×100 mL), 
dried over anhydrous MgSO4, and evaporated. The residue was evaporated with toluene 
(3×20 mL) under reduced pressure and crystallized from an ethyl acetate-hexane mixture to 
afford 404 (586 mg, 90%) as colourless crystals: mp 127-128 °C (ethyl acetate/hexane); 1H 
NMR (400 MHz, CDCl3) δ 2.71 (s, CH3, 3H), 7.36-7.46 (m, 2H, H-1, 2), 8.16-8.20 (m, 1H, 
H-3), 8.26-8.31 (m, 1H, H-8), 8.33-8.38 (m, 1H, H-6); 13C NMR (100 MHz, CDCl3) δ 22.9 
(CH3), 113.2 (C), 115.5 (CF3, q, 1JC-F = 295 Hz), 116.7 (C, C-9), 121.2 (CH, C-3), 125.0 (CH, 
C-6), 125.9 (C, C-5), 126.3 (CH, C-2), 133.0 (CH, C-8), 134.7 (C, C-4), 167.4 (CO, C-13), 
175.0 (CO, C-10); IR (KBr) ν 1735, 1700, 1542, 1450, 1216, 1146 cm-1; MS (EI) m/z (%) 
255 (M⋅+, 36), 213 (41), 186 (5), 144 (100); HRMS (EI) m/z 255.0511 (C12H8F3NO2, M+•, 
requires 255.0507).  
 
 407 was prepared by the Method I. Purification was 
carried out by column chromatography on neutral alumina (8 g of 
Al2O3 pre-treated with 1% Et3N solution in ether and washed with 
dichloromethane) with dichloromethane (RF = 0.40) and the product 
was crystallized from a dichloromethane-hexane mixture to afford 
407 (145 mg, 76%) as white crystals: mp 150-151 °C (dichloromethane/hexane); [α]D -10.0 (c 
1.0, CHCl3); 1H NMR (400 MHz, CDCl3) δ 2.20 (s, 3H, H-7), 2.67 (s, 3H, H-18), 3.27 (d, 
2JH-H = 17.0 Hz, 1H, H-3), 3.51 (d, 2JH-H = 17.0 Hz, 1H, H-3), 5.81 (s, 1H, H-4), 7.26-7.35 (m, 
1H, H-14), 7.35-7.44 (m, 1H, H-15), 7.62 (s, 1H, H-12), 8.48 (d, 3JH-H = 8.2 Hz, 1H, H-13), 
7.73 (d, 3JH-H = 7.9 Hz, 1H, H-16); 13C NMR (100 MHz, CDCl3) δ 23.1 (CH3, C-7), 31.2 
(CH3, C-18), 43.1 (CH2, C-3), 76.1 (C, q, 2JC-F = 51 Hz), 115.9 (CH, C-14), 118.6 (CH, C-
15), 119.7 (CH, C-12), 123.0 (CH, C-13), 123.5 (CF3, q, 1JC-F = 285 Hz), 124.5 (CH, C-16), 
125.7 (C, C-9), 126.1 (C, C-1), 135.5 (C, C-10), 167.5 (CO, C-17), 208.1 (CO, C-6); IR 
(KBr) ν 3496, 3440, 3020, 1704, 1602, 1450, 1384, 1217; MS (EI) m/z (%) 313 (M⋅+, 43), 
271 (10), 244 (11), 214 (29), 144 (100) cm-1; HRMS (EI) m/z 313.0927 (C15H14F3NO3, M+•, 
requires 313.0926); chiral HPLC (Chiralpack, IB, hexane/2-propanol (96:4), 0.75 mL/min, 
tminor = 35.5 min, tmajor = 47.9 min) showed 46% ee.  
 
 406 was prepared by the Method I. Purification of alcohol 406 was 
carried out by column chromatography on neutral alumina (13 g of 
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Al2O3 pre-treated with 1% Et3N solution in ether and washed with dichloromethane) with a 
petroleum ether-dichloromethane mixture (3:7, RF = 0.44) and the product was crystallized 
from a dichloromethane-hexane mixture to afford 406 (324 mg, 79%) as colourless crystals: 
mp 44-46 °C (dichloromethane/hexane); [α]D +13.7 (c 1.0, CHCl3); 1H NMR (400 MHz, 
CDCl3) δ 2.23 (s, 3H, H-7), 3.15 (d, 2JH-H = 17.1 Hz, 1H, H-3), 3.32 (d, 2JH-H = 17.1 Hz, 1H, 
H-3), 5.87 (s, 1H, OH), 7.01 (dd, 3JH-H = 5.1 and 3.3 Hz, 1H, H-10), 7.11 (d, 3JH-H = 3.3 Hz, 
1H, H-9), 7.34 (d, 3JH-H = 5.1 Hz, 1H, H-11); 13C NMR (100 MHz, CDCl3) δ 32.2 (CH3), 45.7 
(CH2), 75.6 (C, q, 2JC-F = 31 Hz, C-2), 123.8 (CF3, q, 1JC-F = 285 Hz), 125.8 (CH, C-9),  126.6 
(CH, C-10), 127.3 (CH, C-11), 141.7 (C, C-1), 209.0 (CO, C-6); IR (KBr) ν 3453 3114, 
2921, 1711, 1422, 1367, 1338, 1167 cm-1; MS (EI) m/z (%) 238 (M⋅+, 37), 181 (15), 169 (54), 
111 (100), 84 (78); HRMS (EI) m/z 238.0277 (C9H9F3O2S requires 238.0275, M+•,); chiral 
HPLC [Chiracel, OJ-H, hexane/2-propanol (96:4), 0.75 mL min-1 tminor = 15.2 min, tmajor = 
21.8 min) showed 82% ee. 
 
 408 was prepared by the Method I. 1H NMR (400 MHz, 
CDCl3) δ  1.67 (s, 3H, H-13), 2.22 (d, 2JH-H = 16.7 Hz, 1H, H-7), 2.37 
(d, 2JH-H = 16.7 Hz, 1H, H-7), 2.68 (d, 2JH-H = 13.8 Hz, 1H, H-11), 
3.05 (d, 2JH-H = 13.8 Hz, 1H, H-11), 5.60 (bs, 1H, OH), 7.21 (m, 5H, 
Ar). Chiral HPLC (Chiracel, OJ-H, hexane/2-propanol (96:4), 0.75 mL/min) showed 0% ee. 
 
384 was prepared by the Method I. Crystallization from ethyl 
acetate-hexane afforded 384 in a form of yellow crystals: [α]D +50.7 
(c 0.6, CHCl3); 1H NMR (400 MHz, CDCl3) δ 2.15 (s, 3H, H-15), 
3.37 (d, 3JH-H = 17.3 Hz, 1H, H-13), 3.68 (d, 3JH-H = 17.3 Hz, 1H, H-
13), 5.71 (bs, 2H, H-11), 6.91 (d, 3JH-H = 8.8 Hz, 1H, H-1), 7.18 (d, 
3JH-H = 8.8 Hz, 1H, H-2); chiral HPLC (Chiralpack, IB, hexane/2-propanol (90:10), 0.75 
mL/min, tminor = 23.9 min, tmajor = 28.0 min) showed 95% ee.  
  
(388). Methanol (1 mL) and concentrated H2SO4 (1 mL) 
were added to a mixture of trimethyl orthoformate (30 mL, 274.2 
mmol) and dimethyl 1,3-acetonedicarboxylate (29.5 mL, 199.9 
mmol). The neat reaction mixture was heated at reflux for 6 h 
under Ar, then diluted with ether (100 mL), washed with saturated aqueous NaHCO3 (3×50 
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mL) and dried (Na2SO4). The solvent was evaporated in vacuo to afford the product in a form 
of yellow oil  which was used in the next step without further purification (20.6 g, 80%): 1H 
NMR (400 MHz; CDCl3) δ 3.67 (s, 3H, H-1), 3.68 (s, 3H, H-7), 3.71 (s, 3H, H-9), 3.83 (s, 
2H, H-5), 5.19 (s, 1H, H-3) in accordance with the literature.159 
 
 
 (390). A 40% aqueous solution of methylamine (26 mL, 300 mmol) 
was added dropwise to the diketone 390 (20.0 g, 106 mol) at 0 °C and the 
reaction mixture was stirred at room temperature overnight. The reaction 
mixture was then diluted with water (100 mL) and extracted with ethyl 
acetate (3×100 mL). The organic layer was dried (MgSO4) and the solvent 
was removed in vacuo. The yellow crystalline residue thus obtained, was 
dissolved in methanol (100 mL). Sodium (5.0 g, 217 mmol) was added slowly in small pieces 
while stirring and the reaction mixture was heated at reflux for 2 h. The methanol was then 
evaporated in vacuo, the residue was dissolved in water and washed with diethyl ether (2×20 
mL). Glacial acetic acid (20 mL) was added to the aqueous layer, which was then extracted 
with CH2Cl2 (3×50 mL). The organic extract was dried (Na2SO4), the solvent was evaporated 
in vacuo and the crude product was purified by crystallization as follows: CH2Cl2 was added 
in portions, until all the residue dissolved. Then diethyl ether was added dropwise until the 
solid product just begun to appear and then few drops of CH2Cl2 were added to dissolve it 
again. The resulting solution was then kept in the fridge overnight, crystals were filtered off 
and washed with a small amount of cold diethyl ether to give the pure product (9.1 g, 55%) in 
a form of white crystals: mp 112 – 114o C (lit159 gives 114oC); 1H NMR (400 MHz; CDCl3) 
δ3.21 (s, 3H, H-9), 3.44 (s, 2H, H-1), 3.76 (s, 3H, H-10), 5.44 (s, 1H, H-4) in accordance with 
the literature.159 
 
 (386). Diketone 390 (1000 mg, 6.45 mmol) and SeO2 (1200 mg, 
10.81 mmol) with one drop of concentrated hydrochloric acid were stirred 
at room temperature in CHCl3 (50 mL) overnight. The mixture was then 
filtered through a short pad of Celite, the filtrate was evaporated in vacuo 
and the product was purified by chromatography on a column of silica gel 
(30 g) with a mixture of CH2Cl2 and AcOEt (90:10) (TLC in a CH2Cl2-AcOEt 90:10 mixture; 
RF  = 0.25, stains visualized by PMA) to give orange crystals (794 mg, 73%): mp 127 – 130o 
C C (lit159 gives 132 oC); 1H NMR (400 MHz; CDCl3) δ 3.32 (s, 3H, H-9), 3.85 (s, 3H, H-
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11), 6.16 (s, 1H, H-4); 13C NMR (100 MHz; CDCl3) δ 27.1 (CH3, C-9), 56.8 (CH3, C-11), 
107.3 (CH, C-4), 155.3 (C, C-5), 158.1(CO, C-2), 162.8 (CO, C-3), 170.5 (CO, C-1) in 
accordance with the literature.159  
 
(385). Speranskatine A was prepared by the Method I. 
White crystals (202 mg, 80%): mp 150-152 oC (decomp.; lit160 gives  
158-160 oC); [α]D +15.0 (c 0.5, MeOH) [lit160 gives [α]D +14.8 (c 
0.54, MeOH)]; 1H NMR (400 MHz; CDCl3) δ 1.26 (s, 3H, H-14), 
2.16 (s, 3H, H-15), 3.23 (s, 3H, H-7), 3.26 (s, 2H, H-10), 3.78 (s, 
3H), 5.45 (s, 1H, H-1); 1H NMR (400 MHz; C6D6) δ 1.49 (s, 3H, H-
14), 2.74 (d, 1H, CHH, 2JH-H = 16.7 Hz, H-10), 2.76 (s, 3H, H-15), 2.86 (d, 1H, CHH, 2JH-H = 
16.7 Hz, H-10), 3.05 (s, 1H, H-7), 5.18 (s, 1H, H-1); 13C NMR (100 MHz; CDCl3) δ 26.6 
(CH3, C-14), 30.6 (CH3, C-15), 50.0 (CH2, C-10), 56.7 (OCH3, C-7), 70.8 (C, C-5), 94.7 (CH, 
C-1), 164.5 (C, C-6), 167.5 (CO, C-2), 172.9 (CO, C-4), 205.5 (CO, C-11); MS 
(CI/isobutane) m/z (%): 228 (M+H), 172 (80), 113 (30), 85 (80); HRMS (CI/isobutene) m/z 
(%): 228.0870 (C10H11NO5, M+H+-H2O, requires 228.0872); chiral HPLC (Chiracel OJ-H 
hexane/2-propanol 9:1, 1 mL min-1) showed 80% ee (tminor = 21.4 min, tmajor = 23.2 min).  
 
 General Method for the Boc-Protection of α-Amino Acids (Method J): 
The α-amino acid (6 mmol) was added to a solution of sodium carbonate (0.5 g) in water 
(100 mL). To the mixture, di-tert-butyl dicarbonate was added (7.5 mmol) in t-butyl alcohol 
(20 mL), after which the mixture was stirred at room temperature overnight. The solution was 
washed with hexane (1×50 mL) and the aqueous phase was cooled to 0 °C. Then a 40% 
aqueous solution of KHSO4 was added, until pH 3 was reached. The mixture was extracted 
with ethyl acetate (3×50 mL) and the organic phase was washed with water (3×50 mL), dried 
over MgSO4, and concentrated under reduced pressure. The product was used directly in the 
next step without further purification.  
 
N-Methyl- L-valine 378. A 250 mL flask was charged with the 
Boc protected N–methyl-L-valine (3.326 g, 15.3 mmol), dry THF (150 
mL), and iodomethane (16.300 g, 114.8 mmol) and cooled to 0 °C under 
Ar atmosphere. Sodium hydride (5.512 g, 229.7 mmol) was then added in 
small portions during 2 h while stirring vigorously. The reaction mixture was then stirred at 
room temperature for 24 h. The reaction was quenched with water (50 mL) and THF was 
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evaporated under reduced pressure. The concentrate was diluted with water (50 mL) and 
washed with ethyl acetate (1×100 mL). The aqueous phase was acidified with 1M 
hydrochloric acid (10 mL) and extracted with ethyl acetate (3×100 mL). The organic phase 
was washed with a water (2×100 mL) and brine (1×100 mL) and dried over MgSO4. The 
solvent was evaporated to give yellow viscous oil, which on crystallization from ethyl acetate 
afforded N-methyl-L-valine 378 (2.868 g, 81%) as white crystals: 1H NMR (400 MHz, 
CDCl3) δ  0.90 (d, 3JH-H = 6.8 Hz, 3H, H-5), 1.01 (d, 3JH-H = 6.8 Hz, 3H, H-6), 2.13-2.36 (m, 
1H, H-4), 2.85 (s, 3H, H-1), 4.22 (d, 3JH-H = 10.4 Hz, 1H, H-2), in agreement with 
literature.161 
 General Method for Coupling of Boc-Protected α-Amino Acids with N-
Sulfonamides (Method K): The corresponding N-sulfonamide (1.22 mmol) was added to a 
solution of the Boc-protected α-amino acid (1.22 mmol) in dry dichloromethane (30 mL), 
followed by dry Et3N (0.25 mL, 1.83 mmol). The reaction mixture was cooled to 0 °C and 
HOBT (1.58 mmol) was added, followed by EDCI (1.58 mmol). The resulting solution was 
stirred at 0 °C for 1h under Ar and then at room temperature for 24 h. The reaction mixture 
was diluted with ethyl acetate (100 mL) and washed with cold 1M hydrochloric acid (2×50 
mL), cold water (2×50 mL), and brine (2×50 mL). The organic phase was dried over MgSO4 
and evaporated under reduced pressure. The product was used directly in the next step 
without further purification.     
 
 General Method for the Boc-Deprotection (Method L): TFA (5 mL) was 
added dropwise to a solution of proline or valine N-sulfonamide (1 mmol) in 
dichloromethane (5 mL) at 0 °C while stirring vigorously. The reaction mixture was stirred at 
0 °C for 1h and then co-evaporated at reduced pressure with toluene (5×10 mL). The crude 
catalyst  was obtained, which was further purified by column chromatography (vide supra).   
 
 371  was prepared by Method J followed by 
Method K and Method L. Purification by column 
chromatography on silica gel (3 g of SiO2) with an ethyl 
acetate-methanol mixture (1:1, RF = 0.30) afforded 371 as 
viscous colourless oil (128 mg, 91% over 2 steps): 1H NMR 
(CDCl3 and drop of d4-MeOH) δ 1.89-2.16 (m, 4H, H-1, 2), 2.29-2.41 (m, 2H, H-3), 4.07 (t, 
3JH-H = 7.0 Hz, 1H, H-5), 6.97 (d, 3JH-H = 4.0 Hz, 1H, H-7), 7.48 (d, 3JH-H = 4.0 Hz, 1H, H-8); 
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13C NMR (100 MHz, CDCl3 and drop of d4-MeOH) δ 24.8 (CH2, C-2), 30.6 (CH2, C-1), 47.2 
(CH2, C-3), 63.4 (CH, C-5), 127.3 (CH, C-8), 131.9 (CH, C-7), 136.2 (C, C-11), 143.5 (C, C-
9), 173.9 (CO, C-6); IR (KBr) ν 3074, 1676, 1397, 1375, 1283, 1203, 1133, 968 cm-1; MS 
(FAB/NOBA) m/z (%) 339/341 (M+H+, 85/83), 273 (25), 142 (32), 75 (100); HRMS 
(FAB/NOBA) m/z 338.9492 (C9H1279BrN2O3S2, M+H+, requires 338.9467).  
 
  372  was prepared by Method J followed by 
Method K and Method L. Purification by column 
chromatography on silica gel (4 g of SiO2) with an ethyl 
acetate-methanol mixture (4:1, RF = 0.30) afforded 372  (82 
mg, 61% over 2 steps) as viscous colourless oil (61% over 2 steps): 1H NMR (400 MHz, 
CDCl3 and drop of d4-MeOH) δ 0.85 (d, 3JH-H = 6.8 Hz, 3H, H-16), 0.91 (d, 3JH-H = 6.8 Hz, 
3H, H-17), 2.14-2.22 (m, 1H, H-15), 3.49 (d, 3JH-H = 4.2 Hz, 1H, H-14), 6.83 (d, 3JH-H = 4.0 
Hz, 1H, H-2), 7.44 (d, 3JH-H = 4.0 Hz, 1H, H-3); 13C NMR (100 MHz, CDCl3 and drop of d4-
MeOH) δ 17.9 (CH3, C-16), 19.5 (CH3, C-17), 31.4 (CH, C-15), 61.5 (CH, C-14), 127.5 (CH, 
C-2), 132.9 (C, C-6), 137.7 (CH, C-3), 141.9 (C, C-4), 173.2 (CO, C-1); IR (KBr) ν 3426, 
3096, 2977, 1675, 1471, 1407, 1219, 1142, 772 cm-1. MS (FAB/NOBA) m/z (%) 297/299 
(M+H+, 49/17), 231 (20), 180 (100), 69 (82); HRMS (FAB/NOBA) m/z 297.0152 
(C9H1435ClN2O3S2 requires 297.0129). 
 
373  was prepared by Method J followed by Method 
K and Method L. Purification by column chromatography on 
silica gel (7 g of SiO2) with an ethyl acetate-methanol mixture 
(RF = 0.30) afforded 373 (153 mg, 60% over 2 steps) as 
viscous colourless oil: 1H NMR (400 MHz, CDCl3 and drop of d4-MeOH) δ 0.89 (d, 3JH-H = 
7.6 Hz, 3H, H-16), 0.92 (d, 3JH-H = 7.6 Hz, 3H, H-17), 2.08-2.17 (m, 1H, H-15), 2.52 (s, 3H, 
H-18), 3.40 (d, 3JH-H = 4.4 Hz, 1H, H-14), 6.89 (d, 3JH-H = 3.5 Hz, 1H, H-2), 7.51 (d, 3JH-H = 
3.5 Hz, 1H, H-3); 13C NMR (100 MHz, CDCl3 and drop of d4-MeOH) δ 18.8 (CH3, C-16), 
19.0 (CH3, C-17), 31.5 (CH, C-15), 33.8 (CH3, C-18), 69.9 (CH, C-14), 127.8 (CH, C-2), 
133.7 (C, C-6), 138.5 (CH, C-3), 141.0 (C, C-4), 170.9 (CO, C-1); IR (KBr) ν 3429, 3107, 
2977, 2882, 1681, 1472, 1206, 1091, 842 cm-1; MS (FAB/NOBA) m/z (%) 311/313 (M+H+, 
53/20), 245 (29), 194 (100), 75 (79); HRMS (FAB/NOBA) m/z 311.0301 (C10H1635ClN2O3S2, 
M+H+, requires 311.0285).  
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 General Method for the Aldol Reaction, using N-Sulfonamide Catalysts 
(Method M): The corresponding non-enolizable ketone was added to the catalyst 371, 372 or 
373 (0.02 mmol) in acetone (3.2 mL) and water (39 µL, 2.16 mmol). The reaction mixture 
was stirred at 10 °C overnight. The reaction mixture was diluted with ethyl acetate (40 mL) 
and washed with water (5×20 mL). The organic layer was dried (MgSO4), the solvent was 
evaporated in vacuo and the product was purified by flash chromatography on a short column 
of neutral Al2O3 (2 g of alumina, pre-treated with 1% Et3N in ether), using ethyl acetate as an 
eluent. 
  Racemic standards (for HPLC) were prepared in the same way, using 20 
mol% of aminoethanol as a catalyst.   
 
Sulfonamide catalyst regeneration: The aqueous phase from the workup above was 
acidified with one drop of concentrated hydrochloric acid and extracted with small portions 
of CH2Cl2 several times. The organic phase was washed with water and brine and dried 
(MgSO4). The solvent was evaporated in vacuo to afford the pure catalyst.  
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6 Appendix 
 
 
Contents: 
 
• 1H and 13C NMR traces of the disilane 1 
 
• 1H and 13C NMR traces of the homoallylic alcohol 4a 
 
• ORTEP diagram of the homoallylic alcohol 4e 
 
• ORTEP diagram of the aminal 12b 
 
• ORTEP diagram of  385 (Speranskatine A) 
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